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ABSTRACT

CHARACTERIZATION OF THE NANCI-NKX2.1 LOCUS:
A NOVEL ROLE FOR LNCRNAS IN BUFFERING TRANSCRIPTION FACTOR EXPRESSION
Michael Herriges
Edward E. Morrisey
Long noncoding RNAs (lncRNA) are capable of regulating gene transcription and other complex
biological processes. However, the role of lncRNAs in vivo, especially within the contexts of lung
development and homeostasis, are still poorly understood. In this work, I establish a new
paradigm where in a subset of lncRNAs act as rheostats to buffer expression of their neighboring
transcription factors (TFs) in vivo. Through analysis of the embryonic and adult lung
transcriptome, I identified lncRNAs expressed in the lung and determined that lncRNAs are
enriched near TF loci. Furthermore, lncRNAs and their neighboring TFs often share similar
expression patterns, suggesting a regulatory relationship between the two genes. To test this
hypothesis I used multiple mouse models, molecular, and proteomic techniques to further
characterize the regulatory relationship between the lncRNA NANCI and its neighboring TF
Nkx2.1, a critical regulator of pulmonary development. These experiments revealed that NANCI
acts in cis to promote Nkx2.1 expression at the transcriptional level, while Nkx2.1 directly
represses NANCI expression. In Nkx2.1 heterozygotes this negative feedback loop leads to
increased expression of NANCI, which is sufficient to normalize Nkx2.1 expression and lung
function. However, concurrent in trans mutations of NANCI and Nkx2.1 disrupt the buffering loop
between these genes causing persistent Nkx2.1 deficiency. This in turn leads to defective
pulmonary development as well as progressive degeneration and reprogramming of the adult
lung epithelium. Altogether this work provides insight into regulation of the TF Nkx2.1 and a
model for studying the in vivo function of lncRNAs associated with other critical TFs.
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CHAPTER 1: Introduction

A portion of this chapter was adapted from work published as part of a review in
Development (Herriges and Morrisey 2014).

1.1 Summary
Long noncoding RNAs (lncRNAs) are transcripts 200 nucleotides or longer that do not
encode a functional protein. While lncRNAs have been shown to regulate a wide variety
of biological processes, their function within the developing and adult lung is still unclear.
Furthermore, the importance of lncRNAs in vivo is still poorly understood and there are
few models for their role within the complex processes of development and tissue
homeostasis. This chapter will provide an overview of pulmonary development including
the role of key transcription factors. It will also summarize the current understanding of
lncRNAs and their diverse biological functions.

1.2 Introduction to the lung
Along with the cardiovascular system, the respiratory system is required for the survival
of most terrestrial animals. The primary function of the lungs is to exchange oxygen in
the external environment with carbon dioxide in the cardiovascular system. While this
process sounds straightforward, it is fraught with multiple barriers to its success. The
entire airway, like the skin, is constantly exposed to the external environment and must
cope with challenges including temperature, particulate matter, pathogens, and
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allergens. Terrestrial life has adapted to these and other challenges through the
evolution of a complex respiratory system consisting of a multitude of endodermal and
mesodermal cell lineages. These cellular components are constantly communicating
with each other to efficiently exchange gas, block blood and fluid loss, and prevent
dangerous infection from pathogens. Lung development has been studied extensively in
recent years resulting in new insights into the molecular pathways that regulate lineage
specification as well as the stereotyped structure of the lung (Cardoso and Lu 2006;
Morrisey and Hogan 2010; Rock and Hogan 2011; Morrisey et al. 2013). In particular,
transcription factors such as Nkx2.1, Foxa1/2, and Gata6 are critical for the coordination
of this process.

1.3 The basics of lung development
The lungs arise from the anterior foregut endoderm, a tissue that generates multiple
organs, including the respiratory system, esophagus, thyroid and liver (Fig. 1.1). In the
mouse, lung specification begins around embryonic day (E) 9.0 as the transcription
factor Nkx2.1 is expressed in endodermal cells on the ventral side of the anterior foregut.
By E9.5, evagination of these epithelial cells results in the formation of the trachea and
two lung buds, marking the beginning of the embryonic stage of lung development (E9.5E12.5). During the embryonic and pseudoglandular stages (E12.5-E16.5), the two lung
buds undergo a highly regulated branching process called branching morphogenesis to
generate a tree-like network of airways with thousands of terminal branches. This is
followed by the canalicular (E16.5-E17.5) and saccular [E18.5-postnatal day (P) 0]
stages, during which these terminal branches narrow and form clusters of epithelial sacs
that will later develop into alveoli in preparation for respiration at birth. Finally, full
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maturation of the alveoli occurs during the alveolarization stage (P0-P14). During all
stages of endodermal development, the surrounding lung mesoderm develops and
interacts with the lung endoderm to promote branching, differentiation, and the
generation of various lineages within the lung, including airway and vascular smooth
muscle and pericytes.

1.4 Specification of the Nkx2.1+ lung endoderm in the anterior foregut
The first evidence of respiratory system specification in the anterior foregut endoderm is
expression of the transcription factor Nkx2.1, which occurs at ~E9.0 in the mouse and 28
days gestation in the human. Studies have shown that Wnt signaling plays a crucial role
in specifying Nkx2.1+ respiratory endoderm progenitors during development. Wnt2/2b
are expressed in the ventral anterior mesoderm surrounding the region of the anterior
foregut endoderm where Nkx2.1+ respiratory endoderm progenitors are located (Goss et
al. 2009). In Wnt2/2b combined null mutants, there is a complete loss of Nkx2.1+ lung
endoderm progenitors and a failure to form the trachea or branching lung (Goss et al.
2009). This phenotype is recapitulated upon loss of β-catenin in the anterior foregut
endoderm (Goss et al. 2009; Harris-Johnson et al. 2009). Forced activation of Wnt/βcatenin signaling leads to an expansion of Nkx2.1+ progenitors in the posterior gut
including the stomach suggesting that Wnt pathway activation is not only necessary, but
also sufficient, to drive lung progenitor identity in foregut endoderm (Goss et al. 2009;
Harris-Johnson et al. 2009).
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Wnt signaling does not act alone in specifying lung fate, and the ability of Wnt/β-catenin
signaling to promote Nkx2.1+ respiratory endoderm progenitor fate is dependent upon
active Bone morphogenetic protein (Bmp) signaling. Loss of Bmp signaling in the
anterior foregut endoderm through inactivation of Bmpr1a/b leads to tracheal agenesis
with retention of the branching region of the lungs (Domyan et al. 2011). Bmp signaling
appears to act by repressing the transcription factor Sox2, which allows for expression of
Nkx2.1 in the presumptive lung endoderm (Domyan et al. 2011). Other major signaling
pathways including Fibroblast growth factor (Fgf), Retinoic Acid (RA), and Hedgehog
(Hh) signaling regulate respiratory specification upstream of Bmp/Wnt signaling;
however, it is still unclear whether any of these factors directly regulate Nkx2.1
expression (Rankin and Zorn 2014). Thus, early specification of Nkx2.1+ lung endoderm
and pulmonary development is the product of a complex regulatory network, much of
which we still do not understand. It is also unclear how much this regulation changes as
Nkx2.1 expression persists during later stages of development or in the adult lung.

1.5 Branching morphogenesis and cell fate specification
After the early budding of the main bronchi, or airways, the lung buds extend into the
surrounding mesenchyme and develop rapidly through a process called branching
morphogenesis that is crucial for generating the highly arborized airway tree. Branching
morphogenesis is essential for forming both the structural airways as well as the terminal
alveolar compartments in which gas exchange occurs. Lung branching proceeds in a
stereotypical fashion and most of the branching that takes place in early development is
genetically hard-wired (Metzger et al. 2008). Although the molecular cues for forming
new branch points are still somewhat unclear, signaling between the developing
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endoderm and mesoderm appears to be crucial for instigating new branch points in the
developing airways (Morrisey and Hogan 2010).

During branching morphogenesis, the lung endoderm begins to develop distinct cell
lineages along its proximal-distal axis. Sox2 expression marks the proximal endoderm
progenitor lineage whereas the combined expression of Sox9 and the transcriptional
regulator Id2 marks the distal endoderm progenitor lineage (Fig. 1.1). Importantly, these
two populations have distinct fates. The proximal progenitors give rise to secretory cells,
ciliated cells, neuroendocrine cells, basal cells, and mucosal cells that all contribute to
the airways (Fig. 1.2). The distal progenitors give rise to type 1 and type 2 alveolar
epithelial cells (AEC1s and AEC2s).

The proximal airway epithelium is responsible for filtering air prior to gas exchange and
is largely composed of secretory cells and ciliated cells. Secretory cells contribute to the
sterilization of air through secretion of mucins, proteases, cytokines, anti-microbial
peptides, and other molecules that entrap or degrade toxic substances (Reynolds and
Malkinson 2010). Although normally quiescent, these cells can also proliferate and
differentiate into the various airway cell lineages following injury, in order to maintain
airway function (Rawlins et al. 2009; Tata et al. 2013). Ciliated cells are multi-ciliated
cells that, through coordinated beating of cilia, contribute to the mucociliary clearance of
the epithelium’s protective mucous barrier and any entrapped substances. Unlike
secretory cells, ciliated cells do not appear to proliferate or differentiate in response to
injury (Rawlins et al. 2007). In addition to these two major cell types, the airway
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epithelium contains a smaller number of neuroendocrine cells, which function as airway
sensors capable of inducing immune responses through neuropeptide production
(Branchfield et al. 2016). In humans, the bronchiolar epithelium also contains goblet
cells, which produce mucins and other molecules found in the mucous barrier lining the
epithelium, as well as basal cells, a stem cell population capable of replacing injured
secretory and ciliated cells (Rock et al. 2010). These two cell types are similarly found in
the mouse trachea, but are rarely found in the airways of healthy mice. However, in both
mice and humans, basal and goblet cell hyperplasia occur in response to epithelial injury
or inflammation (Whitsett 2002; Kotton and Morrisey 2014).

The distal alveolar epithelium is the site of gas exchange in the lung and is composed of
AEC1s and AEC2s. AEC1s are narrow cells that cover the majority of the alveolar
surface and perform gas exchange in the lung. AEC2s produce surfactant lipids and
surfactant proteins that not only maintain alveolar surface tension, but also promote the
destruction of pathogens by alveolar macrophages (Whitsett and Alenghat 2015). Thus,
AEC2s are critical for maintaining the structure and sterility of the alveoli. Like the
proximal airways, the adult alveolar epithelium is normally quiescent; however, type II
cells will proliferate and give rise to type I cells in response to alveolar injury
(Barkauskas et al. 2013).

1.6 Transcription factors dictate lung epithelial development and cell fate
specification
A host of transcription factors have been implicated in the regulation of lung endoderm
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specification and differentiation, including members of the homeobox factor family
(Nkx2.1), the Gata transcription factor family (Gata6), and the forkhead box transcription
factor family (Foxa1/2) (Wan et al. 2004a; Wan et al. 2004b; Wan et al. 2005; Zhang et
al. 2008). Some of these, including the forkhead box (Fox) and Gata factors, are known
to act as pioneer transcription factors which can insert themselves into compacted
chromatin to initiate lineage-specific gene expression programs (Cirillo et al. 2002).
While loss of any of these genes does not completely abrogate initial lung budding, they
are required for subsequent epithelial differentiation and branching morphogenesis
critical for forming functional lungs.

Nkx2.1 is a hallmark transcription factor expressed in the lung and thyroid epithelium as
well as in the ventral forebrain (Lazzaro et al. 1991). In the developing and adult lung,
Nkx2.1 is expressed throughout the lung epithelium, with higher levels of expression
found in the distal epithelium. During branching morphogenesis, Nkx2.1 promotes
proliferation as well as the expression of genes including Bmp4, which directly regulates
branch patterning (Weaver et al. 2000). Nkx2.1 also directly promotes the expression of
genes critical to specific epithelial lineage functions including Scgb1a1 (secretory cells)
and Sftpa, Sftpb, and Sftpc (AEC2s) (Boggaram 2009). Nkx2.1 null mice (Nkx2.1-/-)
develop lung buds, but these lungs do not undergo significant growth or branching
(Minoo et al. 1995; Minoo et al. 1997). Consequently, mice die soon after birth, as they
do not develop the mature cell types necessary for respiration.
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Recent evidence demonstrates that Nkx2.1 is also critical in the adult lung. Postnatal
loss of Nkx2.1 leads to respiratory failure associated with rampant apoptosis of the lung
epithelium as well as ectopic pulmonary expression of a hindgut transcriptional program
(Snyder et al. 2013). In lung adenocarcinomas, loss of Nkx2.1 promotes progression to a
metastatic state, in part due to the loss of Nkx2.1’s pro-differentiation signal (Winslow et
al. 2011). On the other hand, increased expression of Nkx2.1 is associated with nonmetastatic lung adenocarcinomas. This is likely due to Nkx2.1’s ability to promote prosurvival pathways, leading to cell growth, as well as tight junction proteins, which inhibit
metastasis (Yamaguchi et al. 2013). Together these data suggest that Nkx2.1 lies at the
center of a transcriptional network that is critical for both the developing and adult lung.
Despite the importance of Nkx2.1 during these stages, little is known about what directly
regulates Nkx2.1 expression during these time points.

In humans, NKX2.1 haploinsufficiency is associated with the rare disorder called BrainLung-Thyroid-Syndrome (BLTS) that can culminate in respiratory failure if untreated
(Hamvas et al. 2013). Symptoms in BLTS patients include hypothyroidism along with
serious neurological and pulmonary dysfunctions. Pulmonary symptoms are highly
variable, but often include neonatal respiratory distress syndrome, which is characteristic
of under-developed lungs. Recurrent respiratory infections and reduced levels of
surfactant proteins are also common symptoms. Altogether these symptoms are
consistent with the known role of NKX2.1 in promoting epithelial maturation and the
production of surfactant proteins (Minoo et al. 1995; Boggaram 2009). Treatment for
BLTS can include supplemental oxygen, steroids, and lung transplantation (Hamvas et
al. 2013). However, since little is known about how to regulate NKX2.1 expression,
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current treatments address only the symptoms of BLTS and not the underlying NKX2.1
haploinsufficiency.

Like many transcription factors, Nkx2.1 interacts with additional transcriptional regulators
to affect gene expression. One of these is Gata6, which is a member of the Gata
transcription factor family of zinc finger proteins and is highly expressed in the
developing endoderm and vascular smooth muscle of the lung (Morrisey et al. 1996).
During development, lung epithelial specific loss of Gata6 leads to defective epithelial
differentiation and increased proliferation suggesting a developmental block at a more
primitive progenitor state, while postnatal loss of Gata6 in lung epithelium leads to
defective airway epithelial regeneration after injury (Zhang et al. 2008). Importantly, mice
that are heterozygous for both Gata6 and Nkx2.1 have defects in lung epithelial cell
differentiation (Zhang et al. 2007), further supporting a cooperative interaction between
Nkx2.1 and Gata6 in regulating lung epithelial cell differentiation.

Another family of transcription factors called Forkhead box or Fox proteins is a highly
conserved and ancient transcription factor family that contains dozens of family
members that play important roles in several aspects of lung development. In particular,
Foxa1 and Foxa2 are key regulators of endoderm identity and development. While
Foxa1 is not essential for lung development, Foxa2 is critical for late epithelial
differentiation in the lung (Wan et al. 2004a; Wan et al. 2004b; Wan et al. 2005).
Combined loss of both Foxa1 and Foxa2 leads to severe defects in lung epithelial cell
differentiation including loss of AEC2 markers Sftpc and Sftpb as well as airway
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epithelial markers for the secretory (Scgb1a1) and ciliated (Foxj1) epithelial lineages
(Wan et al. 2005). Foxa1/2 also physically interact with Nkx2.1, which is required for
Foxa1/2 to bind and activate pulmonary genes (Costa et al. 2001; Minoo et al. 2007;
Snyder et al. 2013). Postnatal loss of Nkx2.1 results in reallocation of Foxa1/2 to hindgut
genes, contributing to the ectopic expression of a hindgut transcriptional program in mice
with postnatal loss of Nkx2.1 (Snyder et al. 2013).

1.7 Long non-coding RNAs
In addition to protein-based signaling pathways, recent studies have identified small
noncoding RNAs, such as microRNAs (miRNAs), as key regulators of lung development
(Bhaskaran et al. 2009; Dong et al. 2010; Tian et al. 2011). However, it is still unclear
what role long noncoding RNAs (lncRNAs) have in lung development and homeostasis.
lncRNAs are a recently identified class of noncoding RNAs that are 200 nucleotides or
longer and regulate a wide variety of processes (Batista and Chang 2013; Ulitsky and
Bartel 2013). Like mRNA, lncRNAs are often spliced transcripts with 5’ caps and
polyadenylated 3’ ends. However, some lncRNAs are not polyadenylated and on
average lncRNAs are less stable than mRNA (Clark et al. 2012). Furthermore, lncRNAs
are spliced less efficiently than mRNAs, suggesting mRNAs and lncRNAs are processed
differently (Tilgner et al. 2012). Although there is evidence of purifying selection of
lncRNAs over the course of evolution, lncRNAs tend to have poorly conserved primary
sequences (Ponjavic et al. 2007; Hezroni et al. 2015; Iyer et al. 2015). Some lncRNAs
still perform a conserved function, likely due to small regions of conserved sequence or
regions of conserved secondary structure (Ulitsky et al. 2011).

10	
  
	
  

The majority of well-characterized lncRNAs function as scaffolds that interact with DNA
and proteins to recruit macromolecular complexes that regulate gene transcription
(Engreitz et al. 2016b) (Fig. 1.3A). These complexes often include either transcription
factors, like Sox2, or chromatin modifying complexes, such as the polycomb repressive
complex 2 (PRC2) and the trithorax complex (Zhao et al. 2008; Wang et al. 2011; Ng et
al. 2013; Yang et al. 2014). Discrete domains within the lncRNAs mediate the
interactions with these proteins; however, it is still unclear what features are necessary
for these domains to interact with their targets (Tsai et al. 2010; Smola et al. 2016). The
ability of lncRNAs to bind specific genomic loci is either directed by RNA-DNA
interactions or mediated by DNA-binding proteins (Engreitz et al. 2016b). In some cases,
physical proximity to the site of transcription also contributes to interaction specificity.
Targeting by proximity is exemplified by the lncRNA Xist, which helps recruit PRC2 to
silence the cis X chromosome (Engreitz et al. 2013). This lncRNA is normally expressed
from the inactive X chromosome of female mammals and restricted to this chromosome.
If Xist is transgenically inserted into an autosomal chromosome, this chromosome will be
specifically silenced, indicating proximity contributes to Xist targeting (Lee and Jaenisch
1997; Wutz and Jaenisch 2000). Other lncRNAs act in cis to regulate the expression of
neighboring protein-coding genes and are likely also dependent on proximity to regulate
gene expression (Pandey et al. 2008; Wang et al. 2011; Maamar et al. 2013). These
lncRNAs often share a divergent promoter region with their target protein, but other cisacting lncRNAs have their own unique promoter (Wang et al. 2011; Grote et al. 2013;
Kotzin et al. 2016; Luo et al. 2016). It is still unclear if these distinct genomic layouts are
indicative of different functions.
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In addition to regulating transcription, lncRNAs regulate a wide variety of posttranscriptional processes; however, there are fewer examples of these mechanisms
(Geisler and Coller 2013) (Fig. 1.3A). As during transcriptional regulation, these lncRNAs
often act as scaffolds to colocalize multiple components in the nucleus or cytoplasm.
Due to their single-strand structure, several lncRNAs are capable of binding
complementary mRNAs. With the assistance of interacting proteins, these lncRNAs
influence mRNA editing, translation, and turnover (Peters et al. 2003; Faghihi and
Wahlestedt 2009; Gong and Maquat 2011; Carrieri et al. 2012). In other cases, lncRNAs
can block miRNAs or mRNA splicing machinery from binding to specific mRNAs (Krystal
et al. 1990; Faghihi et al. 2010). RNA complementarity also allows for some lncRNAs to
act as miRNA sinks, binding multiple miRNAs in order to prevent them from targeting
other transcripts (Wang et al. 2010; Cesana et al. 2011). Finally, some lncRNAs, such as
Neat1, form nuclear compartments called paraspeckles, which help sequester nuclear
proteins and thus regulate their activity (Mao et al. 2011).

In the case of some lncRNAs, the act of transcription also has a function independent of
the transcript produced. This is exemplified by the lncRNA Airn, which is transcribed
anti-sense and overlapping the gene Igf2r and is required for allele-specific silencing of
the cis-linked genes Slc22a3, Slc22a2, and Igf2r in the mouse placenta (Nagano et al.
2008) (Fig. 1.3B). Airn directly interacts with the Slc22a3 promoter as well as the H3K9
histone methyltransferase G9a to promote silencing of Slc22a3. In contrast, silencing of
Igf2r is dependent on Airn expression but not G9a expression. Transcription of Airn, not
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the Airn transcript itself, prevents recruitment of RNA polymerase II to the overlapping
Igf2r promoter (Latos et al. 2012). Although Airn is the best-studied example of
regulation through transcription, other lncRNAs, such as Bendr and Blustr, are also
thought to regulate the expression of neighboring genes in a transcription-dependent
fashion (Engreitz et al. 2016a). However, it is difficult to separate the influences of
transcription and the specific sequences of the genomic locus, so further studies are
needed to clarify these mechanisms.

1.8 The in vivo function of lncRNAs
Genomic transcription studies have identified thousands of lncRNAs expressed
throughout the body. Surprisingly, lncRNAs on average have a more tissue-specific
expression pattern relative to protein coding genes, suggesting that they may be more
likely to serve tissue-specific functions (Cabili et al. 2011). While extensive research has
been performed using in vitro systems to identify the mechanisms and regulatory
functions of lncRNAs, the significance of many of these lncRNAs in vivo has yet to be
examined (Feyder and Goff 2016). In some cases, lncRNAs with profound functions in
vitro have been shown to have little or unexpected functions in vivo, further emphasizing
the need for detailed in vivo functional analysis (Eissmann et al. 2012; Zhang et al. 2012;
Amandio et al. 2016). To investigate lncRNAs in vivo, researchers have used both RNAtargeted (RNAi, steric interference) and DNA-targeted (CRISPR) strategies (Feyder and
Goff 2016). As many lncRNAs overlap putative promoters or enhancers of neighboring
genes, multiple models are often necessary to clearly demonstrate the importance of the
lncRNA itself as opposed to the overlapping genomic locus. Those lncRNAs that do
have clear in vivo functions regulate a wide variety of biological processes including X
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inactivation (Penny et al. 1996), myeloid cell homeostasis (Kotzin et al. 2016),
adipogenesis (Wei et al. 2016), retinal patterning (Young et al. 2005; Rapicavoli et al.
2010; Rapicavoli et al. 2011; Meola et al. 2012), and limb development (Wang et al.
2011). Unfortunately, there are no known motifs or structures common among these
lncRNAs, making it difficult to predict which other lncRNAs are critical in vivo.

Hundreds of lncRNAs are expressed in the lung, including lncRNAs that regulate
developmental processes such as differentiation and proliferation in other tissues
(Askarian-Amiri et al. 2011; Cabili et al. 2011; Kretz et al. 2012). However, the role of
these lncRNAs in lung development and homeostasis is still unclear. The lncRNA Malat1
is highly expressed in the developing lung as well as other tissues and has been shown
to have both pro-proliferative and pro-metastatic functions (Gutschner et al. 2013).
However, Malat1-/- mice develop normally with no signs of respiratory distress (Eissmann
et al. 2012; Zhang et al. 2012). In contrast, the pulmonary lncRNA Fendrr, which is
upstream and antisense to the transcription factor Foxf1, is necessary for life in mice
(Sauvageau et al. 2013). Deletion of Fendrr in mice results in perinatal lethality due to
incomplete development of the lung mesenchyme, which normally expresses both
Fendrr and Foxf1. Although these same phenotypes occur in Foxf1 heterozygotes it is
still unclear whether Fendrr regulates Foxf1 expression (Mahlapuu et al. 2001;
Sauvageau et al. 2013). In humans, deletion of a genomic locus upstream of Foxf1,
which contains lncRNAs, is associated with lung developmental disorders normally
associated with Foxf1 mutations (Szafranski et al. 2013). Likewise, deletion of a region
downstream of Nkx2.1 containing a lncRNA is associated with phenotypes normally
seen in patients with Nkx2.1 haploinsufficiency (Barnett et al. 2012). This suggests that
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these lncRNAs may regulate their neighboring transcription factors during lung
development and that they may be part of a larger group of lncRNAs influencing lung
development as a whole.

1.9 Conclusion
As I have reviewed in this chapter, pulmonary development and cell fate specification
are complex processes regulated by transcription factors including Nkx2.1, Gata6, and
Foxa1/2. However, the role of lncRNAs within the developing and adult lung is largely
unknown. In this dissertation I identify lncRNAs expressed in the embryonic and adult
mouse lung, including a subset that are associated with transcription factors necessary
for pulmonary development. I then provide a more detailed analysis of the novel lncRNA
NANCI (Nkx2.1 Associated NonCoding Intergenic RNA), which is found downstream of
Nkx2.1. In particular, I will characterize a negative feedback loop between NANCI and
Nkx2.1 that is critical for maintaining Nkx2.1 expression and lung epithelial cell identity.
This work not only establishes a new regulator of Nkx2.1, but also provides a paradigm
for the in vivo function of other transcription factor-associated lncRNAs.
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Figure 1.1. Overview of the stages of lung development.

Figure 1.1. Overview of the stages of lung development. Lung endoderm
specification begins at ~E9.0 on the ventral side of the anterior foregut endoderm
(yellow) where initiation of Nkx2.1 expression commences. By E9.5-E10.0, the formation
of the trachea is observed and the embryonic stage of lung development begins and
ends at E12.5. The other stages of lung development and the time period in which they
occur are displayed. A, anterior; D, dorsal; L, left; P, posterior; R, right; V, ventral.
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Figure 1.2. Progenitors and cell lineages within the developing lung.

Figure 1.2. Progenitors and cell lineages within the developing lung. The Nkx2.1positive endoderm gives rise to both Sox2+ proximal progenitors and Sox9+/Id2+ distal
progenitors, which in turn give rise to distinct sets of differentiated cells. The proximal
progenitors give rise to neuroendocrine (NE) cells, basal cells, secretory cells, ciliated
cells and mucosal cells that all populate the conducting airways. By contrast, the distal
progenitors give rise to type I and type 2 alveolar epithelial cells (AEC1 and AEC2) that
populate the alveoli. Markers expressed in each cell type are indicated in parentheses.
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Fig. 1.3. Models of lncRNA mechanisms

18	
  
	
  

Fig. 1.3. Models of lncRNA mechanisms (A) Models of the regulatory mechanisms
used by different lncRNAs. (B) In addition to the lncRNA product, the act of transcription
can regulate the expression of overlapping genes, as exemplified by Airn. Transcription
of Airn, blocks transcription of the overlapping Igf2r gene and the Airn product goes on to
promote in cis silencing of Slc22a3.
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Chapter 2: Long non-coding RNAs are spatially correlated with
transcription factors and regulate lung development

The data presented in this chapter was previously published in Genes and Development
(Herriges et al. 2014). Dan Swarr performed experiments analyzing lncRNAs LL12,
LL34, and LL35 as well as Ezh2 and Wdr5 pulldowns. Michael P. Morley and Komal S.
Rathi performed bioinformatic analysis. MinMin Lu and Su Zhou performed tissue
sectioning and histological staining. Kate Stewart collected RNA used for RNA-seq.

2.1 Summary
Long non-coding RNAs (lncRNAs) are thought to play important roles in regulating gene
transcription, but few have well defined expression patterns or known biological
functions during mammalian development. Using a conservative pipeline to identify
lncRNAs that have important biological functions, I have identified 363 lncRNAs in the
lung and foregut endoderm. Importantly, I show that these lncRNAs are spatially
correlated with transcription factors across the genome. In-depth expression analyses of
lncRNAs with genomic loci adjacent to the critical transcription factors Nkx2.1, Gata6,
Foxa2, and Foxf1 mimic the expression patterns of their protein-coding neighbor. Loss of
function analysis demonstrates that two lncRNAs, LL18/NANCI and LL34, play distinct
roles in endoderm development by controlling expression of critical developmental
transcription factors and pathways, including retinoic acid signaling. In particular, I show
that LL18/NANCI acts upstream of Nkx2.1 and downstream of Wnt signaling to regulate
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lung endoderm gene expression. These studies reveal that lncRNAs play an important
role in foregut and lung endoderm development by regulating multiple aspects of gene
transcription, often through regulation of transcription factor expression.

2.2 Introduction
The advent of large scale sequencing efforts has resulted in the identification of
thousands of small (<200 nucleotides) and large (>200 nucleotides) non-coding RNAs
that potentially play critical roles in regulating gene expression. Small non-coding RNAs
such as microRNAs, piwi RNAS, and snoRNAs have been shown to be important
players in regulating gene expression in many contexts including tissue development
(Dieci et al. 2009; Wapinski and Chang 2011; Luteijn and Ketting 2013; Yates et al.
2013). In comparison, long non-coding RNAs (lncRNAs) are less conserved and their
function is less well understood. LncRNAs can be transcribed from a unique
transcriptional locus or they can be transcribed from a locus overlapping a proteincoding gene (PCG), in either the sense or antisense direction. Moreover, while many
reported lncRNAs are polyadenylated similar to mRNA, other lncRNAs are not and on
average lncRNAs are less stable than mRNA (Clark et al. 2012). LncRNAs are also
spliced less efficiently than mRNA, further suggesting mRNAs and lncRNAs are
processed differently (Tilgner et al. 2012). LncRNAs often act as scaffolds that help
localize chromatin-modifying complexes important for activating or repressing gene
transcription in cis or in trans (Zhao et al. 2008; Khalil et al. 2009; Wang et al. 2011;
Ulitsky and Bartel 2013).
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The development of the respiratory system is a highly complex process involving the
interaction of foregut-derived Nkx2.1+ endoderm with surrounding cardiopulmonary
mesoderm (Goss et al. 2009; Peng et al. 2013). Nkx2.1 not only marks the early lung
endoderm progenitors within the foregut endoderm, it also plays an essential role in the
morphological development of the airway structure and differentiation of the various
epithelial lineages within the lung (Minoo et al. 1995; Minoo et al. 1997). Other critical
transcription factors such as Gata6 and Foxa1/2 also play key roles in promoting foregut
and respiratory endoderm morphogenesis and differentiation (Yang et al. 2002; Wan et
al. 2004a; Wan et al. 2004b; Wan et al. 2005; Zhang et al. 2008). However, how these
factors themselves are regulated during foregut and lung development, either at the level
of expression or function, remains poorly understood. While small RNAs such as
miRNAs have been shown to play an important role in development of the respiratory
system (Lu et al. 2007; Ventura et al. 2008; Tian et al. 2011), little is known about the
role of lncRNAs in this process. Several lncRNAs are expressed in the lung including
MALAT1, which has been shown to play an important role in lung cancer progression
(Schmidt et al. 2011; Xu et al. 2011; Lai et al. 2012). Although loss of MALAT1 does not
effect lung development (Zhang et al. 2012), chromosomal deletions encompassing
other lncRNAs can cause lethal lung development disorders, suggesting these lncRNAs
may regulate lung development (Stankiewicz et al. 2009; Barnett et al. 2012; Parris et al.
2013; Szafranski et al. 2013). Loss of the lncRNA Fendrr has also been shown to result
in respiratory defects and perinatal lethality (Sauvageau et al. 2013). However, there is
little data on the specific expression patterns or function of lncRNAs in most tissues
including foregut endoderm and the lung.
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In this study, I used RNAseq combined with other methods to identify lncRNAs in the
developing and adult lung. Our conservative pipeline provides a systematic and
comprehensive bridge from transcriptome-wide analysis of lung lncRNAs to the
interrogation of individual lncRNA biological function. I show that a subset of lncRNAs in
the lung are located near transcription factors, including Nkx2.1, Gata6, Foxa2, and
Foxf1, that play important roles in foregut and lung development. In addition to this
subset, I identified several known and novel intergenic lncRNAs that are not associated
with PCGs and many of these have unique expression patterns suggesting an important
functional role in lung development and homeostasis. I assessed biological function for
two lung lncRNAs and show that they exhibit distinct and important roles in regulating
endoderm gene expression including developmental, signaling, and metabolic pathways.
Importantly, I show that one of these lncRNAs, LL18, plays an important role in lung
development by acting upstream of the critical transcription factor Nkx2.1 and
downstream of Wnt/b-catenin signaling to regulate lung endoderm gene expression and
morphogenesis.

2.3 Identification of lncRNAs in the developing and postnatal lung
To identify and begin to characterize the lncRNA transcriptome in the lung, I performed
RNAseq on E12.5 and adult mouse lung polyadenylated RNA. Pair-end reads were
aligned to the mouse reference NCBI 37 release using GSNAP (Wu and Nacu 2010).
Cufflinks was used to assemble 141,614 unique transcripts from E12.5 and adult lung
RNAseq. The assembled transcripts were compared and annotated using Cuffmerge
against the Ensembl (ver 67) gene annotations. Transcripts that mapped to known
lncRNAs were retained and transcripts mapping to all other known genes were removed.
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Transcripts defined by Cuffmerge as unknown, that were also mulit-exonic and longer
than 200 nucleotides were considered putative lncRNAs. These putative lncRNAs were
then filtered for potential coding ability using phylogenetic codon substitution frequency
(PhyloCSF) and by scanning all potential open reading frames per transcript against the
protein domains in Pfam. Moreover, I only included lncRNAs that did not overlap
extensively with exons of coding genes and were not located entirely within the intron of
a coding gene. These analyses resulted in the identification of 363 lncRNAs, 200 of
which were previously annotated and 163 of which are novel (Fig. 2.1A). Using DNAse
hypersensitivity sites 5’ of each lncRNA locus as a guide (Rosenbloom et al. 2013), I
found that DNA binding motifs for forkhead box (Fox), SP1/Krox, and serum response
factors (SRF) factors were enriched in lung lncRNA regulatory regions (Fig. 2.1B). The
high enrichment of Fox binding motifs upstream of lung lncRNA loci suggests regulation
by forkhead transcription factors, which are known to regulate foregut development as
well as lung endoderm and mesoderm development (Wan et al. 2004b; Shu et al. 2007;
Zhou et al. 2008; Chokas et al. 2010; Yu et al. 2010; Li et al. 2012; Parris et al. 2013).

While nucleotide conservation of lung lncRNAs across placental mammals was low
(29%) as has been reported previously for lncRNAs in general (Fig. 2.2) (Derrien et al.
2012), many of these lncRNAs have syntenic transcripts in the human genome
indicating that they are conserved based on genomic location rather than nucleotide
sequence (Fig. 2.1C). Our data also show that previously annotated lncRNAs that I
uncovered in our analysis are more likely to have syntenic human transcripts (Fig. 2.1C).
Lung lncRNAs located near PCGs are more syntenic than lncRNAs located in gene
deserts (Fig. 2.1D). Furthermore, lung lncRNAs located near transcription factor loci
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more often have syntenic human transcripts than lncRNAs found near non-transcription
factor PCGs (Fig. 2.1E). This syntenic conservation of lncRNAs near transcription factor
loci suggests a potential spatial relationship between these two gene subsets.

To further assess the potential spatial correlation between lncRNAs and transcription
factor loci, I measured the genomic distance between lncRNAs and transcription factor
loci. Using our mouse lung lncRNA dataset, I found that the lung lncRNAs in our
database were more likely to be genomically located near transcription factors than other
nontranscription factor PCGs (Fig. 2.3A). This enrichment was observed with all
lncRNAs annotated in both the mouse and human genomes and increases as the
distance from the lncRNA decreases (Fig. 2.3A). Together these observations support a
conserved spatial correlation between lncRNA loci and transcription factor loci.

To validate this spatial correlation between lncRNAs and transcription factors, I utilized a
recently published methodology that allows a direct comparison between different
classes of PCGs and their spatial relationship with genomic loci (Fig. 2.3B) (Favorov et
al. 2012). This method also indicates a statistically positive spatial correlation between
lncRNA and transcription factors in our lung dataset as well as those annotated in the
Ensembl database (Fig. 2.3B-E). Importantly, lncRNAs were spatially correlated with
transcription factors more so than other classes of PCGs such as signaling proteins and
structural proteins. While other classes of PCGs may also be positionally correlated with
lncRNAs, our data suggests that transcription factors are particularly enriched near
lncRNAs.
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2.4 Characterization of the genomic organization of a subset of lung lncRNAs
From the initial RNAseq based screen of the lung transcriptome, I chose seven lung
lncRNAs (LL) for in-depth characterization. Due to the ability of some lncRNAs to
regulate the expression of neighboring PCGs (Orom et al. 2010b; Wang et al. 2011;
Berghoff et al. 2013), four lung lncRNAs (LL18, LL33, LL35, and LL66) were selected
based on the close genomic proximity to transcription factors known to play a critical role
in lung development. LL18, which I have named NANCI, for Nkx2.1 Associated NonCoding Intergenic RNA, is 2.5 kb downstream of Nkx2.1, a transcription factor that is a
global regulator of anterior foregut and lung development and the earliest known marker
of lung endoderm progenitor fate (Fig. 2.4A) (Kimura et al. 1996). LL35 is 2.5kb
downstream of Foxa2, a forkhead transcription factor that is essential for endoderm and
lung development (Fig. 2.4B) (Wan et al. 2004a; Wan et al. 2005). Both NANCI and
LL35 are transcribed in the sense orientation relative to their protein-coding neighbors.
PCR using multiple primers pairs, 5’ RACE, and the presence of unique Pol2 and
H3K4me3 marks indicates that NANCI and LL35 transcripts are driven from unique loci
that are not linked to their PCGs (Fig. 2.4A,B and data not shown). In contrast, LL33 and
LL66 are transcribed in an antisense orientation to their protein-coding neighbors. LL33
has multiple start sites that are upstream of or overlapping with the first exon of Gata6,
an important endoderm transcription factor that is essential for lung epithelial
differentiation and regeneration (Fig. 2.5) (Yang et al. 2002; Zhang et al. 2008). LL66 is
located 1.4 kb upstream of Foxf1, a forkhead transcription factor that plays an important
role in the development of the pulmonary mesenchyme and vasculature and has been
implicated in the pathogenesis of the lethal disorder alveolar capillary dysplasia (Fig.
26	
  
	
  

2.4C) (Stankiewicz et al. 2009). LL66, also known as Fendrr, was recently shown to be
important in lateral plate mesoderm development, similar to its neighboring PCG Foxf1
(Grote et al. 2013; Sauvageau et al. 2013). Q-PCR analysis confirms the differences in
E12.5 and adult mouse lung expression observed in the RNAseq analysis for NANCI
and LL35 (Fig. 2.6A-D). However, RNAseq revealed increased expression of LL66 in the
adult lung relative to the E12.5 lung whereas Q-PCR showed little change (Fig. 2.6E,F).

Three other lncRNAs (LL1, LL12, LL34), which are all located in relative gene deserts,
were selected due to their high level of expression in the E12.5 lung relative to the adult
lung. LL1 and LL12 are previously identified lncRNAs and are known snoRNA host
genes (Fig. 2.4D, E) (Nakamura et al. 2008; Kretz et al. 2012) Tanaka et al., 2000). LL1
is the mouse orthologue of the human lncRNA anti-differentiation non-coding RNA
(ANCR), which is up-regulated in multiple types of cancer and inhibits osteoblast and
keratinocyte differentiation (Kretz et al. 2012; Du et al. 2013; Zhu and Xu 2013). LL12 is
annotated as SnoRNA host-gene 5 (Snhg5) in both the mouse and human genome and
has been implicated in translocation induced B-cell lymphoma and recurrent prostate
cancer (Du et al., 2013; Tanaka et al., 2000). In contrast, LL34 is a novel lncRNA, which
is expressed in the E12.5 lung but is nearly undetectable in the adult lung (Fig. 2.4F). QPCR analysis confirms that expression of all three of these lncRNAs is dramatically
down-regulated in the adult lung compared to the E12.5 lung (Fig. 2.6G,H). I also
confirmed that these lncRNAs do not encode for a detectable protein using in vitro
transcription/translation assays (Fig. 2.7).
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2.5 LncRNAs associated with transcription factors exhibit spatial and temporal
patterns of expression highly similar to their protein-coding neighbors
While the genome wide expression of some lncRNAs has been reported, little data is
available on the spatial and temporal pattern of lncRNA expression during tissue
development. Therefore, I performed extensive in situ hybridization (ISH) and Q-PCR
analysis at different times of lung development and in different tissues to characterize
our subset of lung lncRNAs. NANCI expression is observed in the developing lung,
thyroid, and ventral forebrain in a pattern nearly identical to Nkx2.1 (Fig. 2.8A and Fig.
2.9A-D). Within the developing lung, both genes are expressed throughout the
developing epithelium with lower levels found in the large airway epithelium (Fig. 2.8A).
Expression of NANCI persists in the adult with notable expression observed in large
airway epithelium (Fig. 2.8A). The human orthologue of NANCI, which is annotated as
surfactant associated transcript A3 (SFTA3), is also a lncRNA and is expressed in a
similar pattern as human NKX2.1 in both airway and alveolar epithelium (Fig. 2.10). This
conserved expression pattern may be explained by conserved binding motifs for known
regulators of foregut and lung development (Smad, Forkhead, and Gata) found in the
NANCI promoter locus (Fig 2.11). Despite low sequence conservation between mouse
and human NANCI (26%), their identical expression patterns suggest that there may be
an evolutionarily conserved function. LL35 exhibits strong expression in the lung
epithelium, floor plate, gut endoderm, and liver in a pattern similar to that of Foxa2 (Fig.
2.8B and Fig. 2.9E-H). LL66 is expressed primarily the mesenchyme of the developing
lung and posterior gut, similar to Foxf1 (Fig. 2.9C and Fig. 2.9I-L). These expression
patterns were confirmed using Q-PCR using E12.5 and adult lung cDNA (Fig. 2.9M-N).
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The expression of LL33 is more restricted than Gata6 itself. Within the developing lung,
Gata6 is robustly expressed in the developing epithelium and vascular smooth muscle
(VSM), while LL33 expression can be detected in the VSM but is expressed at low levels
in the developing epithelium (Fig. 2.5B). Outside of the lung, LL33 expression is
observed primarily in the heart (Fig. 2.5D-H). During early heart development, LL33 was
detectable in the atrio-ventricular canal region and in the developing heart valves (Fig.
2.5D-F). In contrast, Gata6 is expressed throughout most of the heart, including the
myocardium (Fig. 2.5I-K) (Morrisey et al. 1996). By E16.5, LL33 expression expands into
the myocardium such that by E18.5 its expression is similar to that of Gata6 in the heart
(Fig. 2.5 G,H,L,M).

2.6 Expression patterns of lung lncRNAs located in gene deserts
We next looked at expression patterns of those lung lncRNAs not associated with a
transcription factor or PCG. At E12.5 and E14.5, LL1/ANCR is expressed in the distal
airway epithelium and at lower levels in the lung mesenchyme (Fig. 2.12A, arrows and
Fig. 2.9 O). Expression in proximal airway epithelium is not observed (Fig. 2.12A,
arrowheads). During development, LL1 expression diminishes until it is no longer
detectable in the adult lung by ISH. Of note, the developing epidermis expresses high
levels of LL1 as has been reported for human ANCR, suggesting that it may play a
similar role in regulating differentiation of mouse keratinocyte progenitors (Fig. 2.9P)
(Kretz et al. 2012). LL12 expression is observed in the embryonic lung epithelium and
persists at low levels in the adult lung (Fig. 2.12B and Fig. 2.9Q). LL12 is also expressed
robustly in the embryonic liver where expression remains high in the adult (Fig. 2.9Q,R).
LL34 is expressed in the developing lung endoderm at E12.5 and E14.5 and its
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expression is rapidly down-regulated such that it is not observed in the adult lung (Fig.
2.12C). Expression of LL34 is absent in tissues other than the lung at E12.5 by Q-PCR
(Fig. 2.9S). At E10.5, LL34 expression is observed throughout the anterior to posterior
axis of the gut endoderm (Fig. 2.9T-W). In the adult, LL34 expression is only detectable
at low levels in the intestine by Q-PCR (Fig. 2.9S).

2.7 Loss of function for select lung lncRNAs reveals important roles in endoderm
development
To define the function of a select subset of lncRNAs in lung epithelial cells, I performed
shRNA-mediated knockdown of NANCI and LL34 in the mouse lung epithelial cell line
MLE12. These lncRNAs represent different the two major categories of transcripts
identified by our analysis including those located near transcription factor loci (NANCI)
and novel lncRNAs expressed in the developing but not adult lung (LL34). Of note, both
lncRNAs are expressed in MLE12 cells and the selected shRNAs exhibited between 8095% knockdown efficiency upon optimization of viral transduction (Fig. 2.13 and data not
shown). Changes in the transcriptome of MLE12 cells upon loss of lncRNA expression
were assessed using microarray assays, which demonstrated that each lncRNA
regulated unique cellular pathways in lung epithelial cells. Loss of NANCI expression
resulted in a significant change in lung epithelial gene expression with more than 1000
genes, up or down-regulated compared to scrambled shRNA expression (Fig. 2.14A,B).
Less dramatic effects were observed with knockdown of LL34, although loss of this
lncRNA resulted in the altered expression of several hundred genes (Fig. 2.14A,B).
Interestingly, there was little overlap between the genes altered by NANCI knockdown in
comparison to LL34 (Fig. 2.14A,B).
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A large number of lung epithelial development genes were down-regulated by loss of
NANCI expression such that respiratory and lung development were top categories of
gene expression changes upon NANCI knockdown (Fig. 2.14C,D and GSE52389).
Importantly, Nkx2.1 was down-regulated along with many targets of Nkx2.1 such as
Sftpc, Abca3, and Aqp5 (Fig. 2.14E). Foxp1, Foxp2, Sox9, and other genes not known to
be directly regulated by Nkx2.1 were also down regulated after loss of NANCI
expression by both microarray and Q-PCR analysis (Fig. 2.14F and GSE52389).
Knockdown of NANCI in the human lung adenocarcinoma cell line H441 likewise
resulted in decreased expression of NKX2.1 and AQP5 (Fig. 2.15). These data suggest
that in both mice and humans NANCI regulates expression of the essential lung
transcription factor Nkx2.1 and, in turn, Nkx2.1 target genes.

LL34 was found to be essential for the expression of several critical lung developmental
genes including Bmp2, Foxa1, Gata6, Fgfr2, Fgfr3, Fgf18, Jag1, and Tgfb3 as noted by
microarray and Q-PCR analysis (Fig. 2.14G,K and GSE52389). Tube development was
one of the top categories of genes altered by knockdown of LL34 (Fig. 2.14H).
Interestingly, loss of LL34 resulted in decreased expression of several important
components of the retinoic acid (RA) pathway including Aldh1a1 and Rarg (Fig. 2.14K
and GSE52389). Decreased expression of these genes as well as other components of
the RA pathway including Aldh1a2, Aldh1a3, and Cyp2b1 was confirmed by Q-PCR (Fig.
2.14I). Many of the developmental regulators whose expression was decreased upon
loss of LL34 are known targets of RA signaling (Fig. 2.14J). Of the 403 known RA
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targets expressed in MLE12 cells, 58 demonstrated altered levels of expression
following knockdown of LL34 (Balmer and Blomhoff 2002) (GSE52389). These data,
along with the restricted expression of LL34 in early foregut endoderm, suggest that
LL34 may modulate RA signaling in the early foregut and lung endoderm.

2.8 NANCI acts upstream of Nkx2.1 and downstream of Wnt signaling to regulate
lung epithelial gene expression
The loss of function data for NANCI indicates its importance for Nkx2.1 expression and
function during lung endoderm development. Given the central role that Nkx2.1 plays in
anterior foregut and lung endoderm development, I chose to further explore the role of
NANCI and determine how its regulation of Nkx2.1 effects lung epithelial differentiation.
To determine how much of NANCI’s effects on gene expression are mediated in part or
in full by Nkx2.1, I attempted to rescue the knockdown of NANCI and, in turn, loss of
Nkx2.1 expression with ectopic overexpression of Nkx2.1. These experiments showed
that increased Nkx2.1 expression rescued the expression of its target genes Abca3,
Sftpc, and Aqp5 as well as partial rescue of Aqp1 expression (Fig. 2.16B,C). Moreover,
ectopic expression of Nkx2.1 lead to increased endogenous Nkx2.1 expression (Fig.
2.16A). Such auto-regulation of Nkx2.1 has been previously suggested by the finding of
conserved Nkx2.1 binding sites in its promoter (Shaw-White et al. 1999; Das et al.
2011). Interestingly, expression of NANCI itself was unaffected by overexpression of
Nkx2.1 suggesting that Nkx2.1 does not regulate NANCI expression (Fig. 2.16A), further
demonstrating distinct differences in regulation of these two loci. Overexpression of
Nkx2.1 did not rescue expression of Nrp1, Nrp2, Cdh1, Foxp1, and Foxp2 suggesting
that NANCI acts independently of Nkx2.1 to regulate the expression of these important
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developmental regulators (Fig. 2.17). I next assessed whether NANCI could promote
Nkx2.1 expression using overexpression of the full-length NANCI transcript in MLE12
cells. Overexpression of NANCI led to increased Nkx2.1 expression suggesting that
NANCI is capable of promoting Nkx2.1 expression in lung epithelium (Fig. 14D).

Previous data has demonstrated that Wnt signaling is an essential inducer of Nkx2.1+
lung endoderm progenitors during anterior foregut development and in in vitro
differentiation of pluripotent stem cells into lung epithelium (Goss et al. 2009; HarrisJohnson et al. 2009; Longmire et al. 2012; Mou et al. 2012). Our data showing that
ectopic Nkx2.1 expression in the context of loss of NANCI expression results in
restoration of the expression of several Nkx2.1 target genes as well as the ability of
ectopic NANCI to increase Nkx2.1 expression, suggests that NANCI acts upstream of
Nkx2.1 to regulate lung epithelial gene expression. To further explore how NANCI acts in
the hierarchy of lung epithelial gene transcription, I assessed NANCI expression in in
vivo models of loss of Nkx2.1 and Wnt signaling in the early lung endoderm. Nkx2.1-/lungs are dysplastic and exhibit decreased expression of several known target genes
including Sftpc, Scgb1a1, and Aqp5 (Minoo et al. 1999). While the Nkx2.1 transcript was
absent in Nkx2.1-/- lung epithelium as expected, NANCI expression was readily observed
and maintained a proximal to distal expression gradient as it did in normal embryonic
lungs (Fig. 2.16E-H). In contrast, loss of Wnt/ β-catenin in the anterior foregut endoderm
of Shhcre:Ctnnb1flox/flox mutants, results in a loss of both Nkx2.1 and NANCI expression
(Fig. 2.16I-L). Together, these data imply a model in which NANCI acts upstream of
Nkx2.1 and downstream from Wnt/β-catenin signaling to regulate a suite of critical lung
developmental genes (Fig. 2.16M).
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Consistent with the observation that NANCI promotes Nkx2.1 expression, NANCI
interacts strongly with Wdr5/trithorax transcriptional activating complex but not
Ezh2/polycomb repressive complex similar to other activating lncRNAs (Figure 2.18)
(Zhao et al. 2008; Khalil et al. 2009; Wang et al. 2011; Ulitsky and Bartel 2013). In
contrast, LL12 interacts strongly with Ezh2/polycomb as has been previously shown
(Zhao et al. 2010). Moreover, loss of NANCI reduces H3K4me3 marks imposed by the
trithorax complex at the Nkx2.1 locus (Fig. 2.16N,O). Together, these data imply a model
where NANCI acts upstream of Nkx2.1 and downstream of Wnt/β-catenin signaling to
regulate a suite of critical lung developmental genes (Fig. 2.14M). Moreover, these data
suggest that NANCI recruits the trithorax complex to activate Nkx2.1 expression, making
it one of the earliest markers for lung endoderm specification (Fig. 2.14P).

2.9 Knockdown of NANCI in the developing mouse lung results in disruption of
epithelial differentiation and loss of Nkx2.1 target gene expression
Many lncRNAs, especially ones located close to PCGs, are transcribed from genomic
regions that overlap potential enhancer elements (Orom et al. 2010a). Therefore, to
further characterize the role of the NANCI non-coding transcript in lung epithelial
development without affecting the NANCI genomic locus, I performed in vivo knockdown
of NANCI using the human SFTPC promoter, which is active throughout the developing
lung epithelium. I utilized the previously demonstrated ability of shRNAs to be processed
from miRNA precursor transcripts to generate a SFTPC driven knockdown construct
(Fig. 2.19A) (Wang et al. 2007). Five F0 SFTPC-NANCIshRNA transgenic mice were
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generated with an average NANCI knockdown of 43% at E17.5 (Fig. 2.20A). SFTPCNANCIshRNA transgenic lungs had reduced saccule formation as noted by H&E staining
and increased mesenchymal thickness between airways (Fig. 2.19B,D). Many of the
genes down-regulated after NANCI knockdown in MLE12 cells were similarly affected in
SFTPC-NANCIshRNA transgenic lungs including Nkx2.1 and its targets such as Sftpc,
Abca3, and Aqp5 (Fig. 2.20A). Likewise, Scgb1a1, an Nkx2.1 target gene not expressed
in MLE12 cells, was downregulated in SFTPC-NANCIshRNA transgenic lungs (Fig. 2.20A).
Decreased expression of both Aqp1 and Cdh1 were also observed similar to the NANCI
knockdown in MLE12 cells (Fig. 2.20B). However, levels for Sox2, Sox9, and Id2 were
unchanged suggesting that in these experiments lung endoderm progenitors were not
drastically perturbed (Fig. 2.20B). Immunostaining for Cdh1 shows that the distal airway
epithelium of SFTPC-NANCIshRNA transgenic lungs retained a columnar morphology as
compared to control littermates, indicating defects in distal sacculation/alveolarization
(Fig. 2.20E). Immunostaining also confirms the reduction in Scgb1a1 expression in the
proximal airways in SFTPC-NANCIshRNA transgenic lungs, consistent with defects in
differentiation of the secretory epithelial lineage (Fig. 2.19G). Sftpc+ alveolar epithelial
type 2 cells were more focally located in SFTPC-NANCIshRNA transgenic lungs rather
than dispersed as observed in transgene negative littermates (Fig. 2.19G).

To determine whether the in vivo knockdown of NANCI mimicked decreased Nkx2.1
expression, Nkx2.1+/- lungs were examined at E17.5. Nkx2.1+/- lungs had an ~40%
decrease in Nkx2.1 expression (Fig. 2.20C). As in SFTPC-NANCIshRNA transgenic lungs,
the Nkx2.1+/- mutant lungs had reduced saccule formation and increased mesenchymal
thickness, as noted by H&E staining (Fig. 2.19C,D). These mutants also had similar
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reductions in Sftpc, Abca3, Aqp5, Scgb1a1, and Aqp1, as noted in SFTPC-NANCIshRNA
transgenic lungs (Fig. 2.20C,D). The number of Sftpc+ distal saccules was also
decreased in a manner similar to the SFTPC-NANCIshRNA transgenic lungs (Fig. 2.19H).
However, the level of Cdh1 expression was not affected in Nkx2.1+/- lungs (Fig. 2.20D).
In contrast, while there were changes in the morphology of the distal airway epithelium
of Nkx2.1+/- lungs as noted by Cdh1 immunohistochemistry, these changes were not as
dramatic as noted in SFTPC-NANCIshRNA transgenic lungs (Fig. 2.20F). Together, these
data suggest that NANCI regulates lung epithelial development in vivo in large part
through its regulation of the critical transcription factor Nkx2.1.
2.10 Discussion
While different methodologies have resulted in the cataloging of thousands of lncRNAs,
it has remained difficult to assess which portion of these transcripts play a functional role
in the cells and tissues where they are expressed. Using conservative criteria to focus
on lncRNAs that may play a functional role in lung development, I identified 363
lncRNAs and show that they are spatially correlated with transcription factors important
for development of the anterior foregut and lung. Importantly, I have identified and
characterized NANCI, a lncRNA located near the important lung endoderm regulator
Nkx2.1 and have shown that NANCI acts upstream of Nkx2.1 and downstream of Wnt/βcatenin to regulate lung epithelial gene expression. In contrast, LL34 regulates RA
signaling, which is critical for foregut endoderm development. Taken together, our data
provide a novel catalogue of lncRNAs in the foregut and lung and show that several of
these play unique and essential roles in foregut and lung epithelial gene expression and
development.
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Our data show that lncRNA loci are spatially correlated with transcription factor loci.
These transcription factor associated lncRNAs are more conserved at the syntenic level
with the human genome than other lncRNAs. Moreover, in several cases they have
expression patterns remarkably similar to their neighboring transcription factors,
suggesting that these lncRNAs are closely associated with the expression and function
of their neighboring transcription factors. I identified NANCI as a critically important
lncRNA located near the lineage regulator Nkx2.1. NANCI’s expression is identical to
Nkx2.1, which correlates with its functional necessity for normal Nkx2.1 expression. The
correlation between NKX2.1 and NANCI is also found in the human lung even though
NANCI is poorly conserved at the nucleotide level. Surprisingly, NANCI expression
persists in the absence of Nkx2.1 expression indicating that Nkx2.1 is not required for
NANCI expression. This is supported by the lack of conserved Nkx2.1 DNA binding
motifs within the NANCI promoter (Fig. 2.11).

This finding was unexpected as the

Nkx2.1 expression pattern is unique and was previously recognized as the earliest
marker of anterior foregut endoderm committed to the lung and thyroid fate (Longmire et
al. 2012; Mou et al. 2012). Our data showing that NANCI acts upstream of Nkx2.1
suggests that NANCI is an earlier marker than Nkx2.1 of anterior foregut lung fate. Our
data shows that both NANCI and Nkx2.1 expression are lost upon inactivation of Wnt/βcatenin signaling in the anterior foregut endoderm, placing NANCI downstream of this
pathway in lung endoderm development. Interestingly, a patient was recently identified
with a chromosomal deletion that encompassed most of NANCI but left the NKX2.1
locus intact (Barnett et al. 2012). This patient had symptoms characteristic of NKX2.1
haploinsufficiency including respiratory distress, suggesting that NANCI has a similar
role of regulating NKX2.1 in the human lung. Knockdown of NANCI in human cells
results in decreased NKX2.1 expression, further supporting a conserved role for NANCI
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in human development. Together, these findings indicate that NANCI acts between
Wnt/β-catenin signaling and Nkx2.1 to regulate a broad array of lung endoderm specific
genes, in part through regulation of Nkx2.1 itself.

Not all lncRNAs located near transcription factors that I identified were expressed in an
identical pattern as their neighboring PCG. LL33, which is located next to the Gata6
locus, exhibited divergent expression pattern in both the developing lung and heart.
Where Gata6 is expressed at high levels in the developing lung epithelium, LL33 is
expressed at low levels in this tissue. Moreover, LL33 expression is not observed at
significant levels in the developing myocardium of the heart until E18.5 whereas Gata6 is
expressed in this tissue from the earliest stages of cardiac development. Such distinct
differences may indicate tissue specific regulatory roles for these lncRNAs during
development.

LL34 is specifically expressed throughout the anterior to posterior axis of early gut
endoderm and its expression continues in the early lung endoderm. However, its
expression is extinguished by late gestation, making it the one of the most embryonicspecific lung lncRNAs identified in our study. This expression pattern correlates with
data showing that loss of LL34 leads to decreased expression of several essential
components of the RA signaling pathway. RA signaling plays a critical role in both early
foregut patterning and lung development. Loss of RA signaling leads to lung agenesis
while additional studies suggest a role for RA signaling in other regions of gut endoderm
including in the pancreas (Martin et al. 2005; Wang et al. 2006; Chen et al. 2007; Bayha
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et al. 2009; Chen et al. 2010). Given LL34’s restricted expression in the gut endoderm in
early development and the important role for RA signaling in endoderm development,
this lncRNA is likely a key regulator of foregut development through modulation of RA
signaling.

The lncRNAs in our data set that are in close proximity with important transcription
factors could be considered enhancer RNAs (eRNAs), which are thought to regulate
their neighboring PCGs through various mechanisms including recruiting chromatin
remodeling complexes or acting as genomic enhancers of the neighboring PCGs (Orom
et al. 2010a). Our data showing that NANCI binds to TrxG/Wdr5 complexes suggests
that this transcript may serve this type of function in regulating Nkx2.1 gene expression
during foregut and lung development. Interestingly, other lncRNAs in our database such
as LL12 bind to both TrxG/Wdr5 and PRC2/Ezh2 at high levels suggesting that it may
play both activating and repressive roles in regulating gene transcription. Of note, LL12
was previously found to be associated with Ezh2 in a genome wide survey of polycomb
associated lncRNAs (Zhao et al. 2010). Further experiments disrupting these
interactions specifically will be required to fully assess their importance in regulating
NANCI function.

Our database of lung lncRNAs reveals important features of this class of transcripts and
also identifies several important players in both lung and foregut development. I have
characterized the tissue specific expression patterns of several of these lncRNAs
revealing that they are often expressed in a pattern exquisitely similar to their
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neighboring PCGs. These data bolster and extend an emerging concept that lncRNAs
are an important regulator of cell lineage differentiation during tissue development and
suggests that a subset act on neighboring transcription factors to regulate their
expression and function.

2.11 Materials & Methods
Library Preparation
Total RNA was extracted from E12.5 and adult mouse lungs using the RNAEasy kit
(Qiagen) and used in the preparation of seqeunicng libraries using the Illumina TruSeq
IRNA sample preparation kit. Paired-end reads were sequenced on a HiSeq 2000 at a
depth of 4 samples per lane to achieve an average 60 million reads per library. Two
libraries per time point were analyzed.

Alignment and Transcript Assembly
Paired end reads were aligned to the mouse reference genome (build NCBI37/mm9)
using the read mapper GSNAP version 2012-07-20 (Wu and Nacu 2010). GSNAP was
executed in the mode to detect both novel and known splice sites. Known splice sites
were obtained from Ensembl build 67. Cufflinks was then used to assemble the
transcriptome for each of the four individual samples (Trapnell et al. 2013). These
individual assemblies where then merged and annotated using Ensembl 67 into a single
collection of transcripts using Cuffmerge. Expression quantification and differential
expression analysis was performed on the transcript using Cuffdiff. Expression values in
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the form of Fragments Per Kilobase of exon per Million reads mapped(FPKM) were
imported into custom database for further analysis.

LncRNA identification pipeline
Potential lncRNAs were discovered using the same pipeline describe by Cabili et al
(Cabili et al. 2011). Briefly transcripts that were multi-exonic, larger than 200 nucleotides
and called with a class code of ‘u’ in Cuffmerge were retained as potential novel
lncRNAs. To remove transcripts which might be novel protein coding genes, PhyloCSF
was used to assess the protein coding potential of each transcript by examining the
over-representation of evolutionary signatures characteristic of alignments of conserved
coding regions, such as the high frequencies of synonymous codon substitutions and
conservative amino acid substitution (Lin et al. 2011). Transcripts with a PhyloCSF score
greater than 100, which roughly indicated a false positive rate of 10% when comparing
know non-coding transcripts, were excluded for further analysis. Transcripts were also
excluded

if

they

contained

a

known

protein-coding

domain.

Pfam

scan

(ftp://ftp.sanger.ac.uk/pub/databases/Pfam/) was used to search all potential open
reading frames against Pfam (Release version 26, PfamA and PfamB). Genebank
accession numbers: LL18/NANCI (mouse: KF856953, human: KF856952) and LL34:
KF876689.

Motif Enrichment

41	
  
	
  

DNAse hypersensitivity sites (Encode) were used to predict protein binding regions
within lncRNA promoters 2.5kb upstream and 300bp downstream of lncRNA
transcription starts sites. DNA sequences overlapping with lncRNA promoter regions and
DNAse hypersensitivity sites were created using BEDTools (Quinlan and Hall 2010).
Novel motifs were discovered using the tool MEME (Czaplinski et al.) and set to find 5
most overrepresented motifs in the input sequences.

Discovered motifs were then

matched to known motifs in the TRANSFAC database (Matys et al. 2006), using the tool
TOMTOM (Gupta et al. 2007) .

Neighbor gene analysis and spatial correlation
Genes from Ensembl were annotated as transcription factors using data from the animal
transcription factor database (http://www.bioguo.org/AnimalTFDB/index.php) (Czaplinski
et al.). A 2x2 tables using distances widnows of 5,10,20,25 and 50 kb of counts was
constructed with lncRNAs near Transcription factor loci, lincRNAs near Non-transcription
factor PCG, PCGs near Transcription loci and PCGs near non-Transcription factor loci.
This count table was used in a single sided Fisher’s exact test to determine if the
proportion of lncRNAs near transcription factors was different than that of PCG with near
transcription factors.
The R package GenometriCorr (Czaplinski et al.) was used to examine the spatial
correlation of lncRNAs with PCGs. Genes groups were formed using the animalTFDB
database for transcription factors, signal proteins define by gene ontology (GO:0038023)
and structural proteins define by gene ontology (GO: (GO:0005198). GenometriCorr
implements various statistical approaches to assess whether the positions of two sets of
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intervals are associated in genomic space. The 363 lncRNAs from the mouse lung and
lncRNAs in Ensembl were compared against groups of PCGs defined as transcription
factors, signaling proteins or structural proteins using the GenomtriCorr relative distance
test. For a positive correlation reference the adult mouse lung H3K4me3 sites, a
promoter mark were compared against protein coding genes expressed in the mouse
lung from determined using our RNA-seq data (FPKM > 5) The distributions relative
distances between lncRNA and the categories of PCGs were plotted use R and tested
for a significance difference to the uniform null distribution using Kolmogorov-Smirnov
test.

Human Syntenic Transcripts
Mouse lung lncRNA loci were mapped to syntenic human (GRCh37/hg19) regions using
the Liftover tool available at the UCSC genome browser website. Human Ensembl
version 75 was used to determine which genes were located in the syntenic regions.

5’ and 3’RACE, and Full-Length LncRNA Cloning
5’RACE was performed with the TaKaRa 5’RACE Core Kit (Clontech, Mountain
View, CA) per manufacturer’s instructions using the PCR primers listed in Table 2.1. The
final reaction products were cloned and sequenced using the TOPO TA Cloning kit and
pCR4 vector (Life Technologies, Grand Island, NY). Primer 1 (Table 2.1) was used for
first-strand synthesis from total RNA extracted from MLE12 cells with Superscript II, per
manufacturer’s protocol. 3’RACE products were subsequently amplified with nested
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PCR primers (Table 2.1). These products were also subsequently closed into the TOPO
vector pCR4. Based on the results of 5’RACE and 3’RACE, PCR primers were designed
to amplify full-length transcripts for each lncRNA of interest. LA Taq (Clontech, Mountain
View, CA) for full-length transcript amplification. Each product was cloned into TOPO
pCR4, sequenced, and then subcloned into the plasmid backbones as described
elsewhere in this Methods section.

In-Vitro Transcription-Translation Assay
The Promega TnT Quick Coupled Transcription/Translation System and
Transcend Non-Radioactive Translation Detection System (Madison, WI) was used to invitro transcribe and translate each full-length lncRNA from the T7 promoter of a
pcDNA3.1+ plasmid, per manufacturer’s instructions. Following completion of the
transcription-translation reaction, 1uL of the reaction product was added to 15uL SDS
sample buffer, heated to 100C for 2 minutes to denature the proteins, and then loaded
onto a 4-12% 1mm 15W NuPage SDS-polyacrylamide gel (Life Technologies, Grand
Island, NY). Protein products labeled with the biotinylated Transcend tRNA were
detected with streptavidin antibody and Western Blue reagent, per manufacturer’s
instructions. The luceriferase T7 control DNA plasmid supplied with the TnT Quick
Coupled Transcription/Translation System was used as a positive control.

Animals

44	
  
	
  

The generation and genotyping of the Nkx2.1-/-, Shhcre, and Ctnnb1flox/flox mice have been
previously described (Brault et al. 2001; Harfe et al. 2004; Taniguchi et al. 2011;
Taniguchi et al. 2013). All animal work was performed under the approval and guidance
of the University of Pennsylvania Institutional Animal Care and Use Committee.

Quantitative Real-Time PCR
Total RNA was isolated from indicated tissues or cell lines using Trizol (Invitrogen,
Carlsbad, CA) per manufacturer’s protocol. cDNA was synthesized from total RNA by
using SuperScript Strand Synthesis System (Invitrogen, Carlsbad, CA, USA).
Quantitative real time PCR was performed using the SYBR green system (Applied
Biosystems, Foster City, CA, USA) with primers listed in the Table 2.2. GAPDH
expression values were used to control for RNA quality and quantity. Five biologic
replicates were used for all cell lines experiments, and biologic triplicates for in vivo
experiments, unless otherwise noted. Data shown are the mean ± SEM.

Histology
Tissues were fixed in 4% paraformaldehyde, embedded in paraffin wax and sectioned at
5 mm intervals. Immunohistochemistry was performed using the following antibodies:
mouse anti-phopho-histone3 (Cell Signaling Technology, Danvers, MA, USA; 1:200),
goat anti-CC10 (Santa Cruz, Santa Cruz, CA, USA; 1:20), rabbit anti-SP-C (Chemicon,
Billerica, MA, USA; 1:500), rabbit anti-Nkx2.1 (Santa Cruz, 1:50), mouse anti-Cdkn1a
(Santa Cruz, 1:100), rabbit anti-Sox9 (Santa Cruz, 1:100), rabbit anti-Rbl2/p130 (Abcam,
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Cambridge, MA, USA; 1:50), rabbit anti-Par3 (Upstate, Billerica, MA, USA; 1:100), rabbit
anti-Sox2 (Seven Hills Bioreagents, Cincinnati, OH, USA; 1:500), rabbit anti-Cdh1 (Cell
Signaling, 1:100). Slides were mounted with Vectashield mounting medium containing
DAPI (Vector Laboratories, Burlingame, CA, USA). In situ hybridization was performed
as described (Cohen et al., 2007; Zhang et al., 2008). Previously described probes were
used to analyze Nkx2.1, Gata6, and Foxa2 expression (Goss, 2009 #1031;Zhang, 2007
#1032). Probes for other genes were amplified from using the primers listed in Table 2.3.

Human Lung Sample Collection
Neonatal lung samples were collected through an institutional review-board
(Nagarajan et al.)-approved registry-biorepository, “Molecular and Clinical Analysis of
Syndromic and Isolated Anomalies of the Foregut”, at The Children’s Hospital of
Philadelphia. Fetal lung samples were collected through an IRB protocol at Temple
University, Philadelphia, PA.

Cell Culture Methods
HEK-293T, MLE12, and H441 cell lines obtained from ATCC (Manassas, VA) were used
for all experiments. HEK-293T cells were cultured in DMEM (Life Technologies, Grand
Island, NY) + 10%FBS + 1% penicillin/streptomycin at 37C, 5% CO2. Antibiotic-free
conditions were used during transfection. MLE-12 cells were cultured in the HITES
medium (Ham’s F12 (Mediatech, Manassas, VA), insulin 0.005mg/mL, transferrin 0.01
mg/mL, transferrin 0.01 mg/mL, sodium selenite 30 nM, hydrocortisone 10 nM, beta46	
  
	
  

estradiol 10 nM, HEPES 10 mM, and L-glutamine 2 mM) + 2% FBS + 1%
penicillin/streptomycin. H441 cells were cultured in RPMI-1640 (Mediatech, Manassas,
VA) + 10%FBS + 1% penicillin/streptomycin at 37C, 5% CO2.
Lentiviral shRNA Knockdown
Suitable target regions for each lncRNA were chosen based on the guidelines outlined
by Birmingham et. al. (Birmingham et al. 2007). Five distinct regions of each target were
chosen for shRNA design. Regions containing known SNPs or repeat elements were
specifically avoided. A minimum of five shRNAs were designed against these regions
using

RNAi

Consortium’s

publically

(http://www.broadinstitute.org/rnai/public/seq/search).

available
Each

target

design

tool

sequence

was

independently verified to be unique through a separate BLAST search. shRNAs were
screened for efficiency; the shRNA construct with maximum knockdown was selected for
subsequent analyses. Sequences of shRNA target sites can be located in Table 2.4.
For knockdown in MLE12 cells shRNA oligos were synthesized by Integrated
DNA technologies (Coralville, IA), phosphorylated, annealed to their complementary
partner, and were then cloned into the pLKO.1-GFP vector. Lentivirus was produced by
transfecting HEK-293T cells at 50-70% confluency with the viral packaging plasmids
psPAX2 & pMD2.G, and the appropriate pLK0.1-shRNA plasmid with FuGENE6
(Promega, Madison, WI). A total of 4ug of DNA (2ug pLKO.1-shRNA, 1.5ug psPAX2,
500ng pMD2.G) + 12uL FuGENE6 was used to transfect each well of a 6-well plate for
screening assays. A total of 10ug DNA (5ug pLKO.1-shRNA, 3.75ug psPAX2, 1.25ug
pMD2.G) + 30uL FuGENE 6 was used to transfect 10cm plate for subsequent
experiments. Fresh media was added 12 hours after transfection. Virus was collected 48
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hours following transfection by passing the virus-containing media through a 0.45
micrometer strainer, and then concentrated with Amicon 100k Ultracentrifugation filters
(Millipore, Billerica, MA) by centrifugation at 2,800 x g for 15 minutes. The viral
concentrate was reconstituted in an equivalent volume of MLE12 media (composition
described above), and then applied to MLE12 cells with fresh media in a 1:4 ratio with
polybrene, 8ug per mL media. Fresh media was added 12 hours after addition virus.
MLE12 cells cultured for 65 hours after infection before collecting and isolating total
RNA. A similar protocol was used to infect H441 cells except the H441 cells were
exposed to virus for 18 hours and cultured in H441 media (composition described
above).

Overexpression of NANCI and Nkx2.1 rescue of NANCI knockdown
NANCI was cloned into pLenti 7.3/V5-DEST using the gateway cloning system, primers
listed in Table 2.5. Lentivirus was produced in HEK-293T cells and used to infect MLE12
cells at 50-70% confluency, as described above. Infected MLE12 cells were grown for 65
hours before collecting and isolating total RNA. Full length Nkx2.1 was cloned into the
pCMV-Tag2B vector as previously described (Zhang, 2007 #1032). MLE12 cells were
infected with NANCI shRNA lentivirus, as described above, and allowed to grow for 24
hours. MLE12 cells were then transfected with a pCMV-Tag2B-Nkx2.1 vector using the
Lonza 4D-Nucleofector system and allowed to grow for another 48 hours before isolating
RNA.

Microarray Analysis
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RNA was isolated from MLE12 cells following infection with either a scrambled control
shRNA or lncRNA target shRNA in triplicate. Biotinylated cRNA probe libraries were
generated form these RNA samples and used with Affymetrix Mouse Gene 2.0ST
arrays. Microarray data were analyzed using the Oligo package available at the
Bioconductor website (http://www.bioconductor. org). The raw data were backgroundcorrected by the Robust Multichip Average (RMA) method and then normalized by an
invariant set method. Differential gene expression between the control and mutant mice
was analyzed by the Limma package available at the Bioconductor website. P values
obtained from the multiple comparison tests were corrected by false discovery rates.
Heatmap displays were created using the freely Dissertation.doc R and the library
heatmap2. Gene Ontology enrichment analysis was performed using the website
DAVID. The Gene Expression Omnibus accession number for the microarray data is
GSE52389.
RNA Co-Immunoprecipitaton
RNA coimmunoprecipitation was carried out as previously described (Moran et
al. 2012). MLE12 cells were grown to 90% confluency on twelve 10cm plates, and then
harvested following trypsinization. The cells were washed twice with sterile PBS, and
were then cross-linked with 0.3% formaldehyde in PBS at room temperature for 10
minutes. The reaction was quenched with glycine at a final concentration of 0.125M.
Cells were then pelleted, washed with PBSx2, and resuspended in 1.2mL RIPA buffer
supplemented with protease inhibitors (1 cOmplete protease inhibitor tablet (Roche,
Indianapolis, IN) and RNase inhibitors (62.5uL RNaseOUT + 125uL SuperaseIN (Life
Technologies, Grand Island, NY)). The cell suspsension was incubated at 37C for 30
minutes, and during this period was vortexed for 30 seconds at 5 minute intervals. The
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cells were then homogenized with a Dounce homogenizer for 1 minute. The cell lysate
was centrifuged to pellet the debris, and the supernatant was transferred to a clean tube.
A 200uL aliquot was set aside as the Input sample, and 500uL was used for each pulldown reaction (500uL for IgG reaction, 500uL for target antibody reaction).
Dynabeads Protein G (Life Technologies, Grand Island, NY) were used for
immunoprecipitation following manufacturer’s instructions. The beads were resuspended
by vortexing for 30 seconds, and then 100uL aliquots were transferred to clean tubes
and resuspended in RIPA buffer supplemented with protease and RNase inhibitors. 2ug
of target antibody (either anti-Ezh2 (Millipore), or anti-Wdr5 (Bethyl Laboratories, Inc.))
was added to the first tube and 2ug of polyclonal IgG antibody to the second tube. The
antibody-bead mixture was intubated at 4C with shaking for two hours. The beads were
then washed with 500uL RIPA buffer, and resuspended in 500uL MLE12 cell lysate. The
antibody-bead-cell lysate mixture was incubated at 4C with shaking for 2 hours. Next,
the beads were washed with high-salt RIPA buffer (1M NaCL, 1%NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 50mM Tris-HCl, 1mM EDTA) and resuspended in Buffer C ( ).
10ug proteinase K was added to each reaction mixture, and incubated at 42C for 30
minutes, followed by incubation at 65C for 4 hours, to reverse the formaldehyde
crosslinks and free the bound RNA. RNA was then isolated from this sample, as well as
the Input, using Trizol, in a standard fashion per manufacturer’s protocol. cDNA was
synthesized as described above with random hexamers, and cDNA content quantified by
Q-PCR. (Table 2.1) As previously described, U1 rRNA was used as an internal control,
Hmbs as a negative control, and LL12/Snhg5 as a positive control for the EZH2
pulldown (Grote, et al 2013; Zhao J, et al 2010).
Generation of NANCI shRNA knockdown transgenics
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The 3.7 kb human SFTPC promoter transgenic expression vector has been described
previously (Yang et al. 2002; Li et al. 2012). The NANCI shRNA construct used above
was used to generate an shRNA-miRNA cassette construct, as described previously
(Wang et al. 2007). This was cloned downstream of the human SFTPC promoter and the
SV40 polyadenylation sequence, excised from the resulting plasmid, purified and
injected into FVBN fertilized oocytes as previously described (Yang et al. 2002; Li et al.
2012). Embryos were collected at E18.5, and gene expression was measured by Q-PCR
(Table 2.1). Whole lungs were isolated; the left lung was fixed for histology and the right
lung was used to isolate total RNA.

Mesenchymal thickness calculations
H&E staining was preformed on SFTPC-NANCIshRNA transgenic lungs, Nkx2.1+/- lungs,
and littermate control lungs for both genotypes. For each lung section two pictures were
taken at 200x near the top and middle of the lung section. These pictures were
overlayed with a uniform grid. Two horizontal and two vertical lines were chosen at
random from each grid. Along a uniform length of each line the mesenchymal length and
number of intersecting airways were measured and these values were then summed
across all four lines. The total mesenchymal length was then divided by the total number
of intersecting airways to obtain the average mesenchymal thickness for that picture.
The mesenchymal thickness of the two pictures were then averaged to get the
mesenchymal thickness for a lung section. The number of lung sections analyzed = 5
(SFTPC-NANCIshRNA transgenic lungs and control littermates), 6 (Nkx2.1+/- lungs), or 4
(Nkx2.1+/+ lungs).
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Table 2.1. RACE primers.

Primer	
  
Designation	
  
LL12-‐RACE-‐RT	
  
LL12-‐5'RACE-‐S1	
  
LL12-‐5'RACE-‐S2	
  
LL12-‐5'RACE-‐A1	
  
LL12-‐5'RACE-‐A2	
  
LL12-‐3'RACE-‐A	
  
LL12-‐3'RACE-‐B	
  
LL34b-‐RACE-‐RT	
  
LL34-‐5'RACE-‐S1	
  
LL34-‐5'RACE-‐S2	
  
LL34-‐5'RACE-‐A1	
  
LL34-‐5'RACE-‐A2	
  
LL34b-‐3'RACE-‐A	
  
LL34b-‐3'RACE-‐B	
  
NANCI-‐RACE-‐RT	
  
NANCI-‐5'RACE-‐S1	
  
NANCI-‐5'RACE-‐S2	
  
NANCI-‐5'RACE-‐A1	
  
NANCI-‐5'RACE-‐A2	
  
NANCI-‐3'RACE-‐A1	
  
NANCI-‐3'RACE-‐B1	
  
NANCI-‐3'RACE-‐A2	
  
NANCI-‐3'RACE-‐B2	
  

Sequence	
  
CAATTCTCTCAGATG	
  
GCACGTTCACAAGGACAATG	
  
GTGCTGTTCCGAAGGTACTA	
  
AGTCTCAGAAGCCTCCAAATC	
  
CACTCACCGACAAGACAAAGA	
  
GGAGCCCAAAGCATCTGAGAGAAT	
  
AGCCTGCGTGTGAAGATCCTA	
  
GAGAATACTGACTTC	
  
GAACTGGCAAGAGTGTCCTT	
  
TATGTGTGCAGCAGGAAAGG	
  
GGCAGGAGGATCTTGTGTTT	
  
TGGGTTTGGTGGCTGTATATG	
  
GCAAGGCATTCCGAAGATAAAC	
  
CATAGTAAGGGCAGTGGGTATTC	
  
AGGCGCATCTTCTTG	
  
GAGAAGCTGTCTCAAGACCT	
  
CCAGATAAGAGGAAGGAGAGAGAGGT	
  
GAAAGTCTGCGAATCTTCCT	
  
AAACCAGATCCAAACATCGC	
  
GCATCCTTGGAGGTCAGAATAA	
  
TTCCTCCAGCACACACAAA	
  
TGTTTAGATGGCGGACATTCA	
  
TCGGAGACTCACCTGCAATA	
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Table 2.2. Q-PCR primers.
Gene

Forward Primer

Reverse Primer

Abca3

TTCATCACCTGATGGCGGTGAAC

ACGCATGATGGCTTTGTCTACAGC

Aldh1a1

GCAGCAGGACTCTTCACTAAA

CACTGGGCTGACAACATCATA

Aldh1a2

GTATATGGGAGCCCTCATCAAG

TGTCTATGCCGATGTGAGAAG

Aldh1a3

TGATGCTGGCCTGGAAAC

TGATGAGAGAGGCTAGGTACAG

Aqp1

TCCTCCCTAGTCGACAATTC

GCAGAGTGCCAATGATCTC

Aqp5

ATGAACCCAGCCCGATCTTT

ACGATCGGTCCTACCCAGAAG

Bmp2

AAGCAACAGAAGCCCAGTT

ACCATGGTCGACCTTTAGGA

Cdh1

AGCTGTCTACCAAAGTGACGCTGA

ACATGAGCAGCTCTGGGTTGGATT

Cyp26b1

ATACCAGCAGTTTGTGGAGAAT

TCACGGATAGCCTTCTCTAGG

Cyp51

GGCCTTAACATAGCCCACTT

CACATTTCTTTCTCCGCTTTCTC

Dhcr24

GAGTCATCGTCCCACAAGTATG

GGCATAGAACAGGTCTGAGTTT

Dhcr7

CCTGACTTCTGCCACAGATT

CAGCCCATTCACCTCATACTT

Endogenous Nkx2.1

TCCTCGGAAAGACAGCATCAGCTT

TCGTGTGCTTTGGACTCATCGACA

Fdft1

TTCTATAACCTGCTGCGATTCC

GCGACTGGTCTGATTGAGATAC

Fgf18

CAAGGGCAAGGAGACAGAAT

TCTCAATGAACACGCACTCC

Fgfr2

TTGCTTCGGGCAAGTAGTC

CCTTCTCTGTGGCATCATCTT

Fgfr3

TGAAGCACGTGGAAGTGAA

CTCCTTGTCGGTGGTGTTAG

Foxa1

CAGGATGTTAGGGACTGTGAAG

TGACAGGGACAGAGGAGTAG

Foxa2

ATCCGACTGGAGCAGCTACTACGC

TGTATGTGTTCATGCCATTCATCCC

Foxf1

GGAGCAGCCATACCTTCACCAAA

ATGCTGGGCGACTGTGAGTGATA

Foxp1

CGAATGTTTGCTTACTTCCGACGC

ACTTCATCCACTGTCCATACTGCC

Foxp2

GCCAGGCTGTGAAAGCATATGTGA

CATTTGCACTCGACATTGGGCAGT

GAPDH

TGCACCACCAACTGCTTAGC

GGCATGGACTGTGGTCATGAG

GATA6

ACAGCAAGATGAATGGCCTCAGCA

TGTGACAGTTGGCACAGGACAGT

Id2

GCCACAGAGTACTTTGCTATCATTCG

ACCCTGAACACGGACATCAGCAT

Jag1

TGACCAGAACGGCAACAA

CTGCAGTCACCTGGAAGTTTA

LL1

TCCCGGATGGCTGTATTAACGCA

GACCGGCTCGGGTGGATC

LL12

CCATTGTTCTTCGCGTCTTC

ATCAATTCTCTCAGATGCTTTGG

LL33

GGCTGCGAGAAGGGAATTGAACAT

GCCTTTCATAAATGCAGCCACGCT

LL34

GAACCTGCTGCCTCGACTAGAGAT

GCCTTTCCTTCACTATATGCTCCG

LL35

TTTGGCCAAGGGAGAAAGCTCAGA

CTTCAGGTAAGTTACAGGCACCGT

LL66

ATTCACGATCCCAGGTGGACTT

CCTATTCGGAGCTCTCTGGTTTCCAT

NANCI

AGGAACGCCTCAATCTGCATCTCA

CCATTGACTGAATTGTCCACGGCA

Nkx2.1

ATGGTACGGCGCCAACCCAGA

CATGCCACTCATATTCATGCCGCT

Nrp1

GCGAAGGAGGATGGAGAG

TATGGTCCCGCCACATTT

Nrp2

GTTTCCTCTTACCTGGGTTT

GTGATGTAGCCAGCATCTT

Nsdhl

CCAGTTGGTCCCAATCCTAA

ATTCTCCACGAAGGTGAAGTC

Rarg

CAGCACTAAGGGAGCAGAAA

GGAGTCGTCCTCAAACATCTC

Ret

CAATGAGACTACTGGCCTTCTC

CAGAAAGACCTGGAGGAAGATG

Sc4mol

CAGACTCCTTCACCACAAGAG

TCCAAGGGATGTGCGTATTC

Sox2

TGCACATGGCCCAGCACTA

TTCTCCAGTTGCCAGTCCAG

Sox9

AGACCAGTACCCGCATCTGCACAA

TCTCTTCTCGCTCTCGTTCAGCA

SPC

AGCAAAGAGGTCCTGATGGAGAGT

CACAACCACGATGAGAAGGCGTTT

Sqle

AGAGCCCGACAGGATAGTT

GATGGGCATTGAGACCTTCTAC

Tgfb1

TAATGGTGGACCGCAACAA

CTTCCCGAATGTCTGACGTATT

Tgfb3

AGGGCAGTCAGAGGAAGAA

GATCCTGCCGGAAGTCAATATAA
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Table 2.3. In situ hybridization primers.

Gene

Forward primer

Reverse primer

LL12

TGCAACGAGGATTTGGAGGCTTCT

TTGTGTCACTGGCTATGCACTCCT

LL34

TGGATGCTGGGAAGGATTTCCTGA

TTGAGCAAGCCATGACCTTTCCTG

LL35

TGCGTGAAAGACTCTGCTGGA

TCAGGGCAGGATTCCTCAGTTGTT

LL66

ATGCATACAACAGGCGGAGGATCT

AATAGATGGCTGAAGGCTGGAGCA

Foxf1

ATGCATACAACAGGCGGAGGATCT

AATAGATGGCTGAAGGCTGGAGCA

LL1

TCCCGGATGGCTGTATTAACGC

ACAGGTTAACACACCTCAATTGCT

NANCI

ACAGCAAGAAGATGCGCCTGTGA

GCGGCTATTATTTCTTGAGTTCCTTTGGTG

LL33

GGGATTTCTTTCGACAAGCTG

TTGAGAGTCTACACCCTTCCT

Table 2.4. shRNA target sequences.

Construct
LL34b_shRNA1
LL34b_shRNA2
LL34b_shRNA3
LL34b_shRNA4
LL34b_shRNA5
NANCI_shRNA1
NANCI_shRNA2
NANCI_shRNA3
NANCI_shRNA4
NANCI_shRNA5

Target sequence
CGAAGGGACCAGTGAAGATAA
CTCATCTGCTCCCAGTTAATT
CCCATTGTAGGAAGCTAATTT
GGCAGTGGGTATTCAACTATA
CACTCAGTATCTTCTTCAAAT
CATCAGCTGCAGGACAAATAT
CCAAAGGAACTCAAGAAATAA
CCATATCAACATGGAATTTAT
GCTTGGCTTGTTTGATGTTTA
TGAGAGTCTTCCAAGAGATTT
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Table 2.5. Full-length transcript primers.

Primer Designation

Sequence

Restriction
Enzyme

NANCI (human)-FT-F

CGGGGTACCCGATGTTTAGCATCCCAAAGCTG

Kpn I

NANCI (human)-FT-R

AGCTCTGCGGCCGCAAATTCATAAGAACTGCTTTCCT

Not I

NANCI-FT-F

CGGGGTACCCGGGAAGCAGTTCTCTCAG

Kpn I

NANCI-FT-R

AGCTCTGCGGCCGCTTAACAAGGAATAGAAGTTT

Not I

LL12-FT-F

TGACAGAAGCTTTTGTCGGTGAGTGAGTTACAGTCG

HindIII

LL12-FT-R

GATGTAGATATCCACTGCCAGAATAAGGAAATAGCTC

EcoRV

LL34-FT-F

GATGTAAAGCTTAGCTTAGGGCTTGAGTACGA

HindIII

LL34-FT-R

GCTCATGGTACCGCTTGGTTGTCAATGCTTGTT

KpnI

LL35-FT-F

TAGGTAGGTACCCTCCCTCCGAGCGCAGGAC

KpnI

LL35-FT-R

ATCGTAGATATCCCATGCCCAGCCTATATATTTGT

EcoRV
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Figure 2.1. Identification of the mammalian lung lncRNA transcriptome.

Figure 2.1. Identification of the mammalian lung lncRNA transcriptome. RNA-seq
was performed on E12.5 and adult lungs to identify 141,614 transcripts generated from
41,554 loci. (A) These were filtered for size, coding potential, and expression to generate
a catalog of 363 lncRNAs expressed in the mouse lung. (B) Motif enrichment analysis
highlights the three most enriched transcription factor DNA binding sites in the 59
regulatory regions of lung lncRNAs. (C) The majority of lncRNAs in this study have a
human syntenic transcript, with previously annotated lncRNAs being more likely than
novel lncRNAs to have a human syntenic transcript. (D) lncRNAs found within 20 kb of
PCGs are more likely to have a human syntenic transcript than lncRNAs with no PCG
gene nearby. (E) lncRNAs with PCG genes that were transcription factors are more
likely to have syntenic human transcripts that those with nontranscription factor PCGs
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Figure 2.2. Conservation plot showing reduced conservation of lung lncRNAs in
comparison to protein coding genes.

Figure 2.2. Conservation plot showing reduced conservation of lung lncRNAs in
comparison to protein coding genes. Using analysis as outlined in Siepel et. al.
(Siepel et al. 2005), a PhastCons conservation score of 0.57 was used as a cutoff for
conservation across placental mammals. All genes with a PhastCons score higher than
0.57 score are considered conserved (right of the dashed red line).
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Figure 2.3. lncRNAs are spatially correlated with transcription factors.

58	
  
	
  

Figure 2.3. lncRNAs are spatially correlated with transcription factors. (A) The odds
of a lncRNA being close to a transcription factor locus are statistically greater in lung
lncRNAs identified in this study and from the Ensembl mouse and human annotated
databases than in PCGs in general. (B) Spatial relationships were determined using the
GenomtriCorr program, which computes relative distances between genomic features,
which were then plotted and compared with a uniform random distribution (dashed line).
The distributions above the line show a positive spatial correlation, while those below the
line show an anti-correlation in spatial position. The distance between lung H3K4me3
marks and lung PCGs provides a positive control for spatial correlation between two
genomic regions. (C) Lung lncRNAs identified in this study show a greater spatial
correlation to transcription factors than other functional classes of PCGs, such as
signaling or structural proteins. (D) This spatial correlation is also true for all lncRNAs
annotated in the mouse Ensembl database. (E) Table of correlation coefficients and Pvalues from comparisons of the distance distributions for gene groups versus a uniform
distribution.
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Figure 2.4. Genomic structure of lncRNAs expressed during lung development
and homeostasis.

Figure 2.4. Genomic structure of lncRNAs expressed during lung development
and homeostasis. Gene plots for LL18/NANCI (A), LL35 (B), LL66/Fendrr (C), LL1/Ancr
(D), LL12 (E), and LL34 (F). The gene plots contain RNA-seq data from both E12.5 and
adult

lungs

combined

with

Pol

II

and

H3K4me3

ChIP-seq

(chromatin

immunoprecipitation [ChIP] combined with deep sequencing) data are from ENCODE
(Rosenbloom et al. 2013). Transcripts were assembled from RNA-seq data using
Cufflinks (purple) and compared with gene annotations in Ensembl (yellow).
60	
  
	
  

Figure 2.5. Identification of LL33, a lncRNA associated with Gata6, and its
expression during lung and cardiac development.
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Figure 2.5. Identification of LL33, a lncRNA associated with Gata6, and its
expression during lung and cardiac development. Geneplot for LL33 showing
multiple start sites that are near or overlap with the 5’ end of the mouse Gata6 gene (A).
Expression of LL33 and Gata6 during lung development (B). Note lower expression of
LL33 in the developing lung epithelium (B, arrows), and expression in the vascular
smooth muscle of the large pulmonary blood vessels for both LL33 and Gata6 (B,
arrowheads). Expression of LL33 and Gata6 in various embryonic and adult mouse
tissues using Q-PCR (C). Expression for each gene is relative to expression in the lung
at that stage. Expression of LL33 (D-H) and Gata6 (I-M) during cardiac development.
Note high level expression of LL33 and Gata6 in the developing atrio-ventricular canal
(D and I, arrows) and in the developing atrio-ventricular valve leaflets (F and K, arrows).
Expression of LL33 is not observed in the myocardium of heart up to E14.5 (E, J,
arrows) but is observed at E18.5 and adult (G, H, L, M). Scale bars=100µm (B, D, F, I,
K) and 500µm (E, G, H, J, L, M).
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Figure 2.6. Expression levels of lncRNAs during lung development and
homeostasis.

Figure 2.6. Expression levels of lncRNAs during lung development and
homeostasis. Expression as measured in FPKMs is shown for lncRNAs and their
associated PCGs at E12.5 and adult lungs: NANCI and Nkx2.1 (A), LL35 and Foxa2 (C),
and LL66 and Foxf1 (E). Expression as measured in FPKMs is shown for lncRNAs not
associated with PCGs: LL1, LL12, and LL34 (G). Q-PCR data for lncRNAs and their
associated PCGs: NANCI and Nkx2.1 (B), LL35 and Foxa2 (D), and LL66 and Foxf1 (F).
Expression as measured by Q-PCR is shown for lncRNAs not associated with PCGs:
LL1, LL12, and LL34 (H). All changes in gene expression shown by Q-PCR are
statistically significant (p<0.05).
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Figure 2.7. In vitro transcription/translation reactions for lung lncRNAs.

Figure 2.7. In vitro transcription/translation reactions for lung lncRNAs. In vitro
transcription/translation reactions were performed for LL1, LL12, LL18/NANCI-mouse,
LL18/NANCI-human, LL34 and LL35 along with the luciferase control plasmid. The
luciferase positive control generated a predicted 62 kDa protein while none of the
lncRNA transcripts generated detectable protein products.
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Figure 2.8. Temporal and spatial expression of lncRNAs located near transcription
factor loci during lung development.
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Figure 2.8. Temporal and spatial expression of lncRNAs located near transcription
factor loci during lung development. ISH was used to determine the expression
patterns of NANCI and Nkx2.1 (A), LL35 and Foxa2 (B), and LL66 and Foxf1 (C), during
lung development. Note the expression of Nkx2.1 and NANCI in the distal lung
epithelium (A, arrows) and at lower levels in the developing proximal airways (A,
arrowheads). Note the expression of Foxa2 and LL35 in the distal lung epithelium (B,
arrows) and at higher levels in the developing proximal airways (B, arrowheads).
Expression of Foxf1 and LL66 is observed in the mesenchyme surrounding both the
distal lung epithelium (C, arrows) and proximal airways (C, arrowheads). (Ai) Airways.
Bars, 100 mm.
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Figure 2.9. Temporal and Spatial expression of lncRNAs outside of the lung.
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Figure 2.9. Temporal and Spatial expression of lncRNAs outside of the lung.
Outside of the lung, NANCI and Nkx2.1 expression is observed in the developing thyroid
(A and C, arrows) at E14.5 and ventral forebrain (B and D) at E14.5. LL35 and Foxa2
expression are observed in the developing anterior foregut endoderm and floor plate at
E10.5 (E and G, arrows and arrowheads, respectively) and the developing liver at E12.5
(F and H). LL66 and Foxf1 expression is observed in the mesenchyme surrounding the
posterior gut (I and K, arrows) and surrounding the esophagus and trachea (J and L,
arrowheads) at E12.5. Q-PCR analysis of NANCI, LL35, and LL66 and their associated
transcription factors in the indicated tissues at E12.5 (M) and in the adult (N). Expression
of LL1 by Q-PCR in various tissues at both E12.5 and in the adult (O). Expression of LL1
is noted in the developing limb epidermis at E15.5 (P, arrow). Expression of LL12 by QPCR in various tissues at both E12.5 and in the adult (Q). Expression of LL12 is noted in
the developing liver at E12.5 (R). Expression of LL34 by Q-PCR in various tissues at
both E12.5 and in the adult (S). Expression of LL34 is noted throughout the gut
endoderm extending from the anterior region of the embryos through the posterior region
(T-W, arrows). LL34 expression is noted in both the esophagus and trachea at E10.5 (V,
arrow and arrowhead). All values are relative to lung expression. Ai=airways, Li=liver,
E=esophagus, T=trachea. Scale bars=100µm (A-E, G, I-L, T-W), 250µm (P, R), and
500µm (F, H).
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Figure 2.10. Comparison of human NKX2.1 and NANCI/LL18 expression in the
lung.
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Figure 2.10. Comparison of human NKX2.1 and NANCI/LL18 expression in the
lung. Neonatal (two months old) human lung sections were used in ISH studies with a
probe against the human NKX2.1 (A) and NANCI (B) transcripts. Human NKX2.1 is
expressed in both proximal airway epithelium (Ai) and in alveolar epithelium (AV) but
absent in pulmonary blood vessels (BV). Human NANCI is expressed in an identical
pattern. Arrows indicate alveolar epithelium expressing both NKX2.1 (A) and NANCI (B).
NKX2.1 (C) and NANCI (D) also have similar expression patterns in human embryonic
lungs (18 weeks gestational age). Both genes are expressed in distal airways
(arrowheads) and large proximal airways (Ai), but not blood vessels (BV) Scale
bars=100µm.
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Figure 2.11. Transcription factor binding motifs are conserved in NANCI promoter
locus.

Figure 2.11. Transcription factor binding motifs are conserved in NANCI promoter
locus. Computational predicted transcription factor binding sites in the promoter region
of NANCI. Conserved predicted sites determined using the phastCons score above 0.75
are highlighted in red. Gata, TTF-1 (Nkx2.1), Forkhead, LEF/TCF, and Smad
transcription factors were analyzed because of their known role in foregut and lung
epithelial development. Only Gata, Fox, and Smad binding sites were identified in
conserved regions between the mouse and human NANCI promoter region.
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Figure 2.12. Temporal and spatial expression of lung lncRNAs located in relative
gene

deserts.

Figure 2.12. Temporal and spatial expression of lung lncRNAs located in relative
gene deserts. ISH was used to determine the expression of LL1/ANCR (A), LL12 (B),
and LL34 (C) during lung development. (A–C) Expression of all three lncRNAs is noted
in the distal lung epithelium at E12.5 and E14.5 (arrows). At E14.5, expression of
LL1/ANCR and LL12 is low in proximal airway epithelium of the lung, while LL34
expression is observed in this region (arrowheads). (A,C) By E16.5, expression of LL1
and LL34 is significantly decreased in the lung. (B) Only LL12 exhibits notable
expression at E16.5 and in the adult. (Ai) Airways. Bars, 100mm.
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Figure 2.13. Testing of shRNAs against NANCI and LL34.

Figure 2.13. Testing of shRNAs against NANCI and LL34. Five different shRNAs
were tested against NANCI (A) and LL34 (B) in MLE12 cells. These initial screens were
then use to optimize viral transduction in MLE12 cells for optimized knockdown and
microarray studies. NANCI-shRNA 1 and LL34-shRNA 2 were used for additional
experiments (A and B, blue asterisks).
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Figure 2.14. shRNA-mediated loss-of-function experiments reveal distinct roles for
NANCI and LL34 in lung epithelial gene.
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Figure 2.14. shRNA-mediated loss-of-function experiments reveal distinct roles for
NANCI and LL34 in lung epithelial gene. (A,B) Venn diagram of microarray analysis of
NANCI and LL34 shRNA knockdowns showing the number of both down-regulated and
up-regulated genes. (C) Heat map of lung epithelial genes altered by knockdown of
NANCI. (D) DAVID/GO (gene ontology) analysis shows that genes related to tube,
respiratory, and lung development (green bars) are top categories altered by NANCI
knockdown. (E) qPCR shows that Nkx2.1 and several of its targets are decreased by
knockdown of NANCI expression. (F) qPCR also shows that expression of additional
genes important for lung development were also down-regulated by knockdown of
NANCI. (G) Heat map for lung developmental and RA pathway genes altered by
knockdown of LL34. (H) DAVID/GO analysis shows that genes related to tube
development (green bar) are a top category altered by LL34 knockdown. Expression of
RA pathway components (I) and lung developmental genes known as RA targets (J) was
verified by qPCR. (J) Note that Fgf18 and Jag1 are not RA targets (blue bars). (K) RA
pathway diagram showing genes affected by decreased LL34 expression in red. All heat
maps represent genes in the indicated category selected by GO analysis. All changes in
gene expression shown by qPCR are statistically significant (P < 0.05).
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Figure 2.15. Knockdown of NANCI in human cell line results in decreased levels of
NKX2.1.

Figure 2.15. Knockdown of NANCI in human cell line results in decreased levels of
NKX2.1. Using shRNAs, NANCI was knocked down in the human lung adenocarcinoma
cell line H441. This resulted in a significant decrease in the expression of NKX2.1 and its
target AQP5 as seen by Q-PCR. Other NKX2.1 targets, such as SFTPC and SCGB1A1,
are not expressed in this cell line. All changes in gene expression shown by Q-PCR are
statistically significant (p<0.05).
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Figure 2.16. NANCI acts upstream of Nkx2.1 and downstream from Wnt/β-catenin
to regulate lung gene expression.
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Figure 2.16. NANCI acts upstream of Nkx2.1 and downstream from Wnt/β-catenin
to regulate lung gene expression. (A) Ectopic Nkx2.1 expression rescues endogenous
Nkx2.1 expression but not NANCI expression in the presence of NANCI shRNA
knockdown. (B) Ectopic Nkx2.1 expression rescues endogenous Sftpc, Abca3, and
Aqp5 expression in the presence of NANCI shRNA knockdown. (C) Expression of Aqp1
is partially rescued by exogenous Nkx2.1 expression in the presence of NANCI
knockdown. (D) Overexpression of NANCI in MLE12 increases Nkx2.1 expression.
Nkx2.1 (E,F) and NANCI (G,H) expression in control lungs (E,G) or Nkx2.1-/- lungs (F,H)
at E14.5. Note the loss of Nkx2.1 expression but persistent NANCI expression in
Nkx2.1-/- lungs. Nkx2.1 (I,J) and NANCI (K,L) expression in the control (I,K) or
Shhcre:Ctnnb1flox/flox mutant (J,L) anterior foregut at E9.5. (M) Together, these data
indicate that NANCI acts downstream from Wnt/β-catenin but upstream of Nkx2.1 to
regulate lung gene expression. (N) ChIP assay for H3K4me3 marks at the Nkx2.1
promoter, the GAPDH promoter, and an unrelated intergenic region. (O) The level of
knockdown achieved for NANCI and the level of decreased Nkx2.1 expression using
scrambled and NANCI-specific shRNAs used in the H3K4me3 ChIP assays. (P) Model
of how NANCI potentially recruits trithorax/Wdr5 complexes to the Nkx2.1 locus to
promote Nkx2.1 gene expression. Bars, 100 mm. (*) P < 0.01; (**) P < 0.05.
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Figure 2.17. Expression of genes not affected by Nkx2.1 rescue in the presence of
a NANCI shRNA knockdown in MLE12 cells.

Figure 2.17. Expression of genes not affected by Nkx2.1 rescue in the presence of
a NANCI shRNA knockdown in MLE12 cells. Expression of Nkx2.1 with simultaneous
knockdown of NANCI in MLE12 cells did not significantly rescue the expression of
Foxp1, Foxp2, Nrp1, Nrp2, or Cdh1. p>0.05 for all assays.
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Figure 2.18. RIP assays showing interaction of NANCI with Wdr5/trithorax and
LL12

with

both

Wdr5/trithorax

and

Ezh2/polycomb.

Figure 2.18. RIP assays showing interaction of NANCI with Wdr5/trithorax and
LL12 with both Wdr5/trithorax and Ezh2/polycomb. RIP assays were performed
using MLE12 cells and antibodies to Ezh2 (A) or Wdr5 (B). Note enrichment of NANCI in
Wdr5

immunoprecipitates

and

enrichment

of

LL12

in

Ezh2

and

Wdr5

immunoprecipitates. Hmbs was used as a negative control mRNA for these experiments.
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Figure 2.19. In vivo knockdown of NANCI results in defective lung epithelial
morphogenesis similar to Nkx2.1 haploinsufficiency.
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Figure 2.19. In vivo knockdown of NANCI results in defective lung epithelial
morphogenesis similar to Nkx2.1 haploinsufficiency. (A) The shRNA used in the in
vitro studies was cloned into the miR-34 premiRNA backbone as previously described
(Wang, 2007 #1008) and expressed in the developing lung epithelium using the human
SFTPC promoter. (B) H&E staining shows a thickened mesenchyme and narrower
airways in SFTPC-NANCIshRNA transgenic lungs versus nontransgenic controls. (D)
Calculation of mesenchymal thickness confirms reduced airway sacculation in SFTPCNANCIshRNA transgenic lungs. (C,D) This same mesenchymal thickening and reduced
airway sacculation was also seen in Nkx2.1+/- lungs. SFTPC-NANCIshRNA transgenic
lungs and Nkx2.1+/- lungs also exhibit decreased Scgb1a1 expression in the proximal
airways (E,F, dotted lines) as well as decreased expression and improper organization
of Sftpc+ cells in the distal airways (G,H, arrowheads). Two different examples from
different transgenic animals or mutants are shown in E–H to demonstrate consistency of
phenotype. Bars: B,C top panels, 500 mm; B,C (bottom panels), G,H, 100 mm; E,F, 50
mm. All changes in gene expression shown by qPCR are statistically significant ([*] P <
0.05) except for the difference in mesenchymal thickness between SFTPC-NANCIshRNA
transgenic lungs and Nkx2.1+/- lungs. (n.s.) Nonsignificant.
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Figure 2.20. NANCI in vivo knockdown results in decreased expression of Nkx2.1
and disrupted epithelial architecture.
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Figure 2.20. NANCI in vivo knockdown results in decreased expression of Nkx2.1
and disrupted epithelial architecture. Q-PCR was used to assess the average
knockdown efficiency in SFTPC-NANCIshRNA transgenic lungs at E17.5 and expression of
Nkx2.1 and its target genes including Nkx2.1, Scgb1a1, Sftpc, Abca3, and Aqp5 which
are all significantly down-regulated (A). Other genes found to be downregulated upon
NANCI knockdown in MLE12 cells are also downregulated in SFTPC-NANCIshRNA
transgenic lungs at E17.5 including Aqp1 and Cdh1 (B). Sox2, Sox9, and Id2 expression
are not altered (B). IHC reveals disrupted architecture in the distal airways (arrows) of
NANCI knockdown lungs, which have a similar Cdh1 staining pattern as proximal
airways (arrowheads) (E). In Nkx2.1+/- lungs many of the same genes as in SFTPCNANCIshRNA transgenic lungs are downregulated (C and D). However, Cdh1 expression
is unaffected (D) but the distal epithelial architecture is disrupted (F).
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Chapter 3: The NANCI-Nkx2.1 gene duplex buffers Nkx2.1
expression to maintain lung development and homeostasis

The data presented in this chapter is currently under review at Nature Cell Biology.
Zheng Cui helped generate the NANCIcreERT2:RFP mouse line. David Tischfield and Isis
Cendan helped analyze brain samples. Michael P. Morley and Apoorva Babu performed
bioinformatic analysis. MinMin Lu and Su Zhou performed tissue sectioning and
histological staining. Yumiao Han performed mass spectrometry analysis of protein
isolates.
3.1 Summary
A subset of long-noncoding RNAs (lncRNAs) are spatially correlated with transcription
factors (TFs) across the genome, but how these lncRNA-TF gene duplexes regulate
tissue development and homeostasis is unclear. I have identified a feedback loop within
the NANCI-Nkx2.1 gene duplex that is essential for buffering Nkx2.1 expression, lung
epithelial cell identity, and tissue homeostasis. Within this locus, Nkx2.1 directly inhibits
NANCI, while NANCI acts in cis to promote Nkx2.1 transcription. Although loss of NANCI
alone does not adversely affect lung development, concurrent heterozygous mutations in
both NANCI and Nkx2.1 leads to persistent Nkx2.1 deficiency and reprogramming of
lung epithelial cells to a posterior endoderm fate. This disruption in the NANCI-Nkx2.1
gene duplex results in a defective perinatal innate immune response, tissue damage,
and progressive degeneration of the adult lung. These data point to a mechanism where
lncRNAs act as rheostats within lncRNA-TF gene duplex loci that buffer TF expression,
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thereby maintaining tissue specific cellular identity during development and postnatal
homeostasis.

3.2 Introduction
Long noncoding RNAs, RNA transcripts 200 nucleotides or longer that do not encode a
functional protein, have been shown to regulate a wide variety of biological processes
(Wapinski and Chang 2011; Li and Chang 2014; Meller et al. 2015; Li et al. 2016).
Despite growing evidence that lncRNAs play important roles in regulating gene
expression, their role in tissue development and homeostasis remains unclear (Li and
Chang 2014; Feyder and Goff ; Perry and Ulitsky). Recent work from our lab and others
has identified a class of lncRNA that are spatially located near critical transcription factor
(TF) genes (Guttman et al. 2009; Ulitsky et al. 2011; Herriges et al. 2014). These TFlncRNA duplexes can be further divided into those that reside upstream and embedded
within the regulatory region of TFs or those that reside downstream and outside of the
proximal promoter and regulatory elements of the TF gene. This spatial localization is
conserved across species with mouse and human TF-lncRNA duplexes exhibiting
common syntenic locations in the genome, which suggests a critical regulatory function
for regulating gene expression.

In both mice and humans the lncRNA NANCI (Nkx2.1 Associated Noncoding Intergenic
RNA) is located downstream of the TF Nkx2.1, a major regulator of pulmonary
development and homeostasis (Herriges et al. 2014). Inactivation of Nkx2.1 during
development leads to dramatic loss in branching morphogenesis along with defective
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lung epithelial lineage differentiation (Minoo et al. 1995; Minoo et al. 1997), while
postnatal loss of Nkx2.1 expression results in defects associated with a loss of lung
epithelial homeostasis and respiratory failure (Snyder et al. 2013). Despite the
importance of maintaining Nkx2.1 expression in the lung, little is known about how its
expression is regulated (Herriges and Morrisey 2014).

Here I show that within the NANCI-Nkx2.1 duplex, NANCI plays an essential role in
regulating tissue identity by acting as a transcriptional rheostat to buffer Nkx2.1
expression. During lung development and in adult lung homeostasis, NANCI acts in cis
to positively regulate Nkx2.1, and in turn, Nkx2.1 directly inhibits NANCI expression.
Together this generates a negative feedback loop between NANCI and Nkx2.1, which
buffers against dramatic reductions in Nkx2.1 expression. NANCI expression is also
controlled through interactions with Hnrnpab and Hnrnpd, which promote turn-over of the
NANCI transcript to modulate NANCI expression, and in turn Nkx2.1 expression.
Surprisingly, loss of NANCI expression by itself has a minimal impact on lung
development and homeostasis. However, concurrent in trans mutations of both NANCI
and Nkx2.1 disrupt the buffering loop, resulting in persistent Nkx2.1 deficiency. This
persistent loss of Nkx2.1 expression leads to defects in the perinatal innate immune
system and progressive lung degeneration due to a loss of lung epithelial cell identity
and cellular reprogramming to a posterior endoderm fate. Together, these findings
establish a new paradigm for TF-lncRNA duplexes in which lncRNAs act as rheostats to
buffer expression of critical TFs to maintain cell fate and normal tissue homeostasis.
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3.3 Expression of NANCI in a subset of Nkx2.1+ cells during lung, brain, and
thyroid development
To fully examine the expression of NANCI in a cell lineage specific fashion as well as the
consequences of loss of NANCI function, I generated a NANCI reporter line
(NANCIcreERT2:RFP)

that

also

disrupts

expression

of

NANCI

(Fig.

3.1A).

The

NANCIcreERT2:RFP allele contains a polyadenylated cassette encoding a tamoxifeninducible cre recombinase (creERT2) linked to a TdTomato red fluorescent protein
(RFP) that replaces much of exon 1 in the NANCI locus including the splice donor site.
This allows for the isolation and characterization of NANCI expressing cells including
tamoxifen inducible lineage tracing. The reporter construct was inserted into a region
lacking H3K4me1 or DNAse hypersensitivity peaks, suggesting the insertion is not
directly influencing a genomic enhancer region (Fig. 3.2A) (Consortium 2012). The
NANCIcreERT2:RFP reporter line exhibits broad expression of RFP throughout the lung
epithelium, consistent with previous NANCI in situ hybridizations expression patterns
(Herriges et al. 2014) (Fig. 3.1B). However, in both embryonic and adult lungs I identified
a subset of Nkx2.1+ cells that expressed little or no RFP (Fig. 3.1C,D white arrow
heads). In contrast, I were unable to find any RFP+/Nkx2.1- cells suggesting that NANCI
is not expressed in cells lacking Nkx2.1 expression.

Outside of the lung, NANCI and Nkx2.1 are co-expressed in the forebrain and thyroid
(Herriges et al. 2014). To characterize NANCI expression in the brain I compared RFP
and Nkx2.1 expression at E12.5 and E18.5. At E12.5, NANCI was expressed in the
medial ganglionic eminence (MGE), anterior entopeduncular/preoptic area (PoA),
hypothalamus, and developing globus pallidus (Fig. 3.2B). This expression pattern
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overlapped with that of Nkx2.1. At E18.5, NANCI continued to be expressed in most
Nkx2.1+ cells of the hypothalamus and globus pallidus. In the thyroid NANCI expression
was restricted to the Nkx2.1+ epithelium (Fig. 3.3A). As in the lung, NANCI expression
was more variable than Nkx2.1 expression.

3.4 NANCI preferentially expressed in alveolar type 2 and secretory epithelial cells
in the mature lung
To further explore the expression of NANCI and how it relates to cell lineage identity in
the lung, I used fluorescence-activated cell sorting (FACS) to isolate adult lung epithelial
cells from NANCIcreERT2:RFP/+ mice based on RFP expression (Fig. 3.4A). This sorting
generated three populations (RFP-High, RFP-Med, and RFP-Low), which were further
analyzed by quantitative real time PCR (Q-PCR) to measure RFP, NANCI, and Nkx2.1
expression (Fig. 3.4B). The expression of NANCI, as well as Nkx2.1, correlated with
RFP expression from the NANCIcreERT2:RFP/+ line. This suggests that the NANCIcreERT2:RFP/+
reporter accurately reflects the variations in NANCI expression, which in turn correlates
with Nkx2.1 expression.

Gene expression analysis of the RFP-High population reveals that it is composed
primarily of Sftpc+ alveolar type 2 (AT2) cells and, to a lesser extent, Scgb1a1+
secretory cells (Fig. 3.1E). Foxj1+ ciliated cells and Pdpn+ alveolar type 1 (AT1) cells
are primarily restricted to the RFP-Med and RFP-Low populations. Analysis of these cell
types by immunohistochemistry (IHC) verifies that AT2 and secretory cells (Fig. 3.1F,
yellow arrows) express higher levels of RFP than neighboring epithelial cells (white
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arrowheads). Likewise, ciliated and AT1 cells (Fig. 3.1F and Fig. 3.4E, yellow arrows)
exhibit lower expression of RFP than neighboring epithelial cells (white arrowheads).
Although they were not detectable by Q-PCR, neuroendocrine cells also express RFP at
higher levels than the surrounding epithelial cells (Fig. 3.4E). FACS sorting of epithelial
cells using an Nkx2.1GFP reporter line likewise reveals three distinct populations of
Nkx2.1 expressing lung epithelium (Fig. 3.1G, Fig. 3.4C,D). However, unlike NANCI
expression, Nkx2.1 expression does not clearly separate the five lung epithelial cell
lineages examined by Q-PCR or IHC (Fig. 3.1H, Fig. 3.4F). These data suggest that
NANCI expression levels, but not Nkx2.1 expression, can delineate epithelial cell
lineages in the lung with the highest levels of NANCI expression found in AT2 and
secretory cells.

3.5 NANCI expression is essential for normal levels of Nkx2.1 expression
Our previous work suggested that shRNA mediated knockdown of NANCI lead to
decreased Nkx2.1 expression (Herriges et al. 2014). Therefore, I analyzed expression of
NANCI and

Nkx2.1

in

NANCIcreERT2:RFP/creERT2:RFP homozygous mice. At E18.5

NANCIcreERT2:RFP/creERT2:RFP mice show an almost complete loss of NANCI expression by
Q-PCR and in situ hybridization (Fig. 3.5A, Fig. 3.6B). This reduced NANCI expression
resulted in decreased expression of Nkx2.1 and known target genes including Abca3,
Sftpa, and Sftpc, while genes not directly regulated by Nkx2.1 (Pdpn, Foxj1) were
unaffected (Fig. 3.6A). In adult mice, loss of NANCI results in a 24% reduction in Nkx2.1
expression, which did not lead to significant changes in the expression of Nkx2.1 target
genes. To determine if expression of other genes are significantly effected upon loss of
NANCI expression, I used RNA-seq to compare gene expression in E18.5 wild-type and
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NANCIcreERT2:RFP/creERT2:RFP lung epithelial cells. Surprisingly, these data did not reveal
significant alterations in gene expression upon loss of NANCI expression, suggesting
that the moderate effect that loss of NANCI has on Nkx2.1 expression does not result in
a dramatic effect on overall lung epithelial gene expression (Fig. 3.6D).

Despite reduced Nkx2.1 expression, NANCIcreERT2:RFP/creERT2:RFP mutants display no
discernable morphological defects at E18.5 or 10 weeks of age (Fig. 3.6C). This is
consistent with the fact that Nkx2.1+/- mice have similarly reduced Nkx2.1 expression
levels, but no clear morphological defects at these stages. Thus, while NANCI promotes
Nkx2.1 expression during lung development, loss of NANCI alone does not reduce
Nkx2.1 expression sufficiently to induce detectable morphological defects.

3.6 NANCI and Nkx2.1 form a negative feedback loop that buffers Nkx2.1
expression
To test whether Nkx2.1 regulates NANCI expression, I analyzed NANCI expression in
Nkx2.1GFP/+ mice, in which the coding region and 3’ UTR of one Nkx2.1 allele are
replaced by GFP (Longmire et al. 2012). At E18.5 these mice have a 25% increase in
expression of NANCI, indicating that Nkx2.1 inhibits NANCI expression (Fig. 3.5B).
Likewise, NANCI expression in Nkx2.1GFP/+ mice increases two- and three-fold at 10
weeks and 6 months of age, respectively. This increase in NANCI expression with age
correlates with increased relative Nkx2.1 expression, such that Nkx2.1GFP/+ mice express
wild-type levels of Nkx2.1 by 6 months. Analysis of NANCI and Nkx2.1 expression in the
brains of Nkx2.1GFP/+ mice indicates a similar feedback loop exists in the brain (Fig.
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3.2C). Furthermore, using chromatin immunoprecipitation:Q-PCR (ChIP-PCR), I found
that Nkx2.1 binds to a predicted Nkx2.1 binding site within the NANCI promoter,
suggesting that Nkx2.1 directly inhibits NANCI expression (Fig. 3.7A,B). This is
consistent with the ability of Nkx2.1 to directly repress expression of genes including
Nrp2 (Nobrega-Pereira et al. 2008). Together, this indicates that NANCI and Nkx2.1
form a negative feedback loop that can buffer Nkx2.1 expression, especially in situations
of compromised Nkx2.1 expression such as in Nkx2.1GFP/+ mice.

To further test this buffering feedback loop, I generated mice with concurrent in trans
mutations of NANCI and Nkx2.1 (NANCIcreERT2:RFP/+:Nkx2.1GFP/+). If NANCI acts in cis,
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice should display a further reduction in Nkx2.1
expression.

Indeed,

at

E18.5,

10

weeks,

and

6

months

of

age,

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice had a significant reduction in Nkx2.1 expression
relative to the other genotypes (Fig. 3.5B). At 6 months these mice also have increased
expression of GFP, which is expressed from the Nkx2.1 locus in cis to the remaining
intact NANCI locus (Fig. 3.5C). This is consistent with NANCI acting in cis, but not trans,
to promote expression of the neighboring Nkx2.1 gene (Fig. 3.5D). Thus, NANCI and
Nkx2.1 act in concert as a buffering system to control the expression of this gene duplex.
Examination of TF-associated lncRNAs in the mouse and human genome shows that
there is a unique subset of lncRNAs that are located downstream of TFs in a similar
duplex formation as NANCI-Nkx2.1 (Fig. 3.5E). These downstream sense lncRNAs may
act through a different mechanism than divergent lncRNAs, which often overlap the
regulatory regions of their neighboring coding gene (Guttman et al. 2009; Sauvageau et
al. 2013; Herriges et al. 2014; Akerman et al. 2016; Anderson et al. 2016). Thus, NANCI
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is one of many downstream TF-associated lncRNAs and may serve as a paradigm for
similar lncRNAs, including those located near the critical TF’s Foxa2 and Neurog1 (Fig.
2.4) (Table 3.1).

3.7 hnRNPab and hnRNPd regulate Nkx2.1 expression through their ability to
modulate NANCI transcript stability
To identify proteins that interact with NANCI and regulate its expression and/or function,
I used mass spectrometry to identify NANCI-protein interactions in a murine lung
epithelial cell line. 44 proteins were found to be consistently enriched in the NANCI
pulldown relative to pulldown with a control RNA transcript of similar length (Table 3.2,
Fig. 3.7C). This included Hnrnpab, Hnrnpd, and Hnrnpa2b1, which were verified by
Western blots (Fig. 3.7D). Hnrnpab and Hnrnpa2b1 have been shown to mediate the
function of the lncRNA lincRNA-Cox2 (Carpenter et al. 2013). In contrast, Hnrnpd
promotes RNA degradation (Brewer 1991; Zhang et al. 1993; White et al. 2016) and
Hnrnpab, a member of the same subfamily, may serve a similar function (Akindahunsi et
al. 2005; Czaplinski et al. 2005). To test the ability of these proteins to regulate NANCI
activity, I used shRNAs to knockdown their expression in MLE12 cells (Fig. 3.7E).
Knockdown of Hnrnpab and Hnrnpd, but not Hnrnpa2b1, resulted in increased
expression of NANCI and Nkx2.1 (Fig. 3.5F). Together this suggests that Hnrnpab and
Hnrnpd regulate NANCI transcript stability and in turn Nkx2.1 expression (Fig. 3.5G).
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3.8 The NANCI-Nkx2.1 buffering loop is essential for lung epithelial development
and the perinatal innate immune response
To determine the effects of disrupting the NANCI-Nkx2.1 buffering loop during
development, I analyzed pulmonary morphology and gene expression at E18.5 and at
postnatal day 4 (P4). At E18.5, both Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+
mutants have mild morphological defects in the developing alveolar space as indicated
by extended distal airspaces that lacked much of the alveolar septation found in wildtype

mice

(Fig.

3.8A).

Moreover,

at

this

time

point

both

Nkx2.1GFP/+

and

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants have reduced expression of markers for several
lung epithelial cell lineages, indicative of delayed pulmonary development (Fig. 3.8B,C).
Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants exhibit ectopic expression of
Hnf4a, a transcription factor expressed in hindgut epithelium, consistent with previous
work suggesting Nkx2.1 represses a posterior endoderm transcription program (Snyder
et al. 2013).

By P4 Nkx2.1GFP/+ mice express normal levels of many lung epithelial markers, except
Sftpc, suggesting compensatory mechanisms for maintaining Nkx2.1 expression in the
perinatal period (Fig 3.8D-F). In contrast, the NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants
exhibit alveolar simplification and decreased expression of lineage markers for AT2,
secretory, multi-ciliated, and AT1 cells (Fig. 3.8F). At P4, Hnf4a expression had
increased dramatically in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants, suggesting increased
activation of ectopic posterior endoderm transcriptional pathways in these mutants due
to persistent Nkx2.1 deficiency.

These data suggest that without NANCI in cis, the

functional Nkx2.1 allele is unable to normalize perinatal Nkx2.1 expression.
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In

addition

to

alveolar

simplification

and

developmental

delay,

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4 display a localized severe perinatal
inflammatory response. This response is exemplified by engorged distal airspaces filled
with a mixture of proteinaceous debris and immune cells (Fig. 3.9A). Flow analysis
indicates a dramatic influx of neutrophils in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4
(Fig. 3.9B). These mutants display gaps in the epithelial barrier in both the proximal and
distal airways (Fig. 3.9C white arrowheads) as well as E-cadherin positive cells in the
airway lumen (Fig. 3.9C yellow arrows). This suggests a loss of epithelial barrier
integrity, which likely contributes to the severe inflammatory response.

To better characterize the causes of this perinatal phenotype I used RNA-seq to
compare gene expression in wild-type, Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+
lung epithelium at E18.5, prior to evidence of an immunological response. By gene
ontology (GO) analysis, NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants displayed altered
expression of several gene categories including increased mitotic cell division and
decreased expression of genes involved in regulation of immune response (Fig. 3.9D).
Combined with the reduced expression of lung epithelial lineage markers, this data
suggest the lung epithelium in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants is more proliferative
but immature compared to wild-type controls or Nkx2.1GFP/+ mutants.

In the immune response categories, expression of colony stimulating factor 2 (Csf2) was
significantly decreased in mutants. Csf2 is a key regulator of epithelial barrier function
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and a cytokine that promotes granulocyte and monocyte maturation (Overgaard et al.
2015; Whitsett and Alenghat 2015). Csf2 deficiency leads to pulmonary alveolar
proteinosis (PAP), in which the pulmonary airspace is filled with non-cellular debris,
similar to the phenotype observed in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4. QPCR

verified

that

Csf2

is

significantly

down-regulated

in

Nkx2.1GFP/+

and

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at E18.5, but only in NANCIcreERT2:RFP/+:Nkx2.1GFP/+
mutants at P4 (Fig. 3.9E). Nkx2.1 binds to the Csf2 promoter, suggesting Nkx2.1 directly
activates Csf2 expression in the maturing pulmonary epithelium (Fig. 3.9G and H).

Despite reduced expression of Csf2, perinatal NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant
lungs contain a large population of neutrophils, suggesting up-regulation of other
cytokines that recruit neutrophils. Using our RNA-seq data as well as Q-PCR, I found
that the cytokine secreted phosphoprotein 1 (Spp1), also known as osteopontin, was upregulated in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at E18.5 (Fig. 3.9F). Spp1 promotes
recruitment of neutrophils, consistent with the increased neutrophil population in
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant lungs (Zissler et al. 2016). However, I did not
observe Nkx2.1 binding to the Spp1 promoter, suggesting that up-regulation of Spp1 is a
secondary response to the barrier defects in these lungs (Fig. 3.9G and H, Table 3.3).
This is consistent with previous Nkx2.1 ChIP-seq data showing that Nkx2.1 binds to the
Csf2 promoter, but not the Spp1 promoter (Snyder et al. 2013). Taken together, these
data suggest that the perinatal phenotype observed in NANCIcreERT2:RFP/+:Nkx2.1GFP/+
mutants results from multiple defects including Csf2 deficiency, elevated Spp1
expression, and a loss of epithelial barrier integrity.
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Despite the profound perinatal phenotype seen in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants,
these animals survive to at least four weeks of age when the lung reaches maturity.
Unlike the earlier time points, at four weeks of age Nkx2.1 expression is not significantly
different between Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs (Fig. 3.10A). This
increase in Nkx2.1 expression is not accompanied by increased expression in NANCI,
suggesting a NANCI-independent mechanism is responsible for the normalization of
Nkx2.1 expression. By four weeks of age, the exogenous immune cells and PAP
phenotype have also resolved and lung morphology is similar to that of wild-type lungs
(Fig. 3.10B). Furthermore, expression of pulmonary cell type markers has largely
normalized to wild-type levels in these mutants (Fig. 3.10C). At this stage Csf2
expression

has

increased

and

Spp1

expression

has

decreased

in

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs, counterbalancing the earlier altered expression of
these cytokines and correlating with a resolution of the innate immune response
observed in the perinatal period.

3.9 Disruption in the NANCI-Nkx2.1 gene duplex leads to a failure of pulmonary
homeostasis and reprogramming of lung epithelium to a posterior endoderm fate
While NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants were relatively normal at four weeks of age,
adult 10 week old mutants began to exhibit inflammation of the large airways as well as
basal and mucousal cell metaplasia (Fig. 3.11A). This phenotype was accompanied by
Nkx2.1 deficiency, consistent with the known role of Nkx2.1 in inhibiting airway
inflammation (Maeda et al. 2011). I also observed reduced expression of Scgb1a1, a
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marker of the airway secretory cell lineage (Fig. 3.11G). In contrast to the perinatal
period, the inflammatory reaction at 10 weeks was not associated with significant
alterations in Csf2 or Spp1 expression (Fig. 3.11G).

Alveolar

simplification

and

bronchiolization

of

the

alveoli

was

observed

in

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at 10 weeks (Fig. 3.11A, black arrowheads).
Bronchiolization of the alveoli is characterized by cells resembling bronchiolar epithelium
lining normal or thickened alveolar walls (Wang et al. 2009). These bronchiolized distal
alveoli consist primarily of Sox2+/Scgb1a1+ cells, suggesting they represent airway
secretory cells (Fig. 3.11B). While I did not observe any Sox2+/Pdpn+ alveolar type 1
cells or Sox2+/Foxj1+, multi-ciliated epithelial cells, there were rare Sox2+/Sftpc+ and
Scgb1a1+/Sftpc+ cells (Fig. 3.11C-F). At 10 weeks of age there is also a resurgence of
ectopic Hnf4a expression in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants (Fig. 3.11G). Pdpn
and Scgb1a1 expression is decreased in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at 10
weeks indicating disruption in the NANCI-Nkx2.1 regulatory gene duplex and defects in
AT1 and secretory cell homeostasis (Fig. 3.11G).

Six month old NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants exhibit further progression of the
phenotypes observed at earlier stages. RNA-seq analysis of the lung epithelial cells at
six months of age revealed decreased expression of genes involved in respiratory and
epithelial development, but increased expression of genes involved in digestion,
confirming the reprogramming of pulmonary epithelial cells to a posterior endoderm fate
(Fig. 3.12A and B, Fig. 3.13A). At this time airway inflammation has resolved, but there
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is a dramatic loss of pulmonary secretory cells and ectopic expansion of goblet
(Muc5ac+) and basal (Krt5+/Trp63+) cells (Fig. 3.12C, Fig. 3.13B). The bronchiolization
of the alveolar region has progressed concomitantly with a sharp decrease in expression
of the AT2 marker Sftpc (Fig. 3.12G and Fig. 3.13A). The bronchiolized alveolar region
contains epithelium bearing markers of secretory and ciliated cells of the proximal
airways as well as ectopic Krt5+/Trp63+ cells in the distal airspaces, suggesting either
loss of alveolar epithelium and extension of airway basal cells into the alveolar space or
a reprogramming of alveolar epithelium into a basal cell phenotype (Fig. 3.12I,J, Fig.
3.13B). Importantly, these bronchiolized regions contain Sox9+/Hnf4a+ cells, resembling
hindgut stem cells (Fig. 3.12G,H). Additional markers of hindgut endoderm including
Lgr5,

Vsig1,

Lgals4,

and

NANCIcreERT2:RFP/+:Nkx2.1GFP/+

Ctse
mutants

are
at

also
six

dramatically
months

(Fig.

increased
6H).

in
The

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ peripheral epithelium is highly apoptotic and degenerative
at this stage (Fig. 3.13C). This correlates with increased expression of immune response
genes and recruitment of macrophages to clear cellular debris in the airways (Fig. 3.12B,
Fig 3.13D,E). These molecular and cellular changes result in a dramatic loss of alveolar
structure in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at this time point (Fig. 3.12C). These
phenotypes are in contrast to all of the other genotypes examined, including Nkx2.1GFP/+
mice, whose gene expression profile and morphology are indistinguishable from those of
wild-type mice (Fig. 3.12C and Fig. 3.13A-C). At these timepoints the adult brain showed
no major morphological defects (data not shown). However, the thyroid of both
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ and Nkx2.1GFP/+ mutants exhibit similar morphological
defects as well as elevated serum TSH levels, consistent with hypothyroidism due to
Nkx2.1 deficiency (Fig. 3.3B,C) (Kusakabe et al. 2006).
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Examination of cell proliferation in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant lungs at 6
months reveals that the Scgb1a1+ secretory cells found in the distal bronchiolized
alveoli are highly proliferative (Fig. 3.13F,H). In contrast, Sftpc+ AT2 cells in these
mutants do not exhibit an increase in proliferation suggesting that they are not
responding to the loss of homeostasis by re-activating a pro-growth regenerative
program (Fig. 3.13G,H). These data indicate that loss of the NANCI-Nkx2.1 rheostat
function on the gene duplex leads to a cell lineage specific loss of lung epithelial
homeostasis caused in part by a reprogramming of distal alveolar epithelium towards a
more posterior endoderm fate. This loss of lung epithelial cell identity also appears to
reduce the regenerative potential of resident AT2 cells, possibly due to the loss of their
native cell fate. Taken together, these studies reveal that NANCI acts as an important
rheostat of Nkx2.1 expression that is necessary for maintaining lung epithelial cell
identity and function.

3.10 DISCUSSION
Several reports have shown that lncRNAs regulate protein-coding genes in cis, however,
few have revealed the in vivo consequences of this regulation (Feyder and Goff 2016;
Kotzin et al. 2016; Quinn and Chang 2016). Genetic inactivation of lncRNAs have often
resulted in no apparent phenotype, leading to the conclusion that many if not most
lncRNAs have little impact on gene regulation and tissue development or that their loss
is compensated for by other mechanisms (Eissmann et al. 2012; Zhang et al. 2012;
Sauvageau et al. 2013; Kohtz 2014). The present study shows that while the loss of the
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lncRNA NANCI alone does not affect overall lung development or homeostasis in a
significant manner, NANCI is required to maintain Nkx2.1 expression. Loss of NANCI’s
rheostat function in situations of compromised Nkx2.1 expression leads to profound
innate immune defects and a reprogramming of lung epithelium towards a posterior
endoderm phenotype. The overall effect on adult tissue homeostasis is dramatic and
provides critical insight into how lncRNAs function as transcriptional rheostats, which are
essential for buffering neighboring protein-coding genes including master transcription
factors such as Nkx2.1.

Previous studies have revealed that lncRNAs are more often found near TFs than other
categories of protein coding genes (Guttman et al. 2009; Ulitsky et al. 2011; Herriges et
al. 2014).

Interestingly, mutations in TFs underlie many human congenital

haploinsufficient diseases (Dang et al. 2008). In particular, NKX2.1 haploinsufficiency
causes a rare but often lethal disorder called Brain-Lung-Thyroid Syndrome (BLTS)
(Hamvas et al. 2013). Symptoms in BLTS patients include respiratory failure along with
serious thyroid and neural dysfunction. However, there is a wide variation in the
phenotypes observed in BLTS patients with many lacking a notable phenotype in any
one of the tissues that express NKX2.1. In addition to BLTS, alterations in NKX2.1 have
been associated with different forms of lung cancer (Yang et al. 2012; Yamaguchi et al.
2013). Given the critical role for TFs such as NKX2.1 in both development and tissue
homeostasis, exquisite control of their expression levels is essential. This fine control
likely requires multiple modes of regulation, but the role of TF-associated lncRNAs in this
system is largely unknown.
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While lncRNA expression has been shown to be highly tissue specific, characterization
of in vivo expression patterns has been hampered by the lack of reporters and the
inability to use standard antibody protein detection techniques (Cabili et al. 2011). I have
overcome these limitations by using a fluorescent and lineage tracing reporter system to
characterize in detail the expression of NANCI and compare it at cellular resolution to its
neighboring transcription factor and gene duplex partner Nkx2.1. I find that NANCI
expression, while highly similar to Nkx2.1, shows cell lineage specific differences of
expression in the embryonic and adult lung. The highest levels of NANCI expression are
restricted to AT2 and secretory lineages suggesting that NANCI plays a preferential role
in the development and homeostatic maintenance of these epithelial lineages. NANCI
null mice have reduced expression of Nkx2.1, verifying previous studies indicating the
NANCI promotes Nkx2.1 expression (Herriges et al. 2014). Surprisingly, Nkx2.1 appears
to repress NANCI expression through directly binding to the NANCI promoter, similar to
how Nkx2.1 directly represses expression of Nrp2, suggesting a feedback loop within the
NANCI-Nkx2.1 gene duplex (Nobrega-Pereira et al. 2008). The net effect of this loop is
to buffer against drastic changes in Nkx2.1 expression, as illustrated by the
normalization of Nkx2.1 expression in ageing Nkx2.1GFP/+ mice. Thus, our studies point
to a new model for lncRNA regulatory function whereby lncRNAs act as rheostats that
buffer expression of neighboring TFs. This model suggests that lncRNAs in such
lncRNA-TF duplexes are not an absolute requirement for expression of neighboring TFs,
but instead act as fine-tuning rheostats that ensure proper TF expression in response to
genetic or environmental stress.
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Utilizing in vivo loss of function models for NANCI and Nkx2.1, I show that loss of NANCI
expression leads to reduced Nkx2.1 expression, but not major morphological defects.
This suggests as yet unknown compensatory mechanisms for regulating Nkx2.1
expression in the absence of NANCI. However, by the end of gestation, both Nkx2.1GFP/+
and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice show signs of pulmonary developmental delay
(Fig. 3.14). Postnatal Nkx2.1GFP/+ mice up-regulate NANCI in a compensatory fashion,
which increases Nkx2.1 expression back to wild-type levels and restores normal
pulmonary maturation. In contrast, concurrent in trans heterozygous loss of both NANCI
and Nkx2.1 leads to persistent Nkx2.1 deficiency at all stages of life. At P4, this
deficiency begins to reprogram lung epithelial cell identity causing ectopic expression of
a hindgut transcriptional program and delay development of pulmonary epithelial cells
necessary for proper lung homeostasis. The persistent Nkx2.1 deficiency in
NANCIcreERT2:RFP/+;Nkx2.1GFP/+ aged mutants leads to a severe pulmonary degenerative
phenotype by six months as the normal alveolar structure is replaced by ectopically
reprogrammed airway and hindgut-like cells. These reprogrammed lung epithelial cells
cannot maintain lung alveolar epithelial cell identity and are unlikely to be able to
efficiently perform gas exchange. This progressive and degenerative phenotype
indicates that while a complete loss of NANCI can be compensated for in the presence
of two intact Nkx2.1 alleles, further decrease in Nkx2.1 expression due to deletion of one
allele, results in a failure to maintain expression of this critical transcription factor. This in
turn results in a loss of adult lung epithelial cell fate.

There have been several lncRNAs identified near important TFs including Gata6, Foxa2,
Foxf1, and eHand (Guttman et al. 2009; Sauvageau et al. 2013; Herriges et al. 2014;
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Anderson et al. 2016). These syntenically conserved lncRNAs are found either upstream
or downstream of their neighboring TF. However, it has been unclear whether the
relative localizations or orientations reflect unique functions. The lncRNA Upperhand,
which is located 150bp upstream and anti-sense to the TF Hand2, has been shown to
play an almost essential role for expression of the TF Hand2 (Anderson et al. 2016). The
lncRNA Fendrr similarly shares a divergent promoter region with the TF Foxf1, but like
NANCI, Fendrr is not absolutely necessary for expression of its neighboring TF
(Sauvageau et al. 2013). In contrast, NANCI is located downstream and sense to
Nkx2.1. This orientation is observed in a significant subset of lncRNAs associated with
crucial TFs like Foxa2 and Neurog1 (Supp. Table. 1) (Herriges et al. 2014). The
downstream orientation of these lncRNAs away from the upstream regulatory regions of
neighboring coding genes suggests a different mode of action than those that share
divergent promoters with the neighboring TF. The NANCI-Nkx2.1 duplex provides a
novel model for how this subset of lncRNAs function as rheostats to buffer expression of
neighboring TF genes. This category of lncRNAs, including NANCI, are likely critical for
maintaining TF expression in response to genetic or environmental stress. Thus, it will
be important to assess their function in trans to their neighboring TF using compound
mutants such as described here. Given the diverse functions identified thus far for
lncRNAs, it is essential that their functions be assessed fully and carefully in vivo to
define their contribution to tissue development and homeostasis. Analysis and
comparison of these lncRNAs will help to reveal the common and unique mechanisms
necessary for their ability to act as buffering rheostats for TF expression.
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3.11 Materials & Methods
Animals
The Nkx2.1GFP mouse line was a generous gift from Darrell Kotton at BU, and its
construction has been previously described (Longmire et al. 2012). The NANCIcreERT2:RFP
mouse was constructed by inserting an expression cassette consisting of an IRES
sequence, creERT2 cDNA linked to a 2A self-cleaving peptide sequence linked to a
TdTomato cDNA, and a polyadenylated stop site into the first splice donor site of NANCI.
Full details on the construction of this reporter line are available upon request. All animal
studies were performed under guidance of the University of Pennsylvania Institutional
Animal Care and Use Committee.

Isolation of Adult Epithelial Cells by FACS
Adult epithelial cells were collected as previously described (Frank et al. 2016).
NANCIcreERT2-TdTomato and Nkx2.1GFP/+ adult lungs were harvested and processed into
single cell suspensions using a dispase (Collaborative Biosciences)/collagenase (Life
Technologies)/DNase solution.

Epithelial cells were sorted from the single cell

suspension using either a MoFlo Astrios EQ (Beckman Coulter) or FACSJazz (BD
Biosciences) flow cytometer with antibody staining for CD31-PECy7 (eBioscience),
CD45-PECy7 (eBioscience), and EpCAM-APC (eBioscience).

Following negative

selection for CD31 and CD45, epithelial cells were isolated by positive selection for
EpCAM then separated based on RFP or GFP expression and sorted into Trizol LS.

105	
  
	
  

Pulmonary Quantitative Real-Time PCR
E18.5 and P4 lungs were harvested and processed into single cell suspensions using a
dispase (Collaborative Biosciences)/collagenase (Life Technologies)/DNase solution.
Epithelial cells were enriched using an EpCAM antibody (eBioscience, 17-5791-82) and
Dynabeads (Invitrogen, Sheep anti-Rat IgG) following manufacturer’s instructions. Adult
lungs (4 weeks, 10 weeks, and 6 months) were harvested and total RNA was isolated
using Trizol (Invitrogen, Carlsbad, CA) per manufacturer’s protocol. cDNA was
synthesized from total RNA by using SuperScript Strand Synthesis System (Invitrogen,
Carlsbad, CA, USA). Quantitative real time PCR was performed using the SYBR green
system (Applied Biosystems, Foster City, CA, USA) with primers listed in Table 3.4.
GAPDH expression values were used to control for RNA quality and quantity.

Forebrain Quantitative Real-Time PCR
For analysis of forebrain transcription, brain regions caudal to the expression of Nkx2.1
at the junction of the hypothalamus were removed and the remaining forebrains were
placed in TRIzol reagent (Invitrogen). RNA was extracted using the PureLink RNA Mini
kit (Invitrogen). cDNA was synthesized using the VILO cDNA synthesis kit (Invitrogen).
qPCR was conducted using Taqman Gene Expression Assays (Applied Biosystems).
Each sample was run in triplicate on the same plate, on a Stratagene MX3005P realtime PCR machine (La Jolla, CA) following the manufacturer’s recommended protocol.

RNA-seq analysis
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E18.5 lung epithelial cells from wild-type, NANCIcreERT2:RFP/creERT2:RFP, Nkx2.1GFP/+, and
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs (3 samples per genotype) collected as described for
Q-PCR and RNA was isolated using Trizol. The University of Pennsylvania NextGeneration Sequencing Core performed library preparation and RNA-seq for these
samples. 6 month epithelial cells were sorted into Trizol as described for FACS, however
epithelial cells were not sorted into distinct populations based on RFP or GFP
expression. Samples were collected from 3 wild-type, 3 Nkx2.1GFP/+, and 4
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs. Library preparation and sequencing for these
samples was performed at GENEWIZ, LLC.

Fastq files were assessed for quality control using the FastQC program. Fastq files were
aligned against the mouse refence genome (mm9) using the STAR aligner (Dobin et al.
2013). Duplicate reads were flag using the MarkDuplicates program from Picard tools.
Per gene read counts for Ensembl (v67) gene annotations were computed using the
Rsubread R package with duplicate reads removed. Gene counts represented as counts
per million (CPM) were first nominalized using TMM method in the edgeR R package
and genes with 25% of samples with a CPM > 1 were removed and deemed low
expressed. The data was transformed using the VOOM function from the limma R
package (Law et al. 2014). Differential gene expression was performed using a linear
models with the limma package. Heatmaps and PCA plots were generated in R. Gene
Ontology enrichment analysis for the Biological Process was performed using R
package GAGE. The Gene Expression Omnibus accession number for the RNA-seq
data is GSE92304.
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TF-lncRNA duplex identification
Gene annotation and position information was obtained from the GENCODE project for
human (v25) and mouse (v12) (Harrow et al. 2012).Genes annotated with
transcript_type of “lincRNA” and “bidirectional_promoter_lncRNA” were used to define
lncRNAs. The distance between each protein coding gene to the closet non-overlapping
lncRNA was computed using the closest function in the Bedtools suite. Protein coding
genes were annotated and filtered as transcription factors using the AnimalTFDB 2.0
database (Zhang et al. 2015)

Flow cytometric analysis of immune populations
Flow cytometry was used to identify immune cells in P4 lungs. P4 lungs were harvested
and processed into a single cell suspension as described for FACS. Cells were stained
Aqua Live/Dead viability stain to exclude dead cells. Cells were then stained with one of
two standard panels of antibodies listed in Table 3.5. After staining for 30 minutes on ice,
cells were washed in PBS and run for data acquisition with a BD LSR11 Cytometer
utilizing the FACS Diva Software (BD Bioscience). Data was analyzed using FlowJo. For
identification of neutrophils and Ly6c+ monocytes I used the following strategy. After
exclusion of dead cells all other cells expressing the common leukocyte marker CD45
were identified. Cd11b+ myeloid cells were then divided into ly6gHigh neutrophils and
Ly6c+ monocytes. For identification of B-cells (B220+) and CD4+ T-cells I used the
following strategy. After exclusion of dead cells all other cells expressing the common
leukocyte marker CD45 were identified and lymphocytes were selected using their side
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scatter and forward scatter profiles. For identification of CD4+ T-cells I gated the
population CD4+ cells. B-cells were identified as those cells that were CD4-/CD8- as well
as B220+.

TSH test
Serum was collected from 10 week old mice and analyzed for TSH levels by ELISA
following manufacturer’s instructions (Thyroid Stimulating Hormone Kit, Cloud-Clone
Corp., ABIN415519)

ChIP:PCR
ChIP:PCR was performed as previously described (Snyder et al. 2013). Adult lung
epithelial cells were isolated from a single cell suspension using an EpCAM antibody
(eBioscience, 17-5791-82) in conjunction with anti-APC microbeads (Miltenyi Biotec,
130-090-855) and LS columns (Miltenyi Biotec, 130-042-401). These cells were
sonicated using a Bioruptor for 8 minutes (30 seconds ON, 30 seconds off) and Nkx2.1bound DNA was purified using an Nkx2.1 antibody (Millipore, 07-601) and the MAGnify
ChIP kit following manufacturer’s instructions. Q-PCR was performed on the isolated
samples using primers listed on Table 3.4 and normalize to samples isolated using a
Rabbit IgG antibody. The mouse genome (mm9, human hg19) was scanned for the
occurrence of Nkx2-1 motifs using the FIMO program from the MEME suite (Grant et al.
2011).
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Sample Preparation for Mass Spectrometry
The MLE12 cell line was obtained from ATCC (Manassas, VA) and cultured in the
HITES medium (Ham’s F12 (Mediatech, Manassas, VA), insulin 0.005mg/mL, transferrin
0.01 mg/mL, transferrin 0.01 mg/mL, sodium selenite 30 nM, hydrocortisone 10 nM,
beta-estradiol 10 nM, HEPES 10 mM, and L-glutamine 2 mM) + 2% FBS + 1%
penicillin/streptomycin. One week before collection half of the MLE12 cells were
switched to SILAC media containing labeled Lysine and Arginine. RNA-pulldown assay
was performed as previously described (Tsai et al. 2010). Proteins were pulled down
using either biotinylated NANCI or biotinylated IRES-GFP-Puro mRNA, a processed
transcript of similar length to NANCI. In each of three experiments, one transcript was
used to pull down proteins from SILAC-labeled nuclear extract and the alternate
transcript was used to pull down proteins from unlabeled nuclear extract. To avoid
protein enrichment due to the SILAC labeling, I alternated which transcript was used to
pull down from the SILAC labeled nuclear extract. The eluted samples were run in a
12% Bis-Tris gel (Life Technologies) and proteins resolved were visualized by Silver
staining. The entire lanes were then excised, diced into 1mm3 pieces taking precautions
against keratin contamination and were alternatively washed in water followed by
100mM NaHCO3 and dehydration in acetonitrile. The samples were reduced using 5mM
dithiothreitol (Sigma) at 55°C and alkylated by 14mM iodoacetamide (Sigma) at room
temperature in the dark. This was followed by in-gel digestion using 1:100 ratio of
sequencing grade modified trypsin (Promega, Madison, WI) to protein ratio overnight at
37°C. These peptides were extracted in the solution outside the gel pieces. These were
subsequently de-salted using C18 reversed phase cartridges (Sep-Pak, Waters) and
dried to remove organic solvents. The dried peptides were resuspended in 0.1 % acetic
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acid for LC-MS/MS analysis and loaded onto an Easy-nLC system (Thermo Fisher
Scientific, San Jose, CA, USA), coupled online with an Orbitrap Elite mass spectrometer
(Thermo Scientific). Paired SILAC-labeled and unlabeled samples were combined
loaded on a pulled-tip fused silica column with a 100 µm inner diameter packed in-house
with 12 cm of 3µm C18 resin (Reprosil-Pur C18-AQ using solvents, 0.1% formic acid in
water (solvent A) and 0.1% formic acid in acetonitrile (solvent B). A gradient of 95
minutes was set for peptide elution from 2-35% buffer B. The mass spectrometer were
operated in positive ion mode and in the data dependent mode with dynamic exclusion
enabled (repeat count: 1, exclusion duration: 0.5 min). Full MS scan (m/z 350 to 1650)
was collected at a resolution of 60,000 at an AGC target value of 1x106. MS2 scans of
the most intense peptide ions was performed using CAD (normalized collision energy =
35%, isolation width = 2 m/z) at an AGC target value of 1x104 or HCD (normalized
collision energy = 36%, isolation width = 2 m/z, resolution = 15,000) at an AGC target
value of 5x104 . Ions with a charge state of one and a rejection list of common
contaminant ions (exclusion width = 10 ppm) were excluded from the analysis.

Proteomics data analysis
MS data were analyzed using Proteome Discoverer 1.4 (Thermo Scientific) for protein
identification/quantification. Mouse UniProt database was used for Mascot searches for
assigning peptide sequences and identification of proteins. The search was performed
for precursor ion mass tolerance of 10 ppm, fragment ion mass tolerance of 0.6 Da,
trypsin digestion and two missed cleavages. Dynamic modifications set were
carbamidomethylation of cysteine, and oxidation of methionine. Common contaminants
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such as keratin and trypsin were eliminated and only peptides with an FDR<1% were
considered.

Western blot
The mass spectrometry results were verified by western blot analysis of proteins isolated
using NANCI, NANCI anti-sense, and IRES-GFP-Puro transcripts. Antibodies were used
to test the enrichment of Hnrnpab (rabbit, Sigma Aldrich, 1:100), Hnrnpa2b1 (mouse,
Santa-Cruz, 1:200), and Hnrnpd (rabbit, Millipore, 1:1000).

In Vitro Lentiviral shRNA Knockdown
Lentiviral work was performed as previously described (Herriges et al. 2014) with the
exception that shRNA oligos (Table 3.6) were annealed into the pLKO.1-Neo vector
generously provided by the Winslow Lab. MLE12 cells cultured for 6 days in media
containing 50 ug/ml Geneticin, to select for infected cells, before collecting and isolating
total RNA.

Pulmonary and thyroid histology
Postnatal lungs were inflated with 2% paraformaldehyde under constant pressure of
25cm (P4) or 30 cm (4 weeks, 10 weeks, or 6 months) water and allowed to fix
overnight.

E18.5 lungs and dissected thyroids were fixed overnight in 2%

paraformaldehyde. Tissue was embedded in paraffin and sectioned. Hematoxylin and
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eosin staining was performed to examine tissue morphology. In situ hybridization was
performed as previously described (Herriges et al, 2014). Immunohistochemistry was
used to detect protein expression using the following antibodies on paraffin sections:
Cleaved Caspase 3(rabbit, Biocare, 1:25), E-Cadherin (rabbit, Cell Signaling, 1:100),
F4/80 (rat, Biolegend, 1:50), GFP (goat, Abcam, 1:100), Hnf4a (goat, SantaCruz, 1:40),
Ki67 (rabbit, Abcam, 1:50), Krt5 (rabbit, Covance, 1:1500), Muc5ac (mouse, Abcam,
1:100), Nkx2.1 (rabbit, Santa Cruz, 1:50), Pgp9.5 (mouse, RDI, 1:100), Pdpn (mouse,
Hybridoma Bank, 1:50), P63 (mouse, Santa Cruz, 1:50), RFP (rabbit, Rockland, 1:250),
Scgb1a1 (goat, Santa Cruz, 1:20), Sftpc (goat, Santa Cruz, 1:50), and Sox9 (rabbit,
Santa Cruz, 1:100).

Forebrain Histology
Embryonic mice were dissected on ice-cold PBS and fixed overnight at 4̊C in RNasefree 4% PFA in 1x PBS. Embryos were then washed two times in 1x PBS and
cryoprotected by immersion through sucrose (15 and 30% sucrose in 1x PBS; solutions
were changed once embryos had sunk). Afterwards they were embedded in freezing
compound and sectioned coronally at 12 um on a cryostat (Leica) and collected onto
slides (Superfrost slides; Fisher Scientific, Fair Lawn, NJ). After allowing the sections to
dry for 30 minutes, brain sections were pre-incubated for one hour in blocking buffer (5%
bovine serum albumin with 0.1% Triton-X-100). Sections were then incubated overnight
at 4̊C with the following primary antibodies: mouse Nkx2.1 (mouse, Abcam, 1:200), RFP
(rabbit, Rockland, 1:1000).
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Statistical Analysis
Statistical analysis was performed on the data using Prism 7. Two-tailed student t-test
was used for comparison of two experimental groups. Statistical data was considered
significant if P < 0.05.
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Table 3.1. Mouse downstream sense TF-associated lncRNAs.

lncRNA Ensemblid
ENSMUSG00000006462
ENSMUSG000000503342
ENSMUSG00000051008
ENSMUSG00000055972
ENSMUSG00000056771
ENSMUSG00000072982
ENSMUSG00000079603
ENSMUSG00000085427
ENSMUSG00000085525
ENSMUSG00000085545
ENSMUSG00000085743
ENSMUSG00000085950
ENSMUSG00000086130
ENSMUSG00000086141
ENSMUSG00000086519
ENSMUSG00000086887
ENSMUSG00000086975
ENSMUSG00000087220
ENSMUSG00000087513
ENSMUSG00000087648
ENSMUSG00000092576
ENSMUSG00000093594
ENSMUSG00000093771
ENSMUSG00000094002
ENSMUSG00000095369
ENSMUSG00000096941
ENSMUSG00000096975
ENSMUSG00000097039
ENSMUSG00000097065
ENSMUSG00000097087
ENSMUSG00000097122
ENSMUSG00000097246

Associated
TF Name
Cebpb
Mef2c
Srebf1
Bach1
Tead4
Zfp354a
Gata3
Sp3
Zfp600
Lhx3
Meis1
Lhx2
Zfp534
Foxa2
Ttf1
Sox5
Bcl11b
Foxq1
Zfp980
Adnp
Obox6
Zfp933
Nfxl1
Sox11
Litaf
Twist2
Zfp945
Myc
Zfp217
Irf8
Rex2
Relb

ENSMUSG00000097266
ENSMUSG00000097361
ENSMUSG00000097393
ENSMUSG00000097454

Fosb
Neurog1
Zfhx3
Elk4

Distance
between
genes
(bp)
760
54302
83860
50730
23666
12289
259236
122711
53075
8535
7663
54270
2649
2675
1011
177138
126363
3774
58489
26474
7427
13147
16198
173632
44479
141024
28957
47613
37973
123513
75485
3924

lncRNA Ensemblid
ENSMUSG00000097483
ENSMUSG00000097633
ENSMUSG00000097712
ENSMUSG00000097879
ENSMUSG00000098053
ENSMUSG00000098659
ENSMUSG00000099957
ENSMUSG00000100119
ENSMUSG00000100198
ENSMUSG00000100253
ENSMUSG00000100341
ENSMUSG00000100354
ENSMUSG00000100430
ENSMUSG00000100538
ENSMUSG00000102052
ENSMUSG00000102408
ENSMUSG00000102777
ENSMUSG00000103043
ENSMUSG00000103108
ENSMUSG00000103283
ENSMUSG00000103413
ENSMUSG00000104529
ENSMUSG00000104861
ENSMUSG00000108113
ENSMUSG00000108434
ENSMUSG00000108621
ENSMUSG00000109091
ENSMUSG00000109364
ENSMUSG00000109459
ENSMUSG00000109957
ENSMUSG00000110304
ENSMUSG00000110821

1927
6566
113593
4194

ENSMUSG00000110834
ENSMUSG00000110929
ENSMUSG00000111058
ENSMUSG00000111078
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Associated
TF Name
Zfp640
Zfp219
Smad7
Zfp931
Pdx1
Hnf4g
En1
Emx2
Myrfl
Hes6
Zic4
Ikzf2
Tshz1
Tfap2b
Pax3
Tbx19
Batf3
Zbtb18
Nrf1
Zfp729a
Pbx3
Rbak
Foxg1
Zim1
Zfp536
Zfp619
Arnt2
Nr2f2
Zxdb
Zfpm1
Irx3
Hmg20a
2010315B0
3Rik
Sox14
Smad6
Prdm1

Distance
between
genes
(bp)
151247
17249
118711
38960
4873
1139507
13749
27780
47369
5455
15127
37427
903768
4150
128892
45928
23713
16615
19436
2446
60014
6436
2792
8902
151036
3983
13360
4249
1213
1921
4278
42970
9666
15794
15956
12854

Table 3.2. Proteins enriched in NANCI pulldown.

Protein

Enrichment
(NANCI/Control)

Average of biological triplicates
Unique
Coverage (%)
Peptides

Hnrnpa2b1

26.79590627

44.85666667

14.33333333

26.15743563

Hnrnpa1

19.66187671

35.12

11.33333333

18.10851525

Hnrnpa3

18.29597726

34.12333333

11.33333333

16.77301708

Hnrnpd

12.29665657

17.98666667

5

8.110516941

Cpsf2

11.73224101

5.843333333

4

15.29694165

Fip1l1

10.4803819

13.31

4.666666667

7.507309066

Hnrnpab

10.28538272

23.27666667

5.333333333

3.215671606

Hnrnpa0

8.534377206

13.00666667

3

6.808525976

Syncrip

7.441130536

22.31

11.33333333

1.988431812

Hnrnpr

7.278811766

20.67666667

11.33333333

1.132265442

6.80829836

6.19

6

0.435017981

Skiv2l2

6.506552632

12.66

10.66666667

1.275821663

Khdrbs1

6.377945304

8.203333333

3

5.905848634

Myef2

5.454586745

6.68

3

4.649694068

Wdr33

5.01726592

4.26

5

3.783690894

Hnrnpm

3.654257552

22.08333333

13

1.682202127

Dhx9

3.132474129

22.37333333

26.66666667

2.563036343

Sf3a1

2.790971634

9.693333333

5.666666667

0.793932017

Ddx27

2.769434557

2.72

1.666666667

1.79441774

Ilf2

2.726481146

30

7.666666667

1.116342463

Snrnp70

2.539140985

16.44333333

7

1.487063115

Ilf3

2.302177706

22.42666667

17

1.313848777

Vim

2.188881356

21.03

9

0.903050916

2.02161603

19.31333333

3

0.517912843

2.003926274

23.21333333

4

0.468569706

Pabpc1

1.95745962

8.28

5.333333333

0.222961394

Gtpbp4

1.83163258

5.996666667

3.333333333

0.092200964

Rpn1

1.790122807

2.026666667

1

0.730691352

Rpl9

1.744151805

15.45

2

0.364928653

Thoc4

1.74394875

37.38333333

6.333333333

0.542127773

Rps11

1.658140994

17.67333333

4.333333333

0.195296788

Nxf1

1.649534346

8.626666667

4.666666667

0.307953135

Rpl11

1.580751905

12.92

2

0.159977791

Rpl17

1.545133206

23.19

3.666666667

0.19199112

1.52733136

4.89

1

0.224194632

Myh9

1.497093944

24.45333333

40.66666667

0.147991043

Myl6

1.494592826

33.99333333

4.666666667

0.213168101

Rpl23

1.493539705

28.80666667

3

0.345062806

U2af1

1.44147518

5.44

1

0.027339661

Rps4x

1.440583496

40.81

11.33333333

0.111729725

Rps9

1.402494194

36.08666667

9.666666667

0.134070349

U2af2

1.39301865

14.73666667

4

0.117876146

Tpm1

1.373993681

12.92666667

3

0.050243088

Acta1

1.282793569

28.38333333

9.666666667

0.042876571

Safb

Rpl10
2500003M10Rik

Snrpb2
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StdDev of
Enrichment

Table 3.3. ChIP Q-PCR primers.
Primer
set
Hnf4a-1
NANCI-1
Sftpb-1
Csf2-1
Csf2-2
Csf2-3
Csf2-4
Spp1-1
Spp1-2
Spp1-3
Spp1-4
Spp1-5
Spp1-6

Forward primer
TGTCCACCTTGGT
GAGACTTGG
CCGCTTTGGGATG
CTAAACA
TCAAGAGCCAGGA
AGGAAGCT
GAACTACCTGAGTT
GTGGAATCT
GCCTTTGGGCAAG
CTCTA
CTCAGGACCTTAG
CCTTTCTC
GGGCCTCCAGGCA
TATT
GATGCTCTTCCGG
GATTCTAAA
ATGCTTTGTGTGTG
TTTCCTTT
GACTGTCTGGACC
AGCATTTA
GATGAGAGGTGGA
GAGGTAGAA
CTCATGGTAGTTC
GTTGCTTTAAT
GATGCTCTTCCGG
GATTCTAAA

Reverse primer
TTGGTTTCTGAC
TGACACCTGGG
CCGTGTAAACA
CGAGGACTTTC
CCCAGGCTTCT
CAATCCTCTACT
CCAGTTCTTGG
AAGGGCTTAT
GAAGGTGGCTG
GAAAGAGAA
GGAGTTCTGTG
GTCACCATTA
AGGTGCTATGG
AAGCAAGAG
AGGAAACACAC
ACAAAGCATTAC
GGAGTGATGTG
TCATGAGGTT
GCAAACCCAAG
CAAGGATG
ATCACCACCAA
GTCACCAATAA
GTCTGGAGTCT
CAGAGCTTATG
AGGAAACACAC
ACAAAGCATTAC
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Target site (mm9)
chr2:163,372,594163,372,759
chr12:57,630,46857,630,574
chr6:72,254,23872,254,300
chr11:54,063,22854,063,344
chr11:54,063,53554,063,611
chr11:54,063,11754,063,215
chr11:54,063,43154,063,521
chr5:104,863,890104,863,981
chr5:104,863,959104,864,076
chr5:104,864,093104,864,175
chr5:104,865,224104,865,326
chr5:104,865,069104,865,174
chr5:104,863,890104,863,981

Result shown
in figures

Enrichment
over IgG

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

No

No

No

No

No

No

No

Yes

No

No

No

No

No

Table 3.4. Q-PCR primers.

Q-PCR primers (Pulmonary)
Gene Name

Forward Primer

Reverse Primer

Abca3
Anxa8

TTCATCACCTGATGGCGGTGAAC
GGGTCTGGGTTGAAATGAGA

ACGCATGATGGCTTTGTCTACAGC
ATCTCCCTGGGAAAAGCAG

Csf2

CCGTAGACCCTGCTCGAATA

TGCCTGTCACATTGAATGAA

Ctse

GCTGACTTTCGGAGGCTATG

GAGAGAGGTCCCTGTGTCCA

Foxj1

AGTGGATCACGGACAACTTCTGCT

TTCTCCCGAGGCACTTTGATGAAG

Gapdh

TGCACCACCAACTGCTTAGC
AAGCTGACCCTGAAGTTCATCTGC

GGCATGGACTGTGGTCATGAG

Hnrnpa2b1

GCTGTCCTCGTAGCTTGACC
TTTCAAAGCTTAAGCCACCA

TTAAGAAGTGCTTCCGGGCT
GTCTTTCTCATCTCGCTCGG

Hnrnpab

CGAGCGGGAACCAGAAC

AGAGAATAAACCCAAACCCTCTT

Hnrnpd

TCCTATCACAGGGCGATCAA

AGGATCAATGACTTTCCCATTCA

Krt5

ACTTGGTGTCCAGGACCTTGTTCT

Lgals4

GACCCTCAACAACAAGTTTGCCTCCT
GGAGGGTTGTACCCAGGACT

Lgr5

TGTGTCAAAGCATTTCCAGC

CAGCGTCTTCACCTCCTACC

Muc5ac

AGCTTGATGGCCTAGTTGTT

TTCAGGTAGCCATTGCTGAG

NANCI

CCTCAATCTGCATCTCAACCT

TGGGACTACCGCCATATCT

Nkx2.1

CGCCTTACCAGGACACCAT

GCCCATGAAGCGGGAGA

Pdpn

AGGTACAGGAGACGGCATGGT

CCAGAGGTGCCTTGCCAGTA

P63
RFP

ATGTGTCCTTCCAGCAGTCAAGCA
CACTACCTGGTGGAGTTCAAG

CTTGATCTGGATGGGGCATGTCTTC
GATGGTGTAGTCCTCGTTGTG

Safb

GCTGAAGAAGCGGAACCT

TCCCACCTTCATCTTCAATGG

Scgb1a1
Sftpa

ATACCCTCCCACAAGAGACCAGGATA
ACTCCCATTGTTTGCAGAATC

ACACAGGGCAGTGACAAGGCTTTA
AAGGGAGAGCCTGGAGAAAG

Sftpb

GAACTGTGTAGCGCTCAGCC

CTCTGATCAAGCGGGTTCAA

Sftpc

AGCAAAGAGGTCCTGATGGAGAGT

CACAACCACGATGAGAAGGCGTTT

Sox9

AGACCAGTACCCGCATCTGCACAA	
  

TCTCTTCTCGCTCTCGTTCAGCA	
  

Spp1

TGGCTATAGGATCTGGGTGC

ATTTGCTTTTGCCTGTTTGG

Vsig1

GCCAGCAGACAGTGGAATTTA

AAAGGGCTTGGAAGGTTTGA

GFP
Hnf4a

CTTGTAGTTGCCGTCGTCCTTGAA

CAGTCCATCAACTTCCTCGG

Q-PCR Taqman primers (Forebrain)
Nkx2.1
NANCI
GAPDH

Mm00447558
CCTCAATCTGCATCTCAACCT

TGGGACTACCGCCATATCT
Mm99999915_gl
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Table 3.5. Flow cytometry antibodies.
Antigen	
   Dilution	
   Company	
  

Catalog/Clone	
  Number	
  

Ly6c	
  

1:150	
  

HK1.4	
  

Ly6g	
  

1:100	
  

BioLegend	
  
BD	
  
Pharmingen	
  

CD45	
  

1:100	
  

BioLegend	
  

30-‐F11	
  

CD8	
  

1:200	
  

eBioscience	
  

53-‐6.7	
  

B220	
  

1:200	
  

eBioscience	
  

RA3-‐6B2	
  

CD44	
  

1:400	
  

IM7	
  

CD11b	
  

1:200	
  

BioLegend	
  
BD	
  
Pharmingen	
  

NK1.1	
  

1:200	
  

BioLegend	
  

PK136	
  

CD11c	
  

1:150	
  

eBioscience	
  

N418	
  

CD4	
  

1:200	
  

BioLegend	
  

RM4-‐4	
  

CD3	
  

1:300	
  

BioLegend	
  

145-‐2C11	
  

1A8	
  

M1/70	
  

Table 3.6. shRNA target sequences.
Gene

Target sequence

Hnrnpab

GGTTGTTGACTGTACAATAAA

Hnrnpa2b1

GCTGTTTGTTGGTGGAATTAA

Hnrnpd

AGCTACAAACCATACTAAATT
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Figure 3.1. NANCI is expressed in a subset of Nkx2.1+ pulmonary epithelial
cells.
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Figure 3.1. NANCI is expressed in a subset of Nkx2.1+ pulmonary epithelial cells.
(A) Schematic of NANCIcreERT2:RFP allele. (B) Comparison of NANCI-RFP and Nkx2.1
expression during development. (C) Expression of NANCI-RFP and Nkx2.1 at E18.5
showing that some Nkx2.1+ cells do not express NANCI as noted by arrowheads. (D)
Expression of NANCI-RFP and Nkx2.1 in the adult lung showing that some Nkx2.1+
cells do not express NANCI as noted by arrowheads. (E) AT2 (Sftpc+) and secretory
(Scgb1a1+) cells are enriched in the FACS isolated RFP-High adult pulmonary epithelial
cells, while ciliated (Foxj1+) and AT1 (Pdpn+) cells are restricted in the RFP-Med and
RFP-Low population. (F) The FACS data are confirmed by IHC using the cell lineage
specific markers Sftpc (AT2), Scgb1a1 (Secretory), and Foxj1 (ciliated) with
representative lineage marker positive (yellow arrow) and lineage marker negative (white
arrowhead) cells displaying different levels of NANCI-RFP. (G) In contrast if cells are
sorted by Nkx2.1-GFP, all four cell types are detectable in the GFP-High population. (H)
These results are confirmed by IHC comparing representative lineage marker positive
(yellow arrow) and lineage marker negative (white arrowhead), which have similar levels
of Nkx2.1. Scale bars=100 µm (B) 25µm (C,D,F,H). For E and G mean ± s.e.m. were
derived from n=6 and n=3 biological replicates respectively (* p<0.05, ** p<0.01, ***
p<0.001, **** p<0.0001, n.s. p>0.05; two-tailed Student’s t-test).
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Figure 3.2. NANCI and Nkx2.1 expression in the mouse brain.
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Figure 3.2. NANCI and Nkx2.1 expression in the mouse brain. (A) Diagram of NANCI
construct insertion site showing that this region is not enriched in the enhancer mark
H3K4me1 nor DNase hypersensitivity marks. (B) NANCI-RFP and Nkx2.1 have highly
similar expression patterns at E12.5 and E18.5. (C) Analysis of NANCI and Nkx2.1
expression in NANCI and Nkx2.1 mutant brains suggests that NANCI and Nkx2.1 form a
buffering loop, similar to their function in the lung epithelium. Cx = Cortex, MGE = Medial
ganglionic eminence, Peoptic area = PoA, GP = Glubus pallidus, Hy = Hypothalamus.
Scale bars=300µm (E12.5), 250µm (E18.5). E12.5 image is a composite of multiple
images of the same section. For C box-and-whisker plots for E12.5 and E18.5 were
derived from n=(9,4,4,3,4) and n=(4,6,4,4,4) biological replicates, respectively (* p<0.05,
** p<0.01, *** p<0.001, **** p<0.0001, n.s. p>0.05; two-tailed Student’s t-test).
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Figure 3.3. NANCI and Nkx2.1 expression in the mouse thyroid.
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Figure 3.3. NANCI and Nkx2.1 expression in the mouse thyroid. (A) As in the lung, in
the thyroid NANCI expression is limited to a subset of Nkx2.1+ epithelial cells (white
arrowheads indicate Nkx2.1+/NANCI-RFP- cells). (B) At 10 weeks and 6 months of age
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ thyroid morphological defects are similar to those seen in
Nkx2.1GFP/+ thyroids. (C) Likewise both Nkx2.1GFP/+ mice and NANCIcreERT2:RFP/
+

:Nkx2.1GFP/+ mice show similarly increased levels of TSH, suggesting hypothyroidism.

Scale bars=50µm (A), 500 µm (B). For C mean ± s.e.m. were derived from n=(11,4,6,8)
biological replicates (** p<0.01, n.s. p>0.05; two-tailed Student’s t-test).
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Figure

3.4.

NANCI-RFP

reporter

accurately

expression.
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reflects

variability

in

NANCI

Figure

3.4.

NANCI-RFP

reporter

accurately

reflects

variability

in

NANCI

expression. Adult lung epithelial cells from (A and B) NANCIcreERT2:RFP/+ and (C and D)
Nkx2.1GFP/+ mice were sorted based on RFP and GFP expression, respectively. Analysis
of the resulting populations by Q-PCR suggests that RFP and GFP expression
accurately reflect variability in NANCI and Nkx2.1, respectively. IHC comparing (E)
NANCI-RFP or (F) Nkx2.1 levels between AT1 (Pdpn+) and Neuroendocrine (Pgp9.5+)
cells (yellow arrows) and neighboring lineage marker negative epithelial cells (white
arrowheads). Scale bars=25µm. For B and D mean ± s.e.m. were derived from n=6 and
n=3 biological replicates respectively (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001,
n.s. p>0.05; two-tailed Student’s t-test).
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Figure 3.5. NANCI and Nkx2.1 form a lncRNA-TF duplex that buffers Nkx2.1
expression.
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Figure 3.5 NANCI and Nkx2.1 form a lncRNA-TF duplex that buffers Nkx2.1
expression. (A) NANCIcreERT2:RFP/ creERT2:RFP mice have reduced expression of NANCI and
Nkx2.1 at E18.5 and 10 weeks of age. (B) In contrast, Nkx2.1GFP/+ mice have increased
NANCI expression, indicating that Nkx2.1 inhibits NANCI. Thus NANCI and Nkx2.1 form
a negative feedback loop that buffers Nkx2.1 expression. (C) Increased expression of
RFP and GFP in 6 month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (D) These data
suggest, a model in which NANCI acts in cis to regulate Nkx2.1 expression. (E) Spatial
classification of lncRNA-TF based on genomic orientation of the lncRNA and TF
identifies other duplexes with the lncRNA located downstream of the TF, similar to the of
NANCI-Nkx2.1 duplex. (F and G) Knockdown of Hnrnpab and Hnrnpd, but not
Hnrnpa2b1, results in increased expression of NANCI and Nkx2.1, suggesting that
Hnrnpab and Hnrnpd inhibit NANCI stability. For A box-and-whisker plots for E18.5 and
10 weeks were derived from n=(5,6) and n=(5,5) biological replicates, respectively. For B
and C box-and-whisker plots for E18.5, 10 weeks, and 6 months were derived from
n=(5,11,7,5), n=(6,9,5,8), and n=(9,5,8,8) biological replicates, respectively. For F mean
± s.e.m. were derived from n=(6,6,5,6) biological replicates (* p<0.05, ** p<0.01, ***
p<0.001, **** p<0.0001; two-tailed Student’s t-test).
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Figure 3.6. Characterization of NANCIcreERT2:RFP/creERT2:RFP mice.
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Figure

3.6.

Characterization

of

NANCIcreERT2:RFP/creERT2:RFP

mice.

(A)

NANCIcreERT2:RFP/creERT2:RFP mice have reduced expression of Nkx2.1 target genes, but not
Foxj1 or Pdpn at E18.5. By 10 weeks of age expression of these genes have
normalized. (B) In situ hybridization using a probe for NANCI verifies that
NANCIcreERT2:RFP/creERT2:RFP lungs do not express detectable levels of NANCI. (C) Despite
reduced expression of Nkx2.1, NANCIcreERT2:RFP/creERT2:RFP lungs do not have major
morphological defects at E18.5 or 10 weeks of age, similar to Nkx2.1GFP/+ lungs. Scale
bars=500µm (B), 200µm (C). For A box-and-whisker plots for E18.5 and 10 weeks were
derived from n=(5,6) and n=(5,5) biological replicates, respectively (* p<0.05, ** p<0.01,
n.s. p>0.05; two-tailed Student’s t-test).
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Figure 3.7. Factors regulating NANCI expression.
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Figure 3.7. Factors regulating NANCI expression. (A) The promoter of NANCI
contains a predicted Nkx2.1 binding site and (B) Nkx2.1 ChIP:PCR indicates that Nkx2.1
binds to this site, suggesting it directly inhibits NANCI expression (Hnf4a=negative
control, Sftpb=positive control). (C) Mass Spectrometry identified 44 proteins that were
consistently enriched in NANCI pulldown relative to control. The heatmap shows the
average of three different pulldowns. (D) Interactions between NANCI and Hnrnpab,
Hnrnpd, and Hnrnpa2b1 were verified by Western blot. The right panel shows the intact
nature of the RNA transcripts used in the pulldown and mass spectrometry experiments.
(E) Knockdown efficiency for shRNAs targeting these four proteins. Data for the controls
(Hnf4a and Sftpb) in Fig. 3.7B is the same as in Fig. 3.9H. For B mean ± s.e.m. were
derived from n=3 biological replicates. For E mean ± s.e.m. for Hnrnpab, Hnrnpd, and
Hnrnpa2b1 were derived from n=(6,6), n=(6,5), and n=(6,6), respectively (* p<0.05, **
p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test).
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Figure 3.8. Disruption of the NANCI-Nkx2.1 buffering loop leads to persistent
developmental delay.
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Figure 3.8. Disruption of the NANCI-Nkx2.1 buffering loop leads to persistent
developmental delay. (A) At E18.5 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice have a mild
morphological defect in the developing alveolar space as noted by thickened septae in
HE stained tissue. (B) IHC for cell type specific markers showing reduced expression of
secretory (Scgb1a1) and AT2 cell (Sftpc) markers. (C) At E18.5, both Nkx2.1GFP/+ and
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice exhibit decreased expression of several cell type
specific markers and ectopic expression of the posterior endoderm marker Hnf4a. (D) By
P4, only NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice exhibit significant alveolar simplification in
HE stained tissue. (E) IHC for cell type specific markers showing reduced expression of
secretory (Scgb1a1) and AT2 cell (Sftpc) markers at P4. (F) At P4 only
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs reduced expression of the pulmonary cell type
markers and ectopic expression of Hnf4a. In contrast, Nkx2.1GFP/+ mice have largely
normalized development. Scale bars=200µm (A,D), 25µm (B,E). For C and F box-andwhisker plots were derived from n=(5,11,7,5) and n=(6,5,7,5) biological replicates,
respectively (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test).
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Figure 3.9. Severe perinatal immune response in P4 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+
mice.
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Figure 3.9. Severe perinatal immune response in P4 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+
mice. (A) A subset of NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice display a localized and severe
innate immune response at P4. (B) Flow analysis indicates that these mice have an
increased infiltration of neutrophils, but not monocytes, B-cells, or helper-T-cells. (C)
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs have defects in epithelial barrier integrity as well as
E-Cadherin+ cells in the airway lumen (white arrowheads and yellow arrows
respectively). (D) Comparison of NANCIcreERT2:RFP/+:Nkx2.1GFP/+ and wild-type mice by
RNA-seq indicates that the former have increased expression of genes involved in the
mitotic cell cycle, but decreased expression of immune response genes. (E)
NANCIcreERT2:RFP/

+

:Nkx2.1GFP/+

lungs

express

lower

levels

of

Csf2.

(F)

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs express higher levels of Spp1, (G) Diagram of
Nkx2.1-enriched ChIP targets for Csf2 and Sftpb, with promoter region defined on
H3K4me3 marks from Encode Project Mouse Lung tracks. (H) Nkx2.1 binds to the
promoter of Csf2, but not Spp1. Data for the controls (Hnf4a and Sftpb) in I is the same
as in Fig. 3.7B. Scale bars=50µm (A), 25µm (C). For B and H mean ± s.e.m. were
derived from n=3 biological replicates. For E and F, E18.5 and P4 box-and-whisker plots
were derived from n=(5,11,7,5) and n=(6,5,7,5), respectively (* p<0.05, ** p<0.01, ***
p<0.001; two-tailed Student’s t-test).
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NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice.
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four
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NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice. (A) Unlike E18.5 and P4, at four weeks of age,
Nkx2.1 expression is not significantly different between Nkx2.1GFP/+ mice and
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. This is not accompanied by increased expression of
NANCI, suggesting a NANCI-independent mechanism is responsible for increased
expression of Nkx2.1 at this time. This normalization of Nkx2.1 is accompanied by
normalization of (B) lung morphology and (C) lung epithelial gene expression. Scale
bars=200µm. For A and C, P4 and 4 week box-and-whisker plots were derived from
n=(6,5,7,5) and n=(10,13,9,8), respectively (* p<0.05, ** p<0.01, *** p<0.001, n.s.
p>0.05; two-tailed Student’s t-test).
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Figure 3.11. Disruption of NANCI-Nkx2.1 duplex buffering loop leads to failure of
pulmonary homeostasis.
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Figure 3.11. Disruption of NANCI-Nkx2.1 duplex buffering loop leads to failure of
pulmonary homeostasis. (A) At 10 weeks of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice
exhibit airway inflammation (HE staining, top row) as well as basal (p63 and Krt5 IHC,
second row) and mucous cell metaplasia (Muc5ac IHC, third row). These mice also
show signs of alveolar simplification and bronchiolization of the alveoli (HE staining, forth
row). (B) Bronchiolized cells in the distal lungs of NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice at
10 weeks are primarily Sox2+/Scgb1a1+. (C and D) These do not express Pdpn or
Foxj1. (E and F) A small subset of these cells are Sox2+/Sftpc+ or Scgb1a1+/Sftpc+
(white arrowheads). (G) Q-PCR for lineage markers confirms a reduction in secretory
(Scgb1a1) and AT1 (Pdpn) cells, but an increase in Hnf4a+ cells. Scale bars=200µm
(A), 25µm (B-F). For G box-and-whisker plots were derived from n=(6,9,5,8) (* p<0.05, **
p<0.01, *** p<0.001; two-tailed Student’s t-test).
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Figure 3.12. Progressive pulmonary degeneration and lineage reprogramming in 6
month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice.
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Figure 3.12. Progressive pulmonary degeneration and lineage reprogramming in 6
month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (A) Principle component analysis of
RNA-seq data from lung epithelial cells of 6 month old wild-type, Nkx2.1GFP/+, and
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (B) GO analysis of these samples indicates that
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice have upregulation of of genes involved in digestion
and innate immune response but decreased expression of genes involved in epithelial
and respiratory morphogenesis. (C) By 6 months, inflammation around the large airways
has receded, leaving behind fibrous tissue (HE staining, top row). The airway epithelium
has reduced expression of the secretory cell marker Scgb1a1 but expanded expression
of basal (p63 and Krt5) and goblet (Muc5ac) cell markers. Normal alveolar architecture
is highly disrupted in NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice (HE staining, bottom row). (DG) The distal bronchiolized epithelium also includes (D) ciliated cells, (E and F) basal
cells and (G) Sox9+/Hnf4a+ cells. (H) Q-PCR for hindgut markers. Scale bars=200µm
(C), 25µm (D-G). For H box-and-whisker plots were derived from n=(8,3,5,5) biological
replicates (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test).
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NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs.
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NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs. At six months of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+
lungs have (A) decreased expression of lung epithelial markers and (B) increased
expression of goblet cell markers. (C) At six months of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+
mice contain a large number of apoptotic cells as indicated by high levels of cleaved
caspase-3. (D and E) At this time the airways are also filled with F4/80+ macrophages.
(F) Scgb1a1+ cells in the bronchiolized epithelium proliferate in response to the ongoing
injury, (G) while the remaining Sftpc+ AT2 cells are largely non-proliferative. (H) Cell
type specific proliferation in NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs is quantified. Scale
bars=50µm. For A and B box-and-whisker plots were derived from n=(8,3,5,5) biological
replicates. For H mean ± s.e.m. were derived from n=5 biological replicates (* p<0.05, **
p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test).
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Figure
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Three

stages

of

NANCICreERT2:RFP/+:Nkx2.1GFP/+ mice.
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NANCICreERT2:RFP/+:Nkx2.1GFP/+ mice.
In this paper I see three phenotypic stages in the NANCICreERT2:RFP/ +:Nkx2.1GFP/+ mice, all
of which are dependent on Nkx2.1 expression. First persistent Nkx2.1 deficiency leads
to a perinatal developmental delay and ectopic expression of Hnf4a leading to an innate
immune response (Stage I). Over the next 4 weeks, Nkx2.1 expression is upregulated
inducing a normalization of development (Stage II). Finally, in the adult lung, persistent
Nkx2.1 deficiency leads to degeneration of pulmonary epithelial lineages and a
resurgence of a hindgut transcriptional program (Stage III).
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CHAPTER 4: Conclusions and Future Directions

4.1 Summary
In recent years numerous labs have identified lncRNAs capable of regulating gene
transcription and other complex biological processes. However, the importance of
lncRNAs in vivo, especially within the contexts of lung development and homeostasis, is
still poorly understood. In this dissertation, I have determined that lncRNAs are enriched
near transcription factor (TF) loci and provided a detailed characterization of the
expression and function of the novel lncRNA NANCI. This work establishes a new
paradigm in which TF-associated lncRNAs act as rheostats to buffer their neighboring
TF. Furthermore, this work has identified a novel regulator of the transcription factor
Nkx2.1, which is critical for the maintenance of lung identity during development and
homeostasis.

In Chapter 2, I used RNA-seq to identify lncRNAs expressed in the embryonic and adult
mouse lung. Surprisingly, I saw lncRNAs located near TF loci critical to pulmonary
development including Nkx2.1, Gata6, Foxa2, and Foxf1. Further analysis revealed that
lncRNAs are enriched near TF-coding genes in both the mouse and human genomes. I
then proceeded to characterize the distinct expression patterns of seven lncRNAs.
Those lncRNAs associated with TFs all had expression patterns highly similar to that of
their neighboring TF, suggesting a regulatory relationship between these paired genes.
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To test this hypothesis I used shRNAs to suppress expression of NANCI in human and
mouse lung epithelial cell lines. In both cases, reduced expression of NANCI was
associated with decreased expression of Nkx2.1 and known Nkx2.1 target genes.
Likewise, shRNA-mediated suppression of NANCI in E17.5 mice phenocopied Nkx2.1
haploinsufficiency. Together, this suggests that NANCI has a conserved function of
promoting Nkx2.1 expression.

In Chapter 3 I employed multiple mouse models, molecular, and proteomic techniques to
further characterize the regulatory relationship between NANCI and Nkx2.1 during
pulmonary development and homeostasis. These results verified my previous findings
that NANCI promotes Nkx2.1 expression at the transcriptional level. Furthermore, I
determined that Nkx2.1 directly represses NANCI transcription, indicating that NANCI
and Nkx2.1 create a negative feedback loop. In Nkx2.1 heterozygotes this buffering loop
leads to increased expression of NANCI, which is sufficient to normalize Nkx2.1
expression and lung function. However, concurrent in trans mutations of NANCI and
Nkx2.1 disrupt the feedback loop between these genes causing persistent Nkx2.1
deficiency. This in turn leads to a defective innate immune response in the perinatal lung
and progressive degeneration and reprogramming of the adult lung epithelium.

These results provide important insight into both the function of TF-associated lncRNAs
as well as the regulation of pulmonary development and homeostasis. In this chapter I
will explore several areas of future research based on these findings. I will first focus on
further elucidating the mechanism through which NANCI regulates Nkx2.1. Next I will
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describe a screen to determine whether similar lncRNA-TF feedback loops exist for
other lncRNA-TF duplexes. Finally, I will discuss experiments to characterize the role of
Nkx2.1 during adult lung epithelial homeostasis and regeneration.

4.2 How does NANCI regulate Nkx2.1 expression?
In this dissertation I have demonstrated that NANCI acts in cis to regulate Nkx2.1 at the
transcriptional level; however, the exact mechanism of this regulation is still unclear.
Datum from chapter 2 suggest that Wdr5 may be bound by NANCI and recruited to the
Nkx2.1 promoter (Fig. 2.18). Wdr5 is a component of the Trithorax complex, which
promotes gene expression through inducing H3K4me3 at gene promoters. However, in
chapter 3 the unbiased pulldown of proteins interacting with NANCI did not identify Wdr5
or any other known components of the Trithorax complex (Table 3.2). This discrepancy
may be due to use of crosslinking in experiments described in chapter 2, but not chapter
3. Recent work on lncRNAs, including Xist, suggests a “hit-and-run” model, where the
lncRNA may dissociate from the chromatin-modifying complex after the initial lncRNAdependent genomic localization (Sunwoo et al. 2015). These brief interactions would
likely not be detected by the experiments performed in chapter 3.

In order to detect the more ephemeral NANCI-protein interactions like those suggested
by the “hit-and-run” model, I would need to use pulldown techniques that incorporate
crosslinking. In recent years two new methods have been designed that would address
this issue: comprehensive identification of RNA binding proteins by mass spectrometry
(ChIRP-MS) and RNA antisense purification-mass spectrometry (RAP-MS) (Chu et al.
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2015; McHugh et al. 2015). These techniques both involve crosslinking endogenous
RNA-protein complexes and then extracting complexes using biotinylated DNA probes
complementary to the RNA of interest. RNA-bound proteins are then identified by mass
spectrometry and verified by western blots as described in chapter 3. Despite some
technical differences these techniques have identified similar binding partners for the
lncRNA Xist, and either could be used to identify NANCI-bound proteins (Chu et al.
2015; McHugh et al. 2015). I could then suppress the NANCI-bound proteins in vitro by
shRNA approaches to determines if they affect Nkx2.1 expression. If any NANCI-bound
proteins are transcription factors or chromatin modifying complexes, it would also be
important to see if loss of NANCI affects protein localization and regulation at the Nkx2.1
promoter. To do this we would use ChIP-PCR to compare protein binding and histone
marks in wild type and NANCIcreERT2/creERT2 E18.5 lung epithelial cells. To determine if
NANCI itself binds the Nkx2.1 promoter directly or indirectly, I can use the techniques
RAP and ChIRP (Chromatin Isolation by RNA Purification) (Chu et al. 2011; Engreitz et
al. 2015). These variants of RAP-MS and ChIRP-MS use similar pulldown methods
followed by sequencing to characterize lncRNA-bound genomic loci, instead of lncRNAbound proteins. Thus I could identify both proteins and genomic regions necessary for
NANCI-mediated regulation of Nkx2.1.

Previous work has established that lncRNAs contain distinct domains that are
responsible for binding to their interacting proteins. This is exemplified by Hotair, which
contains a 5’ domain that binds PRC2 as well as a 3’ domain that binds the
LSD1/CoREST/RET complex (Tsai et al. 2010). To identify similar domains within
NANCI I would employ CRISPRs to generate homozygous deletions of transcribed
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domains within the NANCI locus in a mouse lung epithelial cell line (MLE12s). I would
first delete 75bp and 280bp long conserved regions in the first and last exon of NANCI,
respectively. These are the only regions of conserved sequence or exon structure
between mouse and human, suggesting that they may be important for NANCI’s
conserved function. To identify functional domains I would determine if loss of these
domains affects Nkx2.1 expression or the ability of NANCI to bind to the proteins and
genomic regions identified above. If deletion of these domains does not affect NANCI
function, then I will generate a series of deletions tiling the entire NANCI transcript.
Altogether, these studies would provide important insight into the components and
mechanisms critical for NANCI-mediated regulation of Nkx2.1 expression. This work
would also provide a more detailed frame of reference for studying other TF-associated
lncRNAs.

4.3 Do other lncRNAs act as rheostats that buffer the expression of neighboring
TFs?
The results presented in both chapters 2 and 3 identified lncRNAs associated with other
TFs critical to development and homeostasis. Like NANCI, lncRNAs associated with
Foxf1, Foxa2, and Gata6 are expressed in regions that express their neighboring TF,
suggesting regulatory relationships within these lncRNA-TF duplexes. Ongoing work
within the Morrisey and Swarr labs has determined that the lncRNA FALCOR (Foxa2
Associated Long nonCOding RNA), which is located downstream and sense to the TF
Foxa2, promotes expression of Foxa2 (Swarr et al., in preparation). Furthermore, Foxa2
binds the FALCOR promoter and represses FALCOR expression, indicating that the
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FALCOR-Foxa2 duplex forms a buffering loop similar to the one seen in the NANCINkx2.1 duplex.

Although FALCOR and NANCI are both downstream of their neighboring TFs, the
majority of previously studied TF-associated lncRNAs, including Fendrr and HOTTIP,
are upstream and antisense to their neighboring TF (Wang et al. 2011; Sauvageau et al.
2013). These divergent lncRNAs often share a promoter region with their neighboring TF
and it is unknown whether they perform buffering functions like NANCI and FALCOR.
Ablation of the lncRNA Fendrr in mice phenocopies haploinsufficieny of its divergent TF
Foxf1, suggesting that Fendrr may regulate Foxf1 expression (Sauvageau et al. 2013).
However, it is still unclear whether Fendrr and Foxf1 regulate one another’s expression.
The lncRNA HOTTIP promotes expression of Hoxa13 and other Hoxa genes through
recruitment of WDR5/MLL, but none of these genes have been shown to regulate
expression of HOTTIP (Wang et al. 2011).

To identify other lncRNAs that buffer expression of neighboring TFs I would start with a
series of filters to select lncRNAs of interest. First I would select those mouse lncRNAs
with human orthologs, as the presence of an orthologous lncRNA suggests a conserved
biological function. While I would initially prioritize lncRNAs expressed in the lung, online
databases such as ENCODE could be used to help identify tissues and cell lines
expressing lncRNAs not found in the lung (Rosenbloom et al. 2013). I would then verify
these findings and compare lncRNA and TF expression using in situ hybridization and
Q-PCR. Those lncRNA-TF pairs with correlated expression would be prioritized, as this
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suggests a potential regulatory relationship between the two factors. Finally, I would
ensure that lncRNAs being screened include lncRNAs downstream of their neighboring
TF, like NANCI, as well as divergent lncRNAs, like Fendrr, in order to determine if both
orientations are capable of buffering neighboring TFs.

To determine if a lncRNA regulates its neighboring TF, CRISPR/Cas9 strategies would
be used to delete the promoter and first exon of the lncRNA in a mouse cell line that
expresses that lncRNA. We would then use Q-PCR to measure expression of the
neighboring TF. These experiments would need to be verified using shRNA-mediated
suppression of the lncRNA to clarify that the lncRNA, not an overlapping regulatory
element, is the functional unit. CRISPRs would then be used to eliminate expression of
the TFs regulated by lncRNAs to determine whether these TFs in turn regulate lncRNA
expression. Finally, CRISPRs targeting lncRNAs of interest can be used to generate null
mouse lines. Using techniques similar to those described in chapter 3, we would then
compare the affects of disrupting expression of the lncRNA, TF, or both in vivo. Together
this will identify other lncRNAs capable of acting as rheostats for neighboring TFs and
provide important insight into the regulation of critical TFs throughout the body.
Furthermore, through comparison of these lncRNA-TF duplexes I could identify common
genomic organizations or lncRNA motifs, making it easier to identify other lncRNA
rheostats in the future.	
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4.4 What is the role of Nkx2.1 in the adult pulmonary epithelium?
Even though Nkx2.1 has been shown to play major roles during lung development, little
is known about its role in the adult lung. Recent work demonstrated that complete loss of
Nkx2.1 in the adult murine lung leads to rapid respiratory failure, suggesting that Nkx2.1
is critical for pulmonary homeostasis (Kusakabe et al. 2006; Butt et al. 2008; Snyder et
al. 2013). However, the scope of Nkx2.1 regulatory activity in the adult lung is still
unclear. Nkx2.1’s role in pulmonary regeneration is likewise poorly characterized. As
described in chapter 1, mature lung epithelial cells can proliferate and differentiate in
response to injury to maintain lung function (Rawlins et al. 2009; Barkauskas et al.
2013). While Nkx2.1 has been shown to promote proliferation and differentiation during
development, there is no evidence that it plays a similar role during regeneration (Tagne
et al. 2012). The following sections will cover experiments using mouse models to
explore the role of Nkx2.1 in mature adult lung epithelial cells during homeostasis and
regeneration

4.5 Is Nkx2.1 necessary for maintenance and regeneration of the alveolar
epithelium?
In response to alveolar injury AEC2s have been shown to proliferate and differentiate to
replace damaged epithelial tissue and prevent further degeneration (Barkauskas et al.
2013). This is exemplified by regeneration following influenza infection, a well-studied
pulmonary injury model that directly injures the lung epithelium leading to diffuse alveolar
damage

(Short

et

al.

2014).

As

described

in

chapter

3,

adult

NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice also exhibit a progressive degeneration of the distal
alveolar epithelium. Surprisingly, we saw minimal AEC2 proliferation in these mice
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despite significant damage to the alveolar epithelium (Fig. 3.13). This is consistent with
the pro-proliferative function of Nkx2.1; however, the effects seem to be specific to
AEC2s since neighboring CC10+ bronchiolized alveolar cells were proliferative
(Yamaguchi et al. 2013).

Recent work in the Morrisey lab has identified a subset of AEC2s, known as AEP
(alveolar epithelial progenitor) cells, that are responsible for the majority of alveolar
regeneration following influenza injury (Zacharias et al., in preparation). These cells were
originally identified based on expression of Axin2, a marker of Wnt responsive cells.
During homeostasis these cells are largely quiescent, but can give rise to a small
number of AEC2s and AEC1s. Following influenza injury, AEP cells become more
proliferative and give rise to the majority of new AEC2s during regeneration as well as
new AEC1s and AEP cells. Comparison of AEPs and general AEC2s by RNA-seq
revealed numerous differences between their gene expression profiles. Most notably,
AEPs in both mice and humans have higher Nkx2.1 expression than general AEC2s
(Zacharias et al., in preparation). Altogether, this suggests that Nkx2.1 may be required
for AEP-dependent regeneration of the alveolar epithelium following injury.

To test whether Nkx2.1 is necessary for AEP function I would investigate how loss of
Nkx2.1 in AEPs affects pulmonary homeostasis and regeneration following influenza
injury. In addition to high levels of Nkx2.1, AEPs uniquely express the surface marker
Tm4sf1 (Zacharias et al., in preparation). The Morrisey lab has recently generated a
mouse line, Tm4sf1-CreERT2, in which a tamoxifen inducible Cre recombinase cDNA is
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inserted downstream of the Tm4sf1 promoter. Existing Rosa-YFP and floxed Nkx2.1
(Nkx2.1fl/fl) lines allow for lineage tracing and Nkx2.1 ablation in Cre expressing cells,
respectively.

Thus

I

could

generate

Tm4sf1creERT2/+;RosaYFP/+

and

Tm4sf1creERT2/+;Nkx2.1fl/fl;RosaYFP/+ mice, allowing for lineage tracing of AEPs in the
presence or absence of Nkx2.1. To study these AEPs during homeostasis, adult mice (8
weeks) of both genotypes would be given sufficient tamoxifen to label the majority of
AEPS and then dissected at 3 or 6 months of age. To analyze AEPs during
regeneration, mice will be given tamoxifen at 8 weeks and infected with influenza virus
one week later. These animals would be dissected 14 or 28 days after injury, when the
lung epithelium normally regenerates. Pulmonary tissue will then be analyzed for defects
in morphology, cell composition, proliferation, and gene expression using histological
analysis and Q-PCR. If Hnf4a+ or CC10+ epithelial lineages are seen in the alveoli of
Tm4sf1creERT2/+;Nkx2.1fl/fl;RosaYFP/+ mice, this would suggest that the bronchiolization of
the alveoli seen in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice is in part due to defective AEPs
(Fig. 3.12). Histological analysis of the lineage tracer YFP in combination with markers of
proliferation and cell lineages will also be used to assess if loss of Nkx2.1 affects the
ability of AEPs to proliferate and differentiate.

To determine how loss of Nkx2.1 affects AEPs on a transcriptional level I will analyze
gene expression in AEPs in the presence or absence of Nkx2.1. Fluorescence-activated
cell sorting (FACS) with a Tm4sf1 antibody will be employed to isolate AEPs from
Tm4sf1creERT2/+ and Tm4sf1creERT2/+;Nkx2.1fl/fl mice one week after tamoxifen treatment.
Similar samples could also be harvested during alveolar regeneration to determine how
loss of Nkx2.1 affects transcription during regeneration. To determine which genes
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Nkx2.1 directly targets, I would perform Nkx2.1 ChIP-seq on isolated wild type AEPs
from uninfected mice as well as mice recovering from influenza injury. Altogether, these
experiments will help determine the role of Nkx2.1 in AEPs during homeostasis and
regeneration.

To further elucidate the importance of Nkx2.1 in the adult alveolar epithelium we could
use Sftpc-CreERT2 and Hopx-CreERT2 lines to delete Nkx2.1 in the AEC2 and AEC1
lineages, respectively (Rock et al. 2011; Takeda et al. 2011). These lines could be used
in experiments similar to those described above for the Tm4sf1-CreERT2 line. Given the
role of Nkx2.1 in promoting expression of Sftpa, Sftpb, and Sftpc in AEC2s, loss of
Nkx2.1 in these cells will likely result in severe injury to the lung (Boggaram 2009). The
role of Nkx2.1 in AEC1s on the other hand is harder to predict. While some AEC1 cells
do express Nkx2.1, in general they seem to express Nkx2.1 at lower levels than the
other pulmonary epithelial lineages (Fig. 3.1 and 3.4). Furthermore, if AEC1 function is
reduced in response to loss of Nkx2.1, unaffected AEC2s may proliferate and
differentiate to form replacement AEC1s that express Nkx2.1, diminishing any overall
phenotype (Barkauskas et al. 2013). Altogether these experiments would help establish
the importance of Nkx2.1 in maintenance and regeneration of the adult alveolar
epithelium.
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4.6 What role does Nkx2.1 play in maintenance and regeneration of the adult
airway epithelium?
Data presented in chapter 3 suggests that Nkx2.1 may also play an important role in
maintaining the airway epithelium. The airways of NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice
exhibited a progressive loss of secretory cell lineages, variable inflammation, and
expansion of both goblet and basal cell lineages (Fig. 3.11 and 3.13). These results are
consistent with previous work indicating that Nkx2.1 promotes expression of Scgb1a1, a
marker of mature secretory cells (Boggaram 2009). Furthermore, overexpression of
Nkx2.1 inhibits inflammation and mucous cell metaplasia within adult airways (Maeda et
al. 2011). Together this suggests Nkx2.1 is critical for maintaining normal cellular
composition of the lung airways.

Similar to experiments described in the previous section, lineage specific Cre expressing
mice could be used to analyze the role of Nkx2.1 in secretory (Scgb1a1-CreERT),
ciliated (Foxj1-CreERT2), and basal cells (p63-CreERT2) (Rawlins et al. 2007; Rawlins
et al. 2009; Lee et al. 2014). However, secretory and basal cells can each give rise to all
three of these cell types following injury to the airway epithelium (Rawlins et al. 2009;
Tata et al. 2013). Thus, ablating Nkx2.1 in any one lineage may have minimal affect as
the other lineages can differentiate to produce unaltered cells of the affected lineage.
Therefore, in order to fully understand the role of Nkx2.1 in the proximal airway it will
also be important to ablate Nkx2.1 in all airway lineages using a Sox2-CreERT2 line
(Arnold et al. 2011). Regardless of which Cre line is used, mice would be given
tamoxifen at 8 weeks of age and then dissected at 3 or 6 months of age to determine the
role of Nkx2.1 during airway homeostasis. To analyze the role of Nkx2.1 following airway
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injury I would use naphthalene, an aromatic hydrocarbon that specifically induces airway
epithelial cell necrosis leading to denuded airways and infection (Karagiannis et al.
2012). For these studies mice will be given tamoxifen at 8 weeks of age, injured one
week later, and dissected 14 or 28 days after injury. Samples would be analyzed using
methods similar to those described in the previous section. These experiments would
help determine if Nkx2.1 has a specific role in maintenance and regeneration of the
airway epithelium.

4.7 Closing Remarks
In this dissertation I have characterized the critical role NANCI plays in regulating Nkx2.1
expression and lung identity during pulmonary development and homeostasis. This work
provides new insights into the regulation of Nkx2.1 and the in vivo function of
transcription factor-associated lncRNAs. The future experiments proposed in this
chapter will build on this work by providing significant advances in our understanding of
both lncRNA biology and the regulation of adult lung homeostasis.
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